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Abstract 
Single-stranded, positive-sense icosahedral viruses are major pathogens in 
every kingdom of life. Despite this, their capsid assembly and uncoating 
mechanisms remain poorly understood. This work describes these processes in 
two model systems; satellite tobacco necrosis virus and turnip crinkle virus. For 
satellite tobacco necrosis virus, several aptamers were previously raised 
against the coat protein, where each aptamer folded into stem-loops displaying 
the motif AXXA. Aptamer B3 contained the strongest sequence similarity to the 
cognate genome, including a 10/10 contiguous stretch. Capsid assembly using 
the purified coat protein shows that RNA is critical for capsid assembly, and that 
stem-loops displaying the motif AXXA can efficiently trigger this process. There 
is a clear preference for this loop motif, which is unaffected by the sequence of 
the base paired stem. The structure of the B3-encapsidated virus-like particle 
has been solved by X-ray crystallography to 2.3 Å, together with a lower 
resolution map encompassing the RNA. The presence of B3 results in an 
extension of the N-terminal helices by roughly one and a half turns, such that 
residues 8-11 that are disordered in all previous X-ray structures are now 
visualised, including R8 and K9. The binding of B3 facilitates charge 
neutralisation and trimer formation in the coat protein, resulting in the assembly 
of a T=1 capsid. This assembly mechanism is consistent with additional 
assembly studies using longer RNAs, in which the first step in assembly is 
genomic compaction. This compaction event is driven by multiple binding 
events of coat proteins with packaging signals in the form of stem-loops 
displaying the preferred loop sequence.  
 
v 
 
In turnip crinkle virus, a putative disassembly mechanism has been suggested. 
Expansion and proteolysis mediates extrusion of the viral genome, such that the 
formation of “striposomes”, which are thought to be polysomal arrays of 
ribosomes on extruding RNA, can be visualised by TEM. Purification of 
proteolysed capsids revealed that the cleaved coat proteins become dissociated 
and the remaining protein shells lose their icosahedral symmetry, often 
appearing to begin release of RNA from unique sites in the absence of 
ribosomes. These results explain why coat proteins are essential for wild-type 
infections because they facilitate a ribosome-mediated uncoating mechanism 
avoiding host RNA silencing. The results in this thesis suggest new paradigms 
for capsid assembly and uncoating, which may be exploited by other members 
of the same family of viruses, especially those having similar coat protein folds.  
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1. Structure and function of ssRNA icosahedral viruses 
Single-stranded positive-sense RNA viruses are organised infectious agents 
and obligate intracellular parasites which infect host organisms from every 
kingdom of life1. They do not encode their own replication machinery within their 
genome, so therefore rely on their host for viral progeny production, often to the 
detriment of their host. At their simplest, they are composed of one molecule of 
nucleic acid and multiple protein subunits arranged into a protective container. It 
is this protective container which helps keep the genome intact and transports 
the genome between host organisms.  
 
Virus research has been at the vanguard of molecular biology for some time. 
Many of the tools of molecular biology (such as restriction enzymes2) and basic 
understanding of host cell biochemistry have been gained from virus research. 
Underpinning the relevance virus research has to the fields of molecular biology 
and medical biochemistry are the technologies of phage display3, heterologous 
gene expression4, targeted drug delivery5 and vaccine development6, to name 
but a few. Virus assembly and disassembly are events in the virus life cycle 
where their understanding should greatly contribute to the elucidation of new 
drug targets against viruses. In addition, the self-assembling properties of 
viruses are of great interest in the fields of bionanotechnology7. 
 
This thesis aims to increase the understanding of the processes of virus 
assembly and disassembly in two virus model systems: Satellite Tobacco 
Necrosis Virus (STNV) and Turnip Crinkle Virus (TCV). These are model 
systems for the family of positive sense, single stranded ((+) ss) RNA 
icosahedral viruses. 
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1.1 Model systems for (+) ssRNA virus research 
According to the International Committee on the Taxonomy of Viruses (ICTV), 
ssRNA icosahedral viruses represent ~15% of the viruses in the biosphere8. Of 
these viruses, several are responsible for the diseased states of animals and 
humans such as the common cold, gastroenteritis, hepatitis, polio, foot and 
mouth disease, yellow fever and rubella. Pathogenic viruses represent a serious 
health hazard to any researcher investigating them. This potential hazard can 
be removed by working with viruses and virus-like particles that are similar in 
characteristics but are non-infectious to humans. Detailed information 
concerning (+) ssRNA icosahedral viruses that infect plants and bacteria has 
been ascertained, on their structures, life cycles and virus 
assembly/disassembly characteristics. However, much of this research has 
been directed towards the protein capsid, neglecting the many roles of the RNA 
genome. To this end, these viruses represent ideal model systems for further 
study. 
 
1.2 Virus structure 
Viruses differ vastly in architecture and size, ranging from filamentous or rod 
shaped to spherical, and may be enveloped or non-enveloped. The largest virus 
known is called Megavirus chilensis (or just Megavirus)9, which has a total 
diameter of ~680 nm. The smallest virus isolated to date is satellite tobacco 
mosaic virus (STMV) with a diameter of 16-17 nm. The vast difference in sizes 
between these two viruses also translates to their complexities (see Figure 1.1 
and Table 1.1). Megavirus is composed of a multitude of different proteins, 
contains hundreds of surface ‘hairs’, and has the largest known genome of all 
viruses (>1.2Mbp) which encodes seven aminoacyl-tRNA synthetases9. STMV, 
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by contrast, has a genome size of 1058 nt which encodes just one protein; that 
of its capsid protein10. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Electron micrographs illustrating the size difference between 
Megavirus and STMV.  
The scale bar (300 nm) is shown on the far right to emphasise the differences in 
size.  
 
 
Despite these striking differences, all viruses do share common features, such 
as a protecting shell known as the capsid, a nucleic acid genome, and their 
inability to replicate away from their hosts. An exhaustive review of the 
differences in virus structure is not relevant here. Instead, the overall principles 
of virus structure will be discussed, the methods used to characterise these 
structures, and the symmetry of icosahedral viruses. 
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Table 1.1: Differences between viruses at the opposite ends of their 
complexities 
 
1.2.1 Principles of virus structure 
The principles of virus structure have arisen from the requirements of the virus 
imposed on them from their evolutionary constraints. What are these 
requirements? The first and simplest of these is the general formation of a shell 
which encompasses the genome with protective functionality as it passes from 
host-to-host. The second is one of simple economics: the information which 
codes for the capsid must not exceed the information present within the 
genome. The third is that they must encode strategies for entry and exit from 
their host. The final requirement is that of the principles of protein folding, 
conformational switching and thermodynamics. Viruses must encode all the 
information necessary for a variety of complex tasks. These include packaging 
their genomes, strategies for entry and uncoating, presenting their genome to 
the host’s replication machinery, and also to allow the virus to exit the host cell 
to infect another. The progress made on the elucidation of virus structure in 
atomic detail now allows us a tantalising glimpse of intrinsic similarities across 
 Megavirus chilensis  STMV 
Capsid diameter (nm)  440  16-17 
Genome size  1,259,157 bp  1058 nt 
Total genes  ~1120 proteins  One protein 
Complexity  Contains several 
hundred surface spikes; 
codes for 7 aminoacyl-
tRNA synthetases; 
contains two lipid 
membranes; contains 
genes for sugar, fatty 
acid and protein 
synthesis 
 
 
Has no additional 
features 
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various families of viruses. In the next subsection, the methods of how viruses 
are characterised will be discussed as well as the language needed to describe 
them.  
 
1.2.2 How virus structure is studied 
Electron microscopy is easily the most efficient way of determining the general 
morphology of a virus particle. However, the coarseness of staining methods 
used limits the resolution which can be observed. Negative staining of viruses 
with uranyl acetate, potassium phosphotungstate or other related electron 
dense compounds embeds the virus particles. The electron beam destroys the 
particle itself, but the stain leaves a ‘cast’ around the virus particle. If the particle 
is fully covered by stain, that is, on both the upper and lower surfaces of the 
particle, then contrast of the finer details can be difficult to distinguish11. 
 
In addition to negative stain, viruses can be preserved by rapidly freezing in 
liquid nitrogen or helium. This permits the visualisation of electron scattering 
directly from the structures in the particles themselves and not just from the cast 
created from a negative stain. Furthermore, quantitative methods for image 
analysis have been applied to this method. This technique is called cryo-
electron microscopy (cryo-EM)12. An advantage of using cryo-EM is that regular 
images can be selected from a field of heterogeneous particles and aligned to 
produce an image reconstruction of a virus particle. Image reconstructions are 
possible by the averaging of hundreds or thousands of particles that are all 
uniform. Below is a gallery of different virus structures solved by cryo-EM which 
illustrates the diversity of icosahedral virus structures.  
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Figure 1.2: A gallery of image reconstructions of icosahedral virus 
particles by cryo-EM. Images illustrate the variety of sizes and features of 
viruses, even though the particles are highly regular. The particles are labelled; 
Herpes simplex virus is nucleocapsid only. An image of an immunoglobulin has 
been included for scaling. Scale bar = 50 nm. Figure taken from Field’s 
Virology, 200613. 
 
When particles of an asymmetric nature are viewed, cryo-EM cannot be 
employed to generate an image reconstruction using icosahedral averaging. 
Instead, a tomographic tilt series of images can be processed to generate an 
image. Tomographic reconstructions generally do not provide high resolution 
information due to electron damage occurring whilst generating the data14; 15.  
 
Information obtained from electron microscopy methods are generally not 
comparable to atomic resolution (~5-20 Å). Higher resolution images can be 
achieved by X-ray crystallography, if purified crystals of the virus particles can 
be prepared. Virologists have been purifying crystals of viruses for the analysis 
by X-rays since the 1930’s. The first virus structure to be elucidated was 
Tobacco Mosaic Virus (TMV), where the crystal structure showed that it was 
composed from multiple subunits of a repeating monomeric protein16. These 
data sets, as well as others, led to Watson and Crick hypothesizing that most 
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simple viruses are composed of one or a few identical protein subunits17. X-ray 
crystallography has since been used to characterise a large number of different 
viruses, revealing both similarity and differences in architectures and size 
between different viruses. Addressed in the next subsection are the similarities 
in symmetry and the nomenclature used to address this symmetry. 
 
1.2.3 Symmetry in viruses 
The simplest type of shell is one that is composed of multiple identical subunits 
which can assemble spontaneously. The observation of self-assembly was first 
elucidated with in vitro assembly of TMV18. This led Crick and Watson to 
hypothesize that the structures of viruses would be highly symmetrical17. The 
arguments that contribute towards this hypothesis are simple: Genetic efficiency 
i.e. multiple identical subunits coming together to form a well defined shape; 
and in vitro assembly from these identical subunits resulting in particles of a 
defined size. Together, these observations suggested that the interactions 
between subunits are specific and well ordered. In general, identical subunits 
with specific interactions produce symmetrical objects.  
 
But what exactly is meant by symmetry in this context? The precise definition of 
symmetry being discussed here involves an operation, such as rotation, which 
brings the object of study into view on another plane. For example, if the ‘three-
legs of man’ (the national symbol for the Isle of Man, shown in Figure 1.3) was 
rotated 120° or 240°, it would not be possible to distinguish one leg from 
another. The full symmetry of an object is dependent on a full collection of 
symmetries applying to it. In the case of virus capsids, these operations can be 
rotations, translations or combinations of both. A symmetry axis with a 180° 
8 
 
rotation is called a two-fold symmetry axis; three 120° rotations are called a 
three-fold symmetry axis; and five rotations of 108° are called five-fold 
symmetry axes. The distinction between shape and symmetry is that a shape 
describes the geometry of its outline, whereas symmetry describes the 
rotational operations of the shape. For example, a triangle and the three-legs of 
man have the same symmetries but are of course completely different shapes 
(see Figure 1.3).  
 
Figure 1.3: Three-fold symmetry 
The three-legs of man and an equilateral triangle both share three-fold 
symmetry. 
 
Closed shells that are composed of identical subunits which interact specifically 
and which are roughly spherical in shape can only have one of five geometries: 
the cube, the tetrahedron, octahedron, dodecahedron or the icosahedron. Of 
these geometries, the icosahedron is the most efficient of the designs for 
spherical virus architecture, i.e. they contain the largest number of subunits to 
make a container of a given size, and thus require the minimum coding genetic 
capacity. With these observations, it is not surprising that the extensive use of 
the icosahedron in virus architecture is seen in nature.  
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1.2.4 Icosahedral symmetry 
The icosahedrons, shown in Figure 1.4, look down the five-fold, three-fold and 
two-fold symmetry axes, respectively. Placement of an asymmetric object on 
one face of the icosahedron leads to the generation of 59 others. One such unit, 
one sixtieth of the entire shell, can therefore be described as an icosahedral 
asymmetric unit. In other words, the asymmetric unit is the fundamental jigsaw 
piece used to construct an icosahedron.  
 
 
 
 
 
 
 
 
 
Figure 1.4: Icosahedral symmetry 
Looking down the symmetry axes of an icosahedron. The star represents the 
five-fold axis, the triangle represents the three-fold axis and the ellipse 
represents the two-fold axis. 
 
 
The asymmetric unit, in the context of building a capsid, is the coat protein. In 
the simplest icosahedral viruses, such as the plant satellite viruses, the capsid 
is composed of 60 identical coat proteins which form capsids of a perfect 
icosahedron. But what about larger icosahedral viruses observed in nature? X-
ray crystallography confirmed that these viruses adhered to icosahedral 
symmetry but were not necessarily composed of just 60 subunits. In order to 
explain this phenomenon, Caspar and Klug defined the theory of quasi-
equivalence19. They predicted that capsids could be composed of an ever 
increasing number of subunits and that these subunits could adopt similar yet 
distinct conformations. The protein contacts between each of the subunits need 
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not be identical so larger capsids can be made by increasing the number of 
identical proteins in the capsid adhering to icosahedral symmetry. Caspar and 
Klug defined the icosahedral organisation of capsids with more than 60 protein 
subunits by the triangulation number, T. T is defined by the equation: T = h2 + 
hk + k2  where h and k are integers, which define the position of the five fold 
axes relative to one another on the surface of a lattice (see Figure 1.5)19; 20. 
Hexamers are generally considered to be planar, whereas pentamers are 
considered convexed, propagating curvature into the hexagonal lattice when 
they are inserted. The formation of an icosahedron is generated by inserting 12 
pentamers into relevant positions on the hexagonal lattice. The theory of quasi-
equivalence has since become a paradigm for predicting virus structure20. 
 
1.2.5 Structure of icosahedral viruses 
The first icosahedral virus structure to be elucidated at atomic resolution was 
Tomato Bushy Stunt Virus (TBSV)21. This structure adhered to Caspar and 
Klug’s theory of quasi-equivalence, producing a capsid of T=3 icosahedral 
symmetry with 180 copies of identical coat protein subunits arranged in three 
different conformations, termed A, B and C. Since then, the structures of a 
multitude of different viruses have been elucidated by X-ray crystallography, 
and also many from cryo-EM, where some of which have revealed similarities in 
virus structures infecting hosts from every kingdom of life.  
 
Historically, protein-protein contacts were thought to be the principle driving 
force behind ssRNA virus assembly supported by the spontaneous generation 
of capsids devoid of any nucleic acid22; 23; 24. Now there appears to be an 
accumulation of evidence which suggests that the RNA genome plays multiple 
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roles in a virus infection and is not just a passenger going along for the ride 
(reviewed in 1). Therefore the next few subsections address these observations, 
beginning with RNA structure in capsa. 
 
 
 
 
Figure 1.5: Geometric principles for generating icosahedral quasi-
equivalent surface lattices.  
(a) Hexagons are considered planar when on a surface lattice (they form a flat 
sheet, as shown above) and pentamers are considered convex, introducing 
curvature into the lattice whenever they are inserted. The icosahedral shell is 
composed of hexamers and pentamers, and is generated by inserting 12 
pentamers into an array of hexamers within defined positions on the surface 
lattice. To construct a model of a particular quasi-equivalent surface lattice, one 
face of the icosahedron is generated in the hexagonal net. The origin of that is 
replaced by a pentamer and the (h,k) hexamer is also replaced by a pentamer. 
The third hexamer replaced with a pentamer is identified by its three-fold 
symmetry. The icosahedral face shown in bold defines a T=3 lattice (h=1, k=1). 
Two alternative equilateral triangles are shown as dotted lines for T=7 lattices, 
where h=2, k=1; or h=1, k=2  
(b) The hexagonal lattice of a T=3 particle from (a) (outlined in blue) and the 
T=3 lattice face coloured blue. The ASU is one third of this face, with the 
icosahedron being composed of 20 of these triangles, as shown.  
 
h
k
(1,1)
(0,0)
2,1 1,2
(a)
(b)
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1.3 Structure of RNA within virions 
Even though techniques for generating high resolution images have improved in 
recent years, the roles of RNA in virus assembly are still poorly understood. 
Underpinning this is that there is no high resolution structure available for the 
complete RNA genome in capsa from any virus. Predominantly, the focus has 
been on how protein-protein interactions, typically of hundreds of subunits, give 
rise to stable virus particles.  The principal reason for this is that experimental 
techniques for determining protein structure have been well characterised, 
whereas information on the nucleic acid component is more difficult to obtain. 
This has created a highly protein-centric viewpoint to virus structure and 
assembly25; 26. 
 
However, as knowledge of specific virus structures have increased over the 
years, the focus has turned to exploring the contribution of the genome during 
virus assembly. There are now several examples of viruses where the 
packaging of a subsection of their genomes can be visualised at high or 
moderate resolution27; 28; 29; 30; 31.  Furthermore, biochemical and genetic 
analyses have given glimpses of specific RNA: protein interactions that are 
required to initiate the assembly process32. The next few subsections will 
therefore place the emphasis on these observations, the structural studies of 
viral RNA genomes and the roles of the genome in virus assembly. 
 
1.3.1 Genome packaging of icosahedral (+) ssRNA viruses  
A significant proportion of all viruses known have icosahedral symmetry with a 
(+) ssRNA genome, and include important human pathogens such as the 
Picornaviridae, the Caliciviridae, Astroviridae, as well as members of the 
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Togaviridae and Flaviviridae families1. Upon infection and production of viral 
progeny, several stages are undertaken. These include the disassembly of the 
nucleocapsid in vivo, replication of their genome, expression of their coat 
protein monomers, and recognition of their replicated genome before self-
assembly. Many factors play a role in specific recognition and packaging of viral 
RNA. These include the sequence and the secondary structure of viral RNA 
which serve as recognition signals and the specific, high affinity interactions that 
the capsid protein has with these recognition signals. Recognition sequences 
and their adopted secondary structure for many viruses have been 
determined33; 34; 35; 36, although the structural domains that are involved in RNA 
binding and packaging remain unclear. Many viral coat proteins contain a run of 
basic residues towards the N- or C-terminus that are believed to be of 
importance in RNA packaging. Furthermore, host cell macromolecular 
complexes are also likely to play a part. 
 
1.3.2 Fundamental problems of visualising packaged RNA in high 
resolution 
 
The amount of RNA that can potentially fit into a capsid is intrinsically governed 
by the amount of space available in the interior of each respective viral capsid.  
The fraction of space the RNA genome takes up varies greatly between 
different (+) ssRNA viruses.  
 
General properties of (+) ssRNA genomes can be observed at a low or medium 
resolution by using techniques such as solution X-ray scattering37, neutron 
diffraction38, Raman spectroscopy39 and Cryo-EM40.  
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Structural studies by X-ray crystallography of viruses often do not reveal 
structural information of the RNA. This is because crystal structures are 
governed by the surface contacts of the protein capsid and these occur 
independently of RNA encapsidation. Furthermore, equivalent icosahedral 
viruses have 60-fold symmetry; each protein subunit exists in an identical 
surface environment, even in the presence of differing orientations of interior 
RNA1. Therefore, a typical virus crystal may not contain an ordered structure of 
the genome.  Moreover, data from RNA structure is often lost due to the 
averaging process in structural determination. Regardless of these fundamental 
problems, there has been progress made due to both advancements in 
technology and to serendipity1.  Examples of such are to be discussed in the 
forthcoming subsections. 
 
1.3.2.1 Bean Pod Mottle Virus 
Bean pod mottle virus (BPMV) is a member of the Comoviridae family, which 
are a group of viruses with icosahedral symmetry. It contains a bipartite (+) 
ssRNA genome and its capsid contains pseudo T=3 quasi-equivalent 
symmetry. The two (+) ssRNA strands, RNA1 and RNA2, differ in size of 6kb 
and 3.5kb, respectively. The protein capsid of BPMV is composed of two lots of 
60 protein subunits; one of the subunits is smaller and contains one jelly roll 
domain whereas the second subunit is larger and contains two jelly roll 
domains.  
BPMV was the first virus particle that when visualised by X-ray crystallography, 
a portion of the packaged genome was identified27. A portion of RNA2 was 
observed that revealed density of six well-ordered ribonucleotides about the 
three-fold axis of the virion (see Figure 1.6). The conformation of these ordered 
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structures approximates that one strand is arranged as an A-form RNA helix 
where the bases are stacked on top of one another. However, because the 
electron density is icosahedrally averaged, the actual structure that the RNA 
adopts is unknown. Under recent scrutiny of the helix structure, it suggests that 
the sequence is non-random and may correspond to residues A-Pu-Py-Py-Py-
X41. This suggests that there may be multiple copies of this consensus 
sequence distributed along the length of RNA2. Analysis by bioinformatics 
suggests that this is the case. Almost 200 sequences appear to fit the 
consensus sequence in RNA2, albeit with no regular spacing or patterning 
between them1. 
The interactions between the RNA and the capsid appear to be mediated by 
contact with residues on the N-terminus of the subunit. These interactions are 
mostly governed by water molecules and include contacts to both bases and 
the sugar phosphate moieties on the RNA molecule. The RNA-capsid 
interactions appear to give order to the first 19 residues on the L subunit, which 
are disordered on capsids lacking RNA41.    
 
Figure 1.6: Cut-away view of STMV, BPMV and PaV capsids give rise to 
icosahedrally ordered RNA genomes. The capsid is represented in grey 
whereas the RNA is in red. Taken from Schneemann et al1. 
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Further to the six well resolved RNA nucleotides on RNA2, five additional 
nucleotides could also be modelled into the electron density, albeit with less 
confidence. With these additional bases, this generates a loop structure of 11 
nucleotides, three of which form a trefoil structure at each of the 20 three-fold 
contacts on the virus particle (see Figure 1.6).  
The total amount of the BPMV genome that can be visualised by X-ray 
crystallography is about 660 nt, which corresponds to about 20% of the 
genome27.  X-ray crystallography of BPMV particles containing just RNA 1 
revealed an identical structural arrangement, thus it may be that the RNA 
trefoils represent an important structural arrangement, where this structure 
initiates the assembly of the virion by acting as specific signals for RNA 
packaging1.  
1.3.2.2 Satellite Tobacco Mosaic Virus 
Satellite tobacco mosaic virus (STMV) has a T=1 icosahedral capsid arranged 
from 60 identical subunits of a 17.5 kDa coat protein. The diameter of the virus 
particle is approximately 16-17 nm and as a result is more restricted in its ability 
to package its (+) ssRNA genome. 
 
The three-dimensional structure of STMV was solved to a high resolution of 1.8 
Å by X-ray crystallography10; 29. The resulting electron density revealed density 
consistent with double helical segments of RNA at the two-fold contacts of the 
virion (see Figure 1.6). Each segment contains nine base pairs, which have 
been modelled as complementary A:U pairings, and an unpaired stacked 
nucleotide at the 3' end. In addition, a nucleotide not part of the segment but in 
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close propinquity was detected. These helical segments of dsRNA lie parallel to 
the 30 edges of the capsid and resemble an A-form RNA conformation1.  
 
The densities of the helical segments detected are strongest towards the two-
fold axis but then weaken towards the three-fold axis of symmetry. This 
suggests that the RNA takes different paths into the interior of the STMV 
particle at these points, and therefore becomes invisible as they no longer 
conform to the icosahedral symmetry of the virus particle.  
 
The double helical segments interact intimately with the interior of the STMV 
capsid. A dimer of STMV subunits supports the RNA, effectively functioning as 
a dsRNA binding protein. These interactions are primarily governed by non-
specific interactions with the ribophosphate moieties of the RNA, with many 
contacts being bridged by water molecules. It is interesting to note that 
unencapsidated STMV RNA has a secondary structure of ‘tRNA-like’ 
conformations at the 3' end governed by around 200 nucleotides42. This 
structure does not seem to be present after encapsidation, suggesting that RNA 
is refolded in the packaging process.  
 
Recently, Schroeder et al used chemical probing and computational modelling 
to generate secondary structure predictions that are consistent with the 
crystallography data43. These results showed all possible hairpins that are 
consistent with the experimental data. From these results, a co-transcriptional 
and assembly hypothesis was generated, where the combinations of hairpins 
that were most consistent with the experimental data were used as the most 
representative structure of the ensemble. Multiple packaging solutions could 
18 
 
provide an evolutionary advantage to viruses; therefore it may be that the RNA 
structure can be found in multiple orientations in capsa. Harvey and co-workers 
have since determined an all-atom model using this data and that of the crystal 
structure as constraints for the model. To date, this is the first all-atom model for 
a complete virus to be elucidated, albeit by using a coarse grained approach 
with the RNA genome a beads-on-a-string model44. 
 
1.3.2.3 Pariacoto Virus 
Pariacoto virus (PaV) is an insect virus in the Nodaviradae family, which is a 
group of viruses with a bipartite (+) ssRNA genome and a T=3 icosahedral 
capsid. The three-dimensional structure of PaV has been solved to a high 
resolution of 3 Å by X-ray crystallography45. From the X-ray crystal structure, a 
dodecahedral cage of duplex RNA can be observed (see Figure 1.6), which 
indicates that the (+) ssRNA bipartite genome is reorganised upon 
encapsidation45; 46. These RNA duplexes contain 24 base paired segments, 
where the ends of the RNA duplexes extend towards the three-fold contacts of 
the virion. The total RNA that can be observed corresponds to approximately 
35% of the total viral genome45. Similarly to STMV, the RNA density is weaker 
towards the three-fold contacts, indicating that RNA duplexes drop into the 
interior at some of these positions.  
 
The coat protein interactions with the duplex RNA are mainly of an electrostatic 
nature, which involve residues from all three quasi-equivalent subunits. 
Although the structure of each subunit is chemically identical, they form different 
contacts in their quasi-equivalent locations (see Figure 1.7)45.   
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Figure 1.7: Schematic representation of the T=3 quasi-equivalent lattice. 
The positions of the icosahedral two-fold (green oval), three-fold (red triangles) 
and five-fold (blue stars) axes are indicated. Subunits A5 to A related by 
icosahedral five-fold symmetry. 
 
 
The interactions are most extensive with the N-terminus of the A subunits, 
which form pentagons at the five-fold axis of symmetry (see Figure 1.8)1. The 
N-terminus of the A subunits extend all the way round the edge of the 
icosahedron, where it inserts itself into the major groove of the duplex RNA45. 
Numerous positively charged amino acids such as arginine and lysine form a 
positively charged surface, which functions to partly neutralise the duplex RNA 
backbone.  
 
A 
B C 
A5 
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Figure 1.8:  (a) Structure of the asymmetric unit of PaV. The ordered duplex 
RNA is represented as a stick model and comprises 24 base pairs modelled as 
A:U.  
(b) Close-up view of ordered duplex RNA and its interaction with side 
chains from the three quasi-equivalent coat protein subunits and their 
two-fold related partners. Most contacts are with amino acid side chains from 
the N terminus of the A subunit. In addition, there are two side chain contacts 
from the B subunit and one side chain contact from the C subunit. Figure taken 
from Schneemann et al1. 
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The mechanism of PaV T=3 viral assembly, like other Nodaviruses, involves the 
duplex RNA to function as a molecular switch45; 47; 48. This molecular switch 
operates at the two-fold contacts between the A subunits, where the N-terminal 
arms force the interacting coat proteins to form a flat contact. However, the 
duplex RNA and the ordered peptide arms are absent at the quasi-twofold 
contacts, allowing these subunits to form bent contacts. This exact alternation 
between bent and flat conformations forms the basis of correct T=3 capsid 
formation. 
 
1.3.3.4 MS2  
MS2 is a bacteriophage that infects E. coli and is part of the Leviviradae family. 
The three-dimensional structure of MS2 was characterised by X-ray 
crystallography and refined to a resolution of 2.8 Å49; 50. The capsid contains 
180 proteins arranged as 90 non-covalent dimers with quasi-equivalent T=3 
icosahedral symmetry. The capsid proteins are arranged as three conformers, 
A, B and C, which arrange into dimers of A/B and C/C, respectively. The main 
conformational difference between the three different subunits is in the FG loop 
(a 15 residue loop in between the F and G β-strands), which mediate either a 
five-fold or quasi six-fold contact  
 
Despite high resolution determination of the MS2 capsid, RNA structure inside 
the MS2 bacteriophage was not seen by X-ray crystallography. To obtain 
information about the RNA component, the lower resolution technique of cryo-
EM was employed40, and refined51. In the refined cryo-EM model, approximately 
90% of the genome was observed (see Figure 1.9).  
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Figure 1.9: The organisation of the MS2 genome visualised by cryo-EM 
A cartoon representation of the MS2 coat protein is shown mapped around the 
density of the RNA which is coloured radially from pale blue to pale red. 
Representations are shown at the 2-fold (a), 3-fold (b) and 5-fold (c) for 
comparison. This figure is taken from Torapova et al. 51. 
 
From this model, the genome is organised into two concentric shells, with 
additional density connecting the two shells in columns of density located at the 
five-fold contacts, where the size of these columns of density are consistent 
with double-stranded RNA. The outermost shell of density resides immediately 
beneath the capsid, forming a network which maps out the RNA binding sites of 
the inner surface of the capsid. Underneath the A/B dimers, extended density is 
observed which protrudes towards the five-fold axes of symmetry and forms a 
ring of continuous density around the five-fold axes. Density contributing to RNA 
is also observed beneath each of the C/C dimers, however this density is 
dissimilar to the density observed in respect to underneath the A/B dimers. 
These observations suggest that RNA interactions between these sets of 
dimers are different, which is consistent with a model of RNA-induced 
conformational switching in MS2 assembly.  
 
This so-called dimer switching model assumes that RNA is organised in the 
capsid to maximise the contacts between the RNA and the 60 A/B CP2 dimers. 
This requires that the RNA contacts the A/B positions once at every position, 
(a) (b) (c) 
2-fold axis 3-fold axis 5-fold axis 
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forming the vertices of the outer polyhedron of density52. The path the RNA can 
take in making these contacts can be modelled mathematically using a 
Hamiltonian path.  In total, there are 40,678 possible combinations this path can 
take which are consistent with the density from the cryo-EM map52. MS2 virions 
also contain 1 copy of maturation (A) protein, which is essential for infection53. 
The A protein is known to bind to specific sequences close to the 5' and 3' ends 
of the RNA molecule, essentially circularising the RNA54. Using this information, 
only a total of 66 Hamiltonian paths in the dimer switching model can be 
realised. Combining this information with data from mass spectrometry55 and 
kinetic modelling56 shows that only 3 of these 66 configurations are 
energetically favourable, with one of these 3 being most favourable 
energetically, and therefore most likely52.   
 
1.3.3 RNA folding in capsa is independent from sequence and length 
Encapsidated RNAs are involved in many secondary structure interactions. 
Whether these interactions are governed by the primary sequence of 
nucleotides or facilitated by other factors is of debate. In vitro folding studies of 
RNA have shown that the polynucleotide chain tends to collapse into a 
collection of many non-native states, often with a significant energy barrier 
between them57. This indicates that RNA is guided into the correct conformation 
by exogenous factors as folding prior to virus assembly would result in many 
non-native RNA conformations, which is not what is observed in virus particles. 
It is most likely that some sort of assistance is required to chaperone the folding 
process, most probably the coat protein. Further evidence of this comes from 
the fact that recombinant PaV viral capsids can encapsidate random sequences 
of RNA instead of their wild-type genome46; 58. A heterologous expression 
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system was used to generate random sequences of differing length and 
subjected to cryo-EM and image reconstruction46; 58. The resulting virus-like 
particles with randomly encapsidated RNAs contain a virtually identical double 
stranded dodecahedral cage structure to that of the wild-type. These results 
suggest it is the coat protein that governs encapsidated RNA structure and 
spontaneous folding does not occur prior to assembly. The sequence and the 
length of the RNA chain do not appear to play a role in RNA structure. Instead, 
the RNA appears to adopt this conformation by being condensed with 
assistance to encapsidation by the PaV coat protein dimers46; 58.  
 
Although virus particles can package random sequences of RNA, it is likely that 
viral RNAs have evolved to be preferentially packaged over non-viral RNAs. 
Evidence for this hypothesis is supported from two studies using another 
Nodavirus, flock house virus (FHV). Firstly, FHV particles containing random 
RNAs have different biophysical properties when compared to wild-type FHV 
particles. An example of this is that ‘particle breathing’ can be observed, which 
is detected by a greater susceptibility to protease digestion59. This is probably 
the result of inefficient protein-RNA contacts which give rise to this decrease in 
structural stability. Secondly, FHV viral coat protein preferentially packages 
genomic RNA over other cellular RNA in competition experiments1. Preference 
is probably governed by three main factors; firstly, there may be a particular 
sequence of RNA that viral coat proteins bind with high affinity. Secondly, the 
sequence of RNA may be optimised with viral RNAs so that the correct 
conformation of RNA can be adopted within the viral capsid. Finally, viral RNA 
has a greater propensity to ‘collapse’ compared to other RNAs when presented 
to their complement coat protein60. These factors, as well as others, probably 
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contribute to whether a virus particle can assemble or not. The next subsection 
discusses virus assembly in general and common characteristics in virus 
assembly, giving specific examples where necessary.  
 
1.3.4 In vitro virus assembly 
The earliest capsid assembly experiments were performed with Tobacco 
Mosaic Virus (TMV), which is the classical rod-shaped RNA virus that appears 
in virology text books. It has a diameter of about 18 nm and is around 300 nm in 
length, composed from ~2130 identical disc-shaped subunits stacked in a helix 
around its 6395 (+) ssRNA genome.   
 
The in vitro self assembly of TMV has been well characterised and consists of 
two separate events: nucleation and elongation. TMV nucleation begins by the 
specific recognition of the central pore of the disk monomer to a stem loop 
structure on the TMV (+) ssRNA genome. This in turn melts the stem loop 
structure, thus more of the ssRNA genome is available for binding. This event 
mediates a change in the conformation of the disk protein to form a protohelix, 
which allows further binding of disk proteins to both the top and the bottom, thus 
completing the nucleation reaction. The resulting nucleated structure then 
allows elongation reactions to occur as the RNA is threaded through the central 
pore until stacking of the 5' end is complete. 
 
The hairpin structure is located ~1 kb towards the 3' of its ssRNA genome and 
its specificity is achieved through a repeated G-x-x motif, which is essential for 
coat protein binding61. After this initial stage, disk proteins interact in an 
unspecific manner, although an apparently preferred guanine residue is placed 
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throughout the genome. The positioning of guanine in this way gives an added 
stability by adding two extra hydrogen bonds per trinucleotide-disk protein 
interaction. Surprisingly, it has been demonstrated that TMV coat protein can 
package any ssRNA as long as the initial RNA stem loop initiation signal is 
present in the sequence. This confirms that further RNA-protein interactions are 
not base specific and not sequence driven. 
 
Figure 1.10: Diagrammatic representation of TMV assembly  
(a) TMV coat protein disk recognises stem loop  
(b) Secondary structure of ssRNA is unwound 
(c) Conformational change in coat protein monomer, completes nucleation 
event to form protohelix structure 
(d) Elongation of the protohelix with more subunits using the genome as a 
template until the genome is completely encompassed. Figure adapted from 
Butler et al. 61 
 
The nucleation event in the example of TMV is not unique to TMV capsid 
assembly, and neither is the ability of viruses to package other heterologous 
RNAs. Several other sequence specific protein: RNA interactions have since 
been identified in the assembly of ssRNA viruses; examples include MS235; 62; 
63; 64; 65, poliovirus66, alphaviruses67, turnip crinkle virus (TCV)33, human 
immunodeficiency virus (HIV-1)68 and flock house virus (FHV)69. These specific 
sequences of RNA are known as packaging signals, and are usually stem loop 
(a) (b) (c) 
(d) 
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structures. In this way, it seems the tools necessary for preferential packaging 
of the genome from a milieu of RNA within the infected cell are provided by both 
the RNA and the coat protein.  
 
In the example of MS2, the packaging signal has been identified as a short 
translational operator of 19 nt arranged as a stem-loop (TR) which 
encompasses the start codon of the replicase gene. This operator has been 
implicated in vitro as having sub-nanomolar affinity for CP2, where in vivo it 
initiates the repression of the replicase cistron by displacing replication 
complexes from the RNA70. The molecular detail of this recognition event has 
been extremely well characterised both biochemically and structurally. The TR-
CP interaction had been accepted as being the sole basis for initiation of RNA-
CP in vivo, but recently it has been observed that there may be multiple RNA 
packaging sequences of lower affinity in the MS2 genome (Dykeman et al, 
submitted). This has implications for how the RNA genome controls capsid 
assembly in a cooperative manner and supports the dimer switching model 
described previously. 
 
Some ssRNA viruses can assemble in vitro into structures resembling that of 
their native capsids without the need for RNA. These observations do not 
invalidate the importance of RNA in capsid assembly, but do suggest that the 
information necessary to construct a capsid can be found within the protein of 
these viruses. However, because RNA is required for virus integrity, having 
RNA involved in nucleation is reasonable. It is therefore not surprising that early 
in vitro assembly experiments suggested that assembly was catalysed in the 
presence of RNA at low concentrations in conditions where capsids would not 
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usually form with protein alone71; 72; 73. In addition, many viruses actually require 
RNA for assembly, implicating RNA in important role(s) during the complete life 
cycle of the virus. The next subsections give some background to the model 
system of STNV, the structures of recombinant STNV and the wild-type virus. In 
addition, the recombinant expression system and the sequence specificity of 
RNA to STNV CP will also be discussed. 
 
1.4 Satellite tobacco necrosis virus (STNV)   
Satellite Tobacco Necrosis Virus (STNV) is one of the smallest known viruses; it 
has a diameter of 17 nm and is the satellite virus of Tobacco Necrosis Virus 
(TNV) on which it relies for its replication74; 75. In vivo, STNV infects the root 
cells of tobacco plants, transmitted by the soil fungus Olpidium brassica. Like 
other plant satellite viruses, the coat protein of STNV shows no immuno-cross-
reactivity with its helper virus and displays very little sequence similarity as 
observed both at the amino acid and nucleotide level. The only sequence 
similarity lies in 100-150 nucleotides towards the end of the 3' RNA genome. 
This is the region where the replicase of TNV is thought to bind initially to the 
STNV genome76. 
 
The genome is 1239 nucleotides in length, where the initiation AUG codon of 
the coat protein starts at position 30-32, close to the 5' terminus of the RNA 
genome. This translates a 195 amino acid, 21.54 kDa coat protein monomer, 60 
equivalent copies of which, arrange into a T=1 icosahedral capsid.  
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1.4.1 STNV structure 
STNV readily crystallizes; indeed, it was even observed to crystallize in vivo76. 
This property of STNV has enabled the three-dimensional structure to be 
determined to a high resolution by X-ray crystallography77; 78.  
 
The coat protein monomer has a distinctive jelly-roll β-barrel fold, which despite 
being the same topology as many other plant satellite viruses, is otherwise 
striking in its dissimilarity to other plant satellite viruses79. The crystal structure 
of STNV-1 shows that residues 1-11 were disordered; otherwise the electron 
density can be followed from residues 12 completely to the C-terminal residue77; 
78. Residues 12-24 fold into an α-helix with the remainder of the coat protein 
forming a β-barrel composed of two four-stranded anti-parallel β-sheets. The 
first β-sheet, termed BIDG due to the relative positions in the polypeptide chain, 
has a twist of about 5° per strand. At the 5 fold axis of the icosahedron, the 
strands of the two β-sheets are connected by four short loop regions, whereas 
the three-fold axis is connected by two larger loop regions. Another loop region 
is found connecting the β-strand of βE and βF of the CHEF β-sheet (see Figure 
1.11).   
 
1.4.2 STNV stability, calcium ion binding and capsid swelling 
STNV is a very stable virus particle. It is resistant to both high and low ionic 
strength solutions, as well as being stable between pH 2 to pH 11, and is 
resistant to both nuclease and protease digestion80. Despite being stable in a 
wide variety of harsh conditions, wild-type STNV is still capable of releasing its 
RNA genome when it enters the plant cell cytoplasm.  
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Figure 1.11: Architecture of STNV. (a) Shows the secondary structural 
elements of a single subunit of STNV (Protein Data Bank ID 2BUK), with the 
anti-parallel β-sheets shown in magenta (BIDG) and green (CHEF). The helical 
regions are shown in blue. The three classes of associated calcium ions are 
shown as yellow spheres. The amino acid highlighted in yellow is Arg 28, a 
known trypsin cleavage site. The X-ray structure of the STNV T=1 capsid is 
shown alongside with an icosahedron as a guide to its symmetry. (b) Shows the 
amino acid sequences as single-letter codes of the STNV-1 (upper), STNV-2 
(middle) and STNV-C (lower) CPs. Shown above the sequences are the 
positions of the secondary structure elements in STNV-1 from (a). Figure taken 
from Bunka et al 81. 
(a) 
(b) 
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The proposed mechanism of virus disassembly has not been well 
characterised, but is thought to involve the removal of calcium ions - which 
function to stabilise the capsid - upon entry of the virus capsid into the low 
calcium environment of the plant cell cytoplasm82. Further investigation 
regarding STNV VLP disassembly is discussed in Chapter 5. 
 
Between each subunit of the STNV coat protein, calcium ions are found at three 
different sites (shown as yellow spheres in Figure 1.11). The calcium ion at site 
one is at a general position close to the three-fold axis, and is coordinated by 
the carbonyl oxygen atoms from residues 61 and 64, a carboxylate group from 
Asp194 from the same subunit and another carboxylate group from Glu25, a 
residue found on the adjacent subunit. An octahedral arrangement is completed 
by the presence of two water molecules83; 84. Another calcium ion binding site is 
present at the three-fold axis termed site two, where the calcium ion is 
coordinated by three carboxylate oxygen atoms of Asp55 from the three 
surrounding subunits. The final calcium ion binding site is located at the five-fold 
axis, where the calcium ion is coordinated by the five carbonyl atoms of Thr138 
and two water molecules.  
 
In view of the presence of these stabilising calcium ions in the STNV capsid, 
research was carried out by the lab of Liljas, Montelius and Unge to simulate 
the conditions of the plant cell cytoplasm. Treatment of STNV with divalent 
cation chelating agents, such as EDTA, caused a pH-dependent swelling of the 
virion as well as subsequent sensitivity to nucleases and proteases80. A low-
resolution crystal structure was determined for this slightly expanded STNV 
structure, which showed that the calcium ions present at sites 1 and 2 in the 
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native crystal structure were absent from the EDTA-treated crystal structure, 
whereas the calcium ions present on the five-fold axes of the native crystal 
structure were still present in this expanded form83. The calcium ions in the five-
fold axes can be removed by increasing the pH to pH 884. 
 
1.4.3 RNA structure in STNV 
At first look, satellite tobacco necrosis virus (STNV) is similar in size, shape and 
architecture to STMV. This close relationship however begins to buckle when 
compared biochemically, structurally79 and when the RNA structure is analysed 
in capsa85. 
 
Extensive structural analysis has been carried out on STNV using various 
biophysical techniques, such as neutron diffraction85, X-ray small-angle 
diffraction86 and X-ray crystallography78, where the three-dimensional structure 
has been resolved to 2.5 Å77. Continued crystallographic attempts to get the 
encapsidated RNA visualised at high resolution resulted in no detailed structural 
information of the RNA conformation83; 84. Instead, it was the low resolution 
studies of neutron diffraction which led to a better view of the encapsidated 
RNA conformation85.  
 
1.4.4 Recombinant expression and structural characterisation of STNV 
VLPs  
 
Recombinant STNV coat protein was first expressed in E. coli in 1984, where 
the coat protein was rendered almost completely insoluble, extensive 
proteolysis was detected and no appreciable self aggregation was observed87. 
However, previous success was achieved using a truncated version of the 
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Sesbania Mosaic Virus CP expressed in E. coli, where it spontaneously 
assembled into T=1 VLPs and the crystal structure was characterised88. 
Encouraged by these observations, Lane et al designed a synthetic, codon-
optimised variant of the STNV-1 CP gene to maximise its expression in E. coli89. 
Following expression, the STNV CP spontaneously assembled into particles 
resembling that of their wild-type T=1 capsids as analysed by analytical 
ultracentrifugation (AUC) and transmission electron microscopy (TEM). The 
material was purified and shown to contain a similar RNA content to wild-type 
virus as shown by UV absorbance89.  
 
Large crystals of the purified VLPs grew readily under conditions described 
previously77; 78. From these crystals, X-ray diffraction data were collected at high 
resolution and low resolution to obtain as much information as possible about 
the structure of the protein capsid and the RNA structure inside the VLP.  
 
The high resolution structure was determined by molecular replacement with 
the coordinates of the wild-type (PDB ID: 2STV) used as a model. The electron 
density from the VLP was present in almost the entire polypeptide chain, other 
than residues 1-11, as is the case in the wild-type virus77; 78. The overall density 
showed a high correlation between that of the recombinant VLP and the wild-
type. However, the N-terminal helix was less well defined, with density 
becoming progressively weaker towards the N-terminus (see Figure 1.12).  
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Figure 1.12: Comparison between recombinant STNV CP and wild-type 
STNV CP 
The density from the N-terminal helix is less well defined in the recombinant 
STNV CP (left) compared to the wild-type (right). Residues 1-11 are disordered, 
and not observed in either crystal structure. 
 
 
The high resolution crystal structure showed no interpretable density 
corresponding to RNA, suggesting that there is no repeating structure obeying 
icosahedral symmetry from the RNA. A crystal structure determined at 16 Å with 
H2O/ D2O contrast matching did however reveal RNA density running along the 
5-fold symmetry axis between the clusters of N-terminal helices85. The 
resolution of this density was however too low for any interpretable RNA 
structure to be resolved. Although the recombinant VLPs lack the wild-type 
genome, the A260:280 ratio suggests that recombinant VLPs package a similar 
amount of RNA.  
 
Encouraged by the success of the neutron diffraction study on wild-type virus, 
Lane et al. used low resolution X-ray diffraction data collected between 140-6  Å 
in an attempt to visualise the RNA component. The high resolution model was 
used as the basis for rigid body refinement and 60-fold icosahedral averaging. 
The density from the high resolution model fits the averaged electron density of 
the capsid from the low resolution model well, but leaves a large area of 
electron density unaccounted for (see Figure 1.13). From this density, a short 3 
2BUK3S4G
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bp stretch of A-form double-stranded RNA was modelled with arbitrary 
sequence, and includes an unpaired base at the 3' end of the stem.  
 
Each RNA fragment fits near the inner surface of two adjacent CP subunits and 
close to a neighbouring RNA fragment. These RNA fragments are related to the 
two-fold and five-fold axes, and are arranged as rings under the pentamer 
vertices of the capsid (see Figure 1.14). The protein surfaces facing the RNA 
molecules are highly positively charged, where three basic side chains, Arg 14, 
Lys 17 and Arg 18 lie along one side of the helix, within easy reach of the RNA.  
 
The 3' unpaired base at the top of the RNA duplex lies in a cavity below the 
surface of the protein, which could plausibly accommodate a loop connecting 
the RNA duplex. This region does not abide by icosahedral symmetry well 
enough to be enhanced by icosahedral averaging in the density map. Although 
other orientations of RNA are possible, the stem loop motif is by far the most 
plausible. Larson et al also observed an unpaired base at the 3' end of a duplex 
from electron density observed with STMV. This was also interpreted as the 
start of a loop region joining the stem. In addition, three further basic residues, 
Arg 66, Arg 91 and Lys 123, lie on the inner surface of the neighbouring protein 
subunit, and lie in close enough proximity to make RNA contacts with any 
potential loop (see Figure 1.14a).  
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Figure 1.13: Additional density after modelling of low-resolution averaged 
electron density map. 
(a) The CP is shown in stick representation and fits the electron density for the 
capsid and helical protrusions. Strong additional density is clearly visible 
between helix clusters. 
(b) RNA fragments modelled into electron density. No RNA density observed at 
the 5-fold vertices or in the centre of the particle. 
(c) Stereo view of modelled electron density. 
Figure taken from Lane et al. 89 
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There is also a cavity underneath the five-fold axes. However, there was no 
density that was attributable to RNA observed in this cavity. If the duplex RNAs 
are extended, then they would not be able to avoid interfering with an adjacent 
fragment around the five-fold axes. One plausible explanation is that the duplex 
RNAs that lie at the two-fold axes are each connected by single stranded 
regions that do not adhere to icosahedral symmetry at the five-folds.  
 
Although the recombinant VLP does not encapsidate the STNV genome, the 
mRNA is similar in sequence and secondary structure to the wild-type 
genome81. In addition, it has been observed in other viruses, such as Flock 
House Virus58 and Pariacoto Virus46, that the capsid can impose an architecture 
on heterologous RNA similar to that of the wild type. In order to better 
understand the relationship between the STNV VLPs and the packaging of its 
mRNA ‘genome’, further studies to assess the nature of sequence specificity of 
this phenomenon were undertaken. The next subsection describes these 
studies in detail. 
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Figure 1.14: RNA: protein interactions in recombinant STNV and a stereo 
view inside the capsid 
(a) CP subunit and its specific interactions with modelled RNA duplex. Three 
basic residues (Lys 17, Arg 18 and Arg 14) make good hydrogen bond contacts 
with three phosphate groups on the RNA duplex. Three basic residues (Arg 66, 
Arg 91 and Lys 123) on the inside face of a neighbouring CP subunit also make 
good hydrogen bond contacts with the adjacent RNA duplex. The neighbouring 
subunit is related to the other in relation to its five-fold axis. 
(b) View of the inner surface of the capsid looking from the centre of the particle 
down its five-fold axis. RNA fragments form a ring around the five-fold axis, 
each associated with an N-terminal helix. Figure taken from Lane et al. 89. 
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1.4.5 Degenerate RNA packaging signals in the genome of STNV 
It has previously been established that the expression of STNV CP in E. coli 
results in the production of T=1 STNV VLPs in vivo. It was known from phenol: 
chloroform RNA extraction and RT-PCR that a significant proportion of this 
population encapsidates the STNV CP mRNA. This indicates a degree of 
sequence specificity towards the ‘mRNA genome’ and the STNV CP. The STNV 
VLP crystal structure described in Chapter 1.4.4 shows that there must be 
multiple protein: RNA contacts to account for the density observed89.  
 
In order to determine whether mRNA packaging is sequence-driven, SELEX 
experiments were performed against the RNA binding sites of the STNV CP81. 
In SELEX experiments, it is important to carefully define the selection target. 
For viruses such as MS2 and Turnip Crinkle Virus, the building block for capsid 
formation and therefore the selection target, should be a CP dimer. In the case 
of STNV, it was not exactly known what this selection target should be, as the 
basic capsomere for STNV assembly was not well defined.  
 
To overcome this problem, Bunka et al devised a generic strategy which, in 
principle, should work for any given virus RNA-binding selection target (see 
Figure 1.15). The surface-exposed lysine residues on STNV VLPs (e.g. Lys 27) 
were biotinylated using EZ-link® sulfo-NHS-LC-LC Biotin (Pierce 
Biotechnologies). The biotinylated capsids were then bound to MyOneTM 
streptavidin-coated Dynabeads® beads (Invitrogen) and disassembled by 
exposing to disassembly buffer. The beads were then washed before 
unmodified, disassembled STNV VLPs were added to the immobilised CP in 
reassembly buffer in a sub-stoichiometric ratio. The RNA from the disassembled 
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VLPs was therefore included in the reaction mixture. The rationale behind this 
methodology was that this would, in principle, enable the formation of several 
partially formed capsids on the beads. These partially formed capsids would 
have some RNA bound to them, but should also display some ‘empty’ RNA 
binding sites that are hidden in the VLPs. In addition, it is likely that during 
selection, the formation of tighter binding RNA ligands would displace the bound 
RNA, especially given that only the selected sequences are recovered and 
amplified during each round. These partially assembled targets were therefore 
used for 10 rounds of selections. To remove aptamers directed against epitopes 
on the surface of the VLPs, unmodified VLPs were also added in 10-fold molar 
excess in the selection rounds. 
 
Figure 1.15: Schematic representation of aptamer selection process. 
STNV VLPs were biotinylated by amine modification before being immobilised 
on streptavidin beads and disassembled by exposing to disassembly conditions. 
The particles were then extensively washed. Unmodified disassembled VLPs 
were then added to the immobilised CP in moderation and subjected to 
reassembly conditions. Because the concentration of unmodified CP was 
controlled, the immobilised CP subunits were not able to fully assemble into 
VLPs, therefore displaying a range of partially assembled intermediates. Ten 
rounds of SELEX were then performed in the presence of unmodified VLP 
competitor to remove any aptamers directed against epitopes on the outer 
surface of the VLPs. Figure provided courtesy of Dr Neil Ranson. 
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After 10 rounds of selection, the resulting clones were sequenced, with 17 
aptamers identified (see Table 1.2).  
 
Table 1.2: Sequences of the 10th round STNV-1 CP aptamers 
Out of these 17 aptamers, 16 were unique sequences, with aptamers B5 and 
F2 being identical sequences. When each of the aptamer sequences were 
compared using the Alibee multiple alignment software 
(http://www.genebee.msu.su/services/malign_reduced.html), a number of 
sequence motifs were identified, but there were no clear consensus sequence. 
When these sequences were compared to the genomes of STNV-1, several 
statistically-relevant matches on different regions of the STNV-1 genome were 
Sequence name Sequence Number of residues 
A1 CGTCATGAATAGAGTTTTTTGCGGTCAGCA 30 
A2 GTGTTTATCTTGTCACTAGGTACGGGTATG 30 
A5 CGCGACCATTGAAATCACTTCTGGGGTTAA 30 
B1 GTGTAATTTGGTTTATTCTTTCAATGGTGA 30 
B2 CATTACAACTATCACTTCTCCTC 23 
B3 CCTTTTCAAGACATGCAACAATGCACACAG 30 
B4 CGTTTTAGTTTTCGGGTATTAATAGGCGTG 30 
B5 (& F2) TATGAGTTGATTTGTGGTTTTTGGTAACGT 30 
C1 CTTGATTAACTAAAGGCTAGCAAACAGCG 30 
C2 AACATTTGGATGTATGCCTTAGTTACCTAG 30 
C3 CACAGGTAAGAATCCAGCCCTATACTAACA 30 
C4 TGGACACCCTAAAAATATACGGCTCCCTGG 30 
C5 ACATGCCTTTATTTTGTCTTGGATCTTGAC 30 
D1 GTCTCCATGAACAATATTGTAGCTACAGGTC 30 
D5 CTGTGTAGTTTGAAATCATTATCGCCAACA 30 
E5 GAGCAATCGGGATACCTTCACATGATGTGC 30 
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identified. One of these aptamers, termed B3, contained 16 nt that matched the 
STNV-1 genome from positions 57-81 (see Figure 1.16a). In other words, that is 
a match from 16/25 positions, including a 10/10 contiguous stretch. This is 
unlikely to have occurred by chance, suggesting that this sequence is a 
preferred STNV CP binding site81. MFold analysis of this motif, as well as the 
STNV-1 genomic region and the STNV CP mRNA where this aptamer matches, 
suggest that this sequence folds into a stem loop structure81, a known coat 
protein binding motif62 (see Figure 1.16b). The nucleotides immediately 
adjacent to the matching sequences form base pairs, increasing the 
significance of the match. Density corresponding to RNA in the crystal structure 
from the recombinant VLP is consistent with a stem loop occupying the CP 
binding site89.  
 
Figure 1.16: Identification of a common structural motif 
(a) Sequence alignment of B3 and STNV-1 genome. The matches are shown 
as capital letters whereas the unmatched nucleotides are shown in lower case. 
(b) Analysis of the stem loop structures from aptamer B3, the STNV-1 genome 
and the mRNA. 
(c) The stem loop mutations from the mRNA stem loop to weaken the base 
pairing (SL-) and to strengthen the base pairing (SL+). Figure taken from Bunka 
et al. 81 
 
To assess whether aptamer B3 was functional in vitro, RNase protection assays 
were performed on the aptamer in the presence and absence of STNV CP. The 
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results obtained were consistent with the predicted secondary structure of 
aptamer B3, with the stem loop being protected from nuclease digestion in the 
presence of STNV CP, but digested in the absence of CP. Capsid assembly 
studies with B3 are discussed in Chapters 3 and 4. 
 
In order to explore the significance of the B3: STNV CP interaction in vivo, a 
series of stem loop mutations were made to disrupt (SL-) or to mimic (SL+) the 
stem loop from the wild-type genome, but without changing the amino acid 
sequence of the coat protein (see Figure 1.16c). These mutants were used to 
assess how these mutants affect the production of VLPs and the A260/280 ratios 
relative to the VLPs described in Lane et al89. The results from these studies 
showed that both the yield and A260/280 ratios from each case were identical to 
the original particles. These results suggest that this B3-like stem loop is not a 
unique initiation site in the STNV genome, and that many equivalents of this 
stem loop may exist. This may explain the multiple sequences selected in the 
aptamer selection experiment81.  
 
To test this hypothesis, the other aptamers were scrutinised both for their ability 
to form stem loop structures, and whether they contain sequence similarity to 
the STNV genome. The next best alignment was with aptamer D1 with two 
matches on the STNV genome, one with 17/23 identical matches and another 
with 18/23, both with a contiguous stretch of 5/5 residues. MFold analysis from 
this aptamer predicted that it formed a stem loop structure also displaying the 
motif AXXA, albeit in the context of a 5 nt loop (AACAA). The other aptamers 
were also screened for their ability to produce a stem loop in either a 4 nt loop 
or a 5 nt loop. Four aptamers (A2, B3, B4, and C3) were predicted to form 4 nt 
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stem loops, and an additional five aptamers (A5, C1, D1, D5 and E5) were 
capable of forming 5 nt stem loops. It was therefore postulated that this AXXA 
motif was important for STNV CP binding. Further analysis from the rest of the 
aptamers was carried out, which included the fixed flanking regions of the 
aptamers. In addition, aptamers were screened against producing a stem loop 
with six nucleotides in the loop. These analyses identified an additional 5 
aptamers capable of forming these structures, with only aptamers B1 and B2 
incapable of doing this. One of these aptamers (B1) was much shorter than the 
rest81. 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 1.17: Secondary structure predictions of selected aptamers 
(a) The secondary structure of the next best aptamer match (D1) to two portions 
of the STNV-1 genome, all of which can be folded into stem loops displaying the 
AXXA motif. 
(b) MFold secondary structure Figures displaying the other aptamers capable of 
forming either a 4, 5 or 6 nt stem loop displaying AXXA. The selected regions 
are shown in green, whereas the fixed regions are shown in black. Figure taken 
from Bunka et al. 81 
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In order to probe the STNV genome for stem loop sequences containing 4 to 6 
nucleotides in the loop and allowing for non-Watson-Crick base pairing in the 
stem, a series of six degenerate sequences were set up. This analysis identified 
30 potential stem loops81, enough to satisfy the density corresponding to the 
RNA binding sites found in the crystal structure of the STNV VLP89. 
 
1.5 Uncoating and disassembly 
Despite the multitude of different molecular mechanisms that viruses utilise for 
infection, all viruses share the same goal: to transport their viral genome from 
an infected cell to a non-infected cell, delivering it to either the cytoplasm or the 
nucleus, in a replication-competent manner. In order to achieve this goal, the 
virus has to overcome several barriers depending on the host it would like to 
infect. The target of virus infection can either be a neighbouring uninfected cell, 
or a cell in another organism. Uncoating is an integral part of this process, 
where the virus is generally destabilised or modified, disassembled and the 
genome is presented to the replication machinery. The progressive success of a 
virus through these stages of infection is completely dependent on the 
processes of the host cell. This ‘Trojan horse’ strategy is necessary because 
viruses are simple; they are generally incapable of having multiple independent 
functions. Another problem the virus must overcome is that of performing a 
balancing act: viruses must be stable enough to protect their genomes but 
dynamic enough to dissociate and deliver the genome to the host’s replication 
machinery.  
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Strategies by which viruses enter the host cell differ depending on the structure 
of the virus. Enveloped viruses tend to enter the cell by membrane fusion, either 
by direct means or after endocytosis90. For non-enveloped viruses, this mode of 
penetration is not possible; therefore they have evolved other ways of entering. 
Many animal viruses, for example, enter the cell by receptor mediated 
endocytosis. Endocytosis is a process which mediates the controlled 
internalisation of large macromolecules that would normally be incapable of 
passing the membrane by diffusion or facilitated through ion channels91. It can 
come in many different flavours, such as clathrin-mediated endocytosis (CME), 
macropinocytosis, caveolar/lipid raft-mediated endocytosis, or as yet unknown, 
poorly characterised methods92. 
 
The most understood process that viruses utilise is the CME pathway. CME is 
an endocytic process driven by the accumulation of clathrin and the formation of 
a clathirin coat on the cytoplasmic leaf of the lipid bilayer. The production of 
primary endocytotic vesicles requires a large number of cellular factors, some of 
which are exploited by viruses. A subset of these are known as attachment 
factors and receptors; including the transferrin receptor, low-density lipoprotein 
receptors or carbohydrate moieties of proteoglycans, glycolipids and 
glycoproteins92.  
 
The most commonly exploited attachment factors are the glycosaminoglycans 
(GAGS), particularly heparin sulphate92. Upon virus binding to these attachment 
factors, clathrin on the inside of the membrane cause the membrane to curve 
and pinch off into the cell, resulting in the formation of an early endosome93. 
Once the early endosome has formed, it is organised into a sorting centre called 
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the endosomal network, where the resulting endosome can either be sent back 
to the cell surface in a recycling endosome, or be targeted for degradation to 
the late endosome and the lysosome. The pH of the early and late endosome is 
lower than that of the cytoplasm. Viruses can therefore take advantage of this 
change in pH, driving conformational changes in the coat protein which enables 
the escape of the particle91.  
 
The first virus to be identified using this pathway was the semliki forest virus94. 
Since then, a multitude of different viruses have been identified, such as 
adenovirus 2 and 5, hepatitis C virus, dengue virus and influenza A virus. In 
addition to CME, some viruses may use additional entry mechanisms at the 
same time, such as those described for influenza A95. Adenovirus undergoes a 
conformational change upon acidification, but the DNA genome is not released 
into the cytoplasm. Instead, a modified, uncoating intermediate is released and 
exploits the cellular transport machinery in order to be transported to the 
nucleus96.  
 
Plant viruses, on the other hand, need to employ different strategies to 
overcome the major barrier of the cell wall. Unlike DNA bacteriophages, which 
operate complex injection mechanisms to insert their genome into the 
cytoplasm of the bacterial cell, plant pathogens rely on physical damage to the 
cell wall97. This damage may have arisen through seed or vegetative 
propagation, or in other examples, by using insects or fungi as agents that 
damage or weaken the cell wall97. The relationship between the virus and its 
vector is often very specific (and complex), and accounts for the specificity of 
the plant pathogen to that of its host range98.  
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The uncoating of some plant viruses have been shown to occur co-
translationally. This process is mediated by the ribosome, where translation of 
the viral genome often results in the formation of striposomes; this has been 
observed both in vitro99 and in vivo100. The first striposomes observed were from 
TMV. In 1984, Wilson and co-workers found that by treating TMV under mildly 
alkali conditions, some of the subunits of the TMV dissociated from the 5' end of 
the RNA. Exposure of these modified TMV particles to cell-free expression 
systems resulted in the production of viral proteins. Further analysis showed 
that TMV RNA can be attached to as many as 24 ribosomes101.  
 
1.6 Host antiviral mechanisms 
Over the course of evolution, the virus and host have coexisted, imposing an 
evolutionary pressure on both102. On the one hand, the host has developed 
mechanisms to prevent virus infection and to eliminate virally infected cells. On 
the other hand, the virus has evolved an array of immune evasion techniques. 
As viruses infect cells in every kingdom of life, antiviral defence mechanisms 
can be found in all organisms. For example, bacteria have evolved by 
expressing restriction enzymes103. Restriction enzymes recognise specific 
sequences and denote them as foreign; these sequences are then destroyed by 
the restriction enzyme, leaving the host DNA untouched. Bacteriophage have 
evolved to express proteins which interfere with this function, by mimicking the 
shape and the charge distribution of DNA and blocking the restriction enzyme’s 
active site103.  
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Higher organisms have evolved more elaborate defence mechanisms, such as 
the innate/ adaptive immune systems and RNA interference. Vertebrates have 
an extremely intricate immune system to protect themselves against viral 
infection. Details of this are complex, and way beyond the scope of this thesis. 
Instead, a brief overview will be described and a few examples given as to how 
viruses are able to evade the immune system.  
 
The immune system is generally split into two separate categories for 
convenience and thought of as two separate entities; innate immunity and 
adaptive immunity. This can often be misleading. In reality, adaptive and innate 
immunity is inextricably linked, where the mechanisms of each enhances the 
others ability to recognise and destroy foreign, infectious microorganisms. The 
innate immune response is also sometimes referred to as the non-specific 
immune response, because unlike acquired immunity, it protects non-
specifically against pathogens and is the first line of defence. The components 
of the innate immune system include phagocytes, mast cells and natural killer 
cells amongst others. Adaptive immunity on the other hand, recognises foreign 
invaders specifically and has an immunological ‘memory’ of when it last 
encountered the foreign invader. When this memory event is triggered, it leads 
to a cascade of events which results in the secondary immune response being 
activated. This secondary immune response is fierce, and becomes more 
ferocious every time the pathogen is encountered. The key players involved in 
this are the memory B- and T-cells, which are the main targets during 
immunization strategies. 
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Viruses have adapted to the immune system in different ways depending on the 
coding capacity of the virus. Small viruses, such as the Picornaviridae and 
retroviruses, change their immunodominant antigens so the immune system 
does not recognise them. Larger viruses can express a large array of proteins 
with specific effects on immune recognition and effector functions. In general, 
viruses utilise three main generic strategies to evade the immune system:  
 
(1) Rapid mutation or ‘hiding’ of their immunodominant epitopes to avoid 
detection by the humoral immune response. Examples of viruses utilizing these 
evasion techniques are Influenza A (mutates haemagglutinin/ neuraminidase 
antigens by antigen drift/ shift104) and HIV (as well as rapid mutation, coats its 
immunodominant antigens with carbohydrate, resulting in a ‘masking’ effect 
from neutralising antibodies105).  
 
(2) Interfere with the functioning of the cellular immune response. Examples 
include human cytomegalovirus (HCMV) and herpes simplex virus (HSV) 
(downregulate the production of natural killer cells and express a major 
histocompatabilty complex (MHC) class 1- homologue, so the immune system 
recognises the infected cell as ‘self’, and binds inhibitory receptors of the 
immune system for protection).  
 
(3) Interfere with immune effector functions, such as inhibiting inflammation, 
activation of complement, apoptosis and signalling. Examples include HCMV, 
HSV and Adenovirus (they each express multiple homologues to subvert these 
immune functions). For a review, please refer to Vossen et al 102. 
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The other defence mechanism involved is called RNA interference. This 
mechanism was first recognised in plants, but has subsequently been found in 
all eukaryotic organisms106. The primary roles of RNA interference is for the 
regulation of gene expression and for protection against invading viruses and 
transposons. Its utility is dependent on the generation of short fragments (~21-
26 bp) of complementary RNA106. The production of these complementary 
fragments is manufactured from precursor dsRNA molecules by an enzyme 
called Dicer. The dsRNA molecule is then separated into two strands; the guide 
strand binds either an RNA-induced silencing complex (RISC) or a RNA-
induced transcriptional silencing complex (RIST), while the complementary 
strand gets degraded107. RISC is responsible for the degradation of the mRNAs 
or viral RNAs in question, whereas RIST induces methylation of the chromatin 
to downregulate transcription107; 108. Despite dsRNA molecules being the 
strongest triggers for RNA silencing mechanisms, ssRNA or ssDNA can also 
activate silencing, mediated by a dsRNA intermediate generated by the RNA-
dependent RNA polymerase107.  
 
Plant viruses have evolved ways to circumvent this silencing. Evidence 
suggests that in some plant viruses, the capsid proteins directly interfere with 
the silencing mechanisms described above. This suggests that the capsid 
protein contains multiple functions, further illustrating how genetic economy is 
exploited within this class of viruses109. One such plant virus, turnip crinkle 
virus, is described in the next subsection. 
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1.7 Turnip Crinkle Virus 
Turnip crinkle virus (TCV) is a member of the Carmovirus genus and is a family 
member of the Tombusviridae, the family being named after its founder Tomato 
Bushy Stunt Virus (TBSV).  Experimentally, TCV has a very broad host range, 
but in nature its host specificity is determined by its insect vector, small jumping 
flea beetles. There are 9 species belonging to the genus Phyllotreta and a 
further 2 species belonging to the genus Psylliodes. When the beetles feed on 
the plant, the cell wall becomes damaged, which enables TCV to enter the plant 
cell and undergo its life cycle.  
  
The three-dimensional structure of TCV has been solved by X-ray 
crystallography to a resolution of 3.2 Å110. The structure of TCV is very closely 
related to southern bean mosaic virus (SBMV) and TBSV, where the latter was 
used to elucidate the structure by phase refinement110. Despite these striking 
structural similarities, the coat proteins of these viruses do not share significant 
sequence similarity at the amino acid level. This is most evident by the domain 
organisation of the coat proteins, suggesting that similarities exist in the 
mechanisms of capsid assembly and uncoating. 
 
The diameter of TCV is ~330 Å and is composed of 180 copies of a single 
polypeptide chain. The conformations of this polypeptide differ in a symmetry-
related fashion, where these differences create 3 different quasi-conformers 
termed A, B and C. These conformers form non-covalent dimers (CP2) via 
interactions with their C-terminal projecting (P) domains. These connect via 
short hinge regions to globular domains termed the shell (or S) domains, which 
creates the shell of the capsid. The capsid is composed of 90 CP2, 60 of which 
53 
 
exist in the A/B conformation and 30 of which exists in the C/C conformation. 
These differ in hinge angles between the S and P domains, but are principally 
differentiated in their N-terminal domains. The N-terminal (R) domain forms an 
extended region in the polypeptide chain. In the C/C dimers, this region forms 
an additional β-strand structure at the edge of the S domain which extends to 
make contacts with the symmetry-related R domains to form an additional 
structure termed the β-annulus at the three-fold axis. The equivalent structures 
in the A/B dimers are disordered, where the electron density is not seen in the 
X-ray crystal structure. The N-terminal regions of the R domains in both the A/B 
dimers and the C/C dimers disappear towards the centre of the particle, where 
they presumably interact with RNA via positively-charged amino acids in the N-
terminal regions. 
 
1.7.1 In vitro disassembly and reassembly of TCV 
Like a lot of other plant viruses, TCV contains calcium ions which function to 
stabilise the capsid of TCV. Conditions for the dissociation of TCV in vitro have 
been established, where incubation on ice with buffers containing EDTA, high 
ionic strength and alkali pH results in fully disrupted virus particles111. 
Dissociated particles can be separated into two distinct species as judged by 
size exclusion chromatography34. One of these species, termed the RP-
complex, elutes in the excluded volume whereas the other species, CP2, is 
separated. The RP-complex has been well characterised, and contains 1 
molecule of RNA, 3 CP2 and a unique entity known as p80
34. The p80 protein is 
a covalent dimer of the TCV CP, and insensitive to separation under reducing 
conditions, SDS, urea, boiling and mildly acid and alkali conditions. The exact 
nature of the chemical cross-link in p80 has not been determined112. 
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Figure 1.18: Architecture of TCV 
(a) TCV capsid 
TCV is organised as a capsid with T=3 architecture, containing 180 CP 
arranged into 3 conformers termed A,B and C. The A conformers (green) are 
packed around the 5-fold symmetry axes, whereas the B (blue) and C (pink) 
conformers interdigitate around the 3-fold axes. The icosahedron drawn around 
the capsid indicates the orientation, where it’s viewed along its 3-fold axis.  
(b) Structure of the β-annulus  
At the 3-fold symmetry axes, the N-terminal arms from the C conformers are 
partially ordered and intertwine to form a structure termed the β-annulus. This 
structure is highlighted in dark blue, where the protein subunits are shown in 
cartoon representation.  
(c) The domain organisation of the TCV CP 
The P domain forms the surface spikes which are typical of the Tombusviridae, 
whereas the S domain forms the continuous shell of the capsid. The N-terminal 
regions are largely disordered, where they are proposed to bind RNA via their 
basic amino acids. Figure taken from Bakker et al. 113 
 
Reassembly of dissociated TCV in vitro can be performed using two 
methodologies, termed pH jump and sequential dialysis34. Sequential dialysis 
into buffers first containing high ionic strength low pH, and then low ionic 
strength low pH were used when the concentration of TCV was low, or when 
the dissociated virus was separated by size exclusion chromatography34. The 
pH jump methodology involves dilution of concentrated dissociated virus into a 
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buffer at physiological pH. It was shown that TCV can either be assembled from 
free CP2 by using either the RP-complex or by using free RNA
34. TCV can be 
reassembled by heterologous RNAs, but assembly has a strong preference for 
TCV RNA when subjected to other RNAs in competition experiments34. This 
selectivity was shown to be independent of p80, so therefore should be 
mediated by binding of 3 CP2 to a region on the TCV genome
34.  
 
1.7.2 The RP-complex 
Formation of an RP-complex and free CP2 during disassembly is indicative of 
high affinity interactions between 3 CP2 on a unique site of RNA. As p80 is not 
important for capsid assembly, it is possible that it is bound to another position 
on the RNA molecule. In addition, it is plausible that the CP2 would have the 
same conformation in the capsid as in the growing shell. The two dimer 
conformers in TCV come as either A/B or C/C. The conformation of the dimers 
is dependent on the N-terminal R domains, on whether they are in the folded 
conformation (C) or the extended conformation (A/B). It is unlikely that the 3 
CP2 in the RP-complex to be in the A/B conformation because conditions for 
RP-complex generation involve the removal of Ca2+ ions from the 3-fold axis, so 
it is unlikely that these are present to stabilise A/B dimer formation34. It is more 
likely that these 3 CP2 are found in the C/C dimer conformation to mediate the 
formation of the first β-annulus structure34. 
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Figure 1.19: Proposed structure of the RP- complex 
The model depicts three CP2 in the C/C conformation joined by 1 set of arms 
which intertwine to form the β-annulus. This structure also interacts with several 
sites on the TCV genome. RNase treatment of the RP-complex revealed 
portions of RNA that were protected from digestion, revealing an RNase 
footprint. These areas of protection are discussed next. Figure modified from 
Wei et al., 34. 
 
1.7.3 Specific RNA: CP2 interactions in TCV 
Dissociated TCV can be fractionated into 2 distinct species, where one of these 
is the RP-complex111. Subsequent RNase digestion of the RP-complex revealed 
2 regions of RNA protection, presumably protected by the specific interactions 
of the 3 CP2 on the unique binding sites of the RNA genome
114. These 
undigested sequences were then determined, and found to be on 2 general 
locations on the TCV genome. One of these sites, Fa, was located downstream 
of the amber codon on the replicase gene. The position of the binding site 
suggests that TCV CP binding may regulate the read-through event, thereby 
affecting the expression of the replicase. The second region of CP binding was 
located on the CP gene, where analysis of the sequences found two regions 
(Fd and Fe) which are separated by about 200 nt. Each of these has the 
potential to form stem loops secondary structures.  
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These two sites were further investigated in regards to TCV capsid assembly by 
in vivo deletion mutations in the polymerase gene and the CP gene33. Using 
these experiments, it was found that a 186 nt portion from the FdFe region at 
the 3' end of the CP gene was critical for capsid assembly, and that a bulged 
hairpin loop of 28 nt was the most vital element33. When this 186 nt portion was 
inserted into the CP gene of TBSV RNA in the presence of TCV CP, it was 
found that TBSV RNA was encapsidated. These results implicated this region of 
RNA essential for TCV assembly33. 
 
1.8 Overview of thesis 
This work describes the in vitro assembly and disassembly of two virus 
systems; recombinant satellite tobacco necrosis virus-like particles (STNV 
VLPs) and turnip crinkle virus (TCV). In addition, the three dimensional X-ray 
crystal structure of STNV encapsidating the aptamer B3 is described, as well as 
how RNA sequence specificity affects the capsid assembly of STNV VLPs in 
vitro.  
 
In Chapter 2, the Materials and Methods of the general techniques used with 
Chapter specific details are provided as appropriate. Chapter 3 details the 
recombinant expression and purification of recombinant STNV VLPs and the 
role of the basic N-terminus during capsid assembly. The RNA-dependence of 
capsid assembly is described and the purification of STNV CP from STNV VLPs 
is explained, including how proteolysis was controlled. Purified STNV CP was 
also extensively characterised biochemically.  
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Chapter 4 describes an analytical ultracentrifuge sedimentation velocity 
(svAUC) assay which helps characterise the efficiency of capsid assembly 
through STNV CP titrations. These titrations are performed using a fixed 
concentration of RNA, where several RNAs were examined which differed in 
sequence and length. TEM images from each titration complement the results 
from the svAUC assay. Furthermore, large-scale production and purification of 
STNV-B3 VLPs were characterised by X-ray crystallography. The X-ray crystal 
structure of STNV-B3 is described and a capsid assembly mechanism is 
proposed based on this structure.  
 
Chapter 5 describes evidence for the uncoating mechanisms of TCV and STNV, 
respectively, and Chapter 6 is a general discussion which puts this work into 
context with the literature already known for this class of viruses. 
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2. Materials and methods 
2.1 Materials 
 
2.1.1 General Chemicals 
All chemicals were purchased from Sigma Aldrich Co, Fisher Scientific Inc., or 
Ambion. 
 
2.1.2 Molecular Biology Reagents 
All restriction enzymes were manufactured by New England Biolabs. DNA size 
markers were purchased from Invitrogen. Prestained protein markers were 
purchased from New England Biolabs. Lysozyme, DNase I and Streptavidin 
were purchased from Sigma Aldrich Co.  
 
2.1.3 Competent cells 
Protein expression was performed with transformed BL21 (DE3) Gold pLysS 
(Stratagene) competent cells. Plasmid preparations were performed using 
HiSpeed Plasmid Maxi Kit (QIAGEN) on transformed XL-1 Blue competent cells 
(Stratagene). See Appendix, Table 9.1 describing genotypes of these strains. 
 
2.1.4 DNA primers 
All DNA primers were purchased from Eurofins MWG.  
 
2.1.5 RNA oligonucleotides 
All RNAs of ≤ 30 nt were synthesized by Amy Barker as described in Chapter 
2.4.4.  
60 
 
Table 2.1: Buffer composition 
All buffers were autoclaved or filtered through a 0.2 µm filter prior to use. 
Buffer Recipe 
1 X STNV native buffer 50 mM HEPES, 200 mM NaCl pH 
7.5 
1 X STNV disassembly buffer 50 mM HEPES, 1 M NaCl, 3 mM 
EDTA pH 8.5 
10 X STNV disassembly buffer 500 mM HEPES, 100 mM EDTA, pH 
8.5  
1 X STNV reassembly buffer 50 mM HEPES, 3 mM CaCl2 pH 7.5 
10 X SDS-PAGE running buffer 30.3 g Tris, 144 g Glycine, 10 g 
SDS, make up to 1 L with ddH2O 
Coomassie brilliant blue 30 g (NH4)2SO4, 10 % v/v Acetic 
acid, 0.5 g Coomassie stain (G-250), 
make up to 1 L with  ddH2O 
2 X Laemmli sample loading buffer 0.625 mL 1M TRIS-HCl pH 6.8, 2 
mL 10 % SDS, 1 mL Glycerol, 0.5 
mL β- mercaptoethanol, 1 g 
Bromophenol blue, 0.875 mL  
ddH2O 
SDS-PAGE stacking buffer 12.5 mL 1 M Tris-HCl, pH 6.8, 1 mL 
10 % SDS, 76.5 mL  ddH2O. 
SDS-PAGE resolving buffer 94 mL Tris-HCl pH 8.8, 2.5 mL 10% 
SDS, 3.5 mL  ddH2O 
10 X MOPS buffer 400 mM MOPS free acid, 100 mM 
NaOAc, 10 mM EDTA, pH 7 
Luria Broth (rich) 20 g tryptone, 10 g NaCl, 10 g yeast 
extract, adjusted to pH 7 with NaOH 
LB agar 1 L LB media and 20 g agar 
5 X TBE buffer 54 g Tris, 27.5 g Boric acid, 20 mL of 
50 mM EDTA solution, adjust to pH 
8 and top up to 1 L  with ddH2O 
1 X TCV native buffer 10 mM sodium phosphate, 10 mM 
MgCl2 pH 7.5 
10 X TCV expansion buffer 1 M Tris, 50 mM EDTA pH 8.5 
2 X TCV disassembly buffer 200 mM Tris, 10 mM EDTA 2 M 
NaCl pH 8.5 
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2.2 General methods 
 
2.2.1 Electrophoresis 
2.2.1.1 SDS-PAGE gel preparation 
Polyacrylamide gels were made using resolving buffers and stacking buffers, 
respectively, detailed in Table 2.1. Resolving gels (15 %) were prepared using 4 
mL resolving buffer, 1 mL ddH2O and 5 mL 30 % acrylamide: bisacrylamide 
(37.5:1) (SequaGel, National Diagnostics). Polymerisation was initiated by 
adding 20 µL tetramethylethylenediamine (TEMED) (Lancaster Synthesis) and 
100 µL ammonium persulphate (APS) (Fisher Scientific). Gels were poured into 
0.75 mL spacer plates (Biorad) and the interface was made by pouring a 
minimal volume of 50 % (v/v) isopropanol (Fisher Scientific) on to the top of the 
gel before the gel polymerised. Stacking gel (3 %) was prepared with 4.5 mL 
stacking buffer and 0.5 mL 30 % acrylamide: bisacrylamide (37.5:1) 
(SequaGel). Polymerisation was initiated by adding 10 µL TEMED and 50 µL 
APS. The isopropanol was removed from the resolving gel and stacking gel was 
poured to the top of the gel. A 10-well or a 15-well gel comb (Biorad) was added 
before the stacking gel was allowed to set. 
 
2.2.1.2 SDS-PAGE 
Samples (15 µL) were prepared by adding an equal volume of 2 X Laemmli 
sample loading buffer (Sigma Aldrich) and boiling for 5 mins. 10-15 µL of 
sample was loaded into each well of the SDS-PAGE gel before being run at 150 
V for 1.5-2 h in 1 X SDS-PAGE running buffer. The gel was removed from the 
gel plates and the stacking gel was removed. The gel was fixed in 12.5 % 
trichloroacetic acid (TCA, Fisher Scientific) before being stained by Coomassie 
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brilliant blue G-250 (Fisher Scientific). Coomassie stain was removed after 2-24 
h and the gel was washed with deionised H2O before being de-stained in 
deionised H2O until the background was removed. Gel images were captured 
using the Syngene Gel Doc. 
 
2.2.1.3 Denaturing RNA agarose gel electrophoresis 
RNA was separated by electrophoresis on a 1 % (w/v) denaturing RNA agarose 
gel. The agarose gel was prepared by melting 0.5 g agarose in 36 mL of 
distilled water before 5 mL of 10 X MOPS buffer and 9 mL 37 % (v/v) 
formaldehyde (Sigma) was added to the molten agarose. RNA samples (0.5 µg) 
containing 0.1 ng ethidium bromide were prepared in 2 X gel loading buffer 
(Ambion) and boiled for 1 min at 95 ºC. The samples were run at 1-5 V/cm in 1 
X MOPS buffer for ~1 h before visualising using the transilluminator filter on the 
Syngene Gel Doc. 
 
2.2.1.4 Denaturing RNA polyacrylamide gel electrophoresis 
Denaturing PAGE gels (10 %) were prepared using the 29:1 UreaGel system 
(SequaGel, National diagnositics). The gels were pre-run for ~2 h in TBE buffer 
at 15 W before the RNA samples were prepared with 2 X gel loading buffer 
(Ambion) and incubated at 95 ºC for 2 mins. The sample wells were rinsed with 
syringing buffer into the wells before the samples were loaded, including a 10 
bp ladder (NEB). The gel was run at 15 W for ~1 h in 1 x TBE buffer and 
stained with ethidium bromide solution for ~20 mins. The gel was rinsed in 
deionised H2O before being visualised using the transilluminator filter on the 
Syngene Gel Doc. 
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2.2.2 Preparation of grids for transmission electron microscopy (TEM) 
Each grid (Agar Scientific) was irradiated with UV for 15 mins. A 5 µL droplet of 
sample was added onto the carbon-coated grid and allowed to adsorb onto the 
grid for 30 s. After this incubation time, the grid was dabbed onto filter paper 
(Whatman No. 1®) to remove excess unbound protein and the grid was stained 
by pipetting approximately 30 µL of 1 % (w/v) uranyl acetate onto the grid 
surface and the excess removed by flicking onto filter paper. This was 
performed three times before dabbing off further excess onto filter paper. The 
grids were then left to air-dry for 5 mins before they were visualised. 
 
The images were captured using a JEOL 1200 EX transmission electron 
microscope (TEM) operating at 80 keV; a Phillips CM 10 operating at 80 keV or 
a Technai F12 Spirit operating at 120 keV. Images were taken using an 
exposure time ~1-2 s, automated based on the brightness of the beam. Film 
was captured using Kodak ISO film (JEOL 1200 EX and Phillips CM 10) or CCD 
camera (Technai F12 Spirit). Film was developed by Martin Fuller and digitised 
using an Imacon FlexTight 848 scanner.  
 
2.2.3 Phenol: chloroform extraction and ethanol precipitation of RNA 
STNV VLPs (0.5 mg) were added to 500 µL of acidic phenol: chloroform 
(25:24:1) (Applied Biosystems) and vortexed until the solution went cloudy. The 
sample was centrifuged at 16,300 g for 1 min and the upper aqueous layer 
removed from the phenol. This step was repeated before loading and vortexing 
with an equal amount of chloroform: isoamyl alcohol (24:1) (Applied 
Biosystems) and centrifuged at 16,300 g for 1 min. This step was repeated to 
ensure that the phenol was removed from the RNA sample. Two volumes of 
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ethanol and a tenth volume of 3 M sodium acetate pH 5.2 were added and the 
sample was incubated at -80˚C for 3-16 h to precipitate the RNA. The 
precipitate was pelleted by centrifugation at 16,300 g for 30 mins at 4ºC and the 
ethanol removed whilst being careful not to dislodge the pellet. The pellet was 
washed carefully with 70 % (v/v) cold ethanol and vacuum dried before being 
resuspended in 20 μL of nuclease free water. The RNA concentration was 
calculated by its UV absorbance using the equation:  
 
Equation 2.1: µg/mL RNA = 40 X A260. 
 
2.2.4 Transformation 
A 50 µL aliquot of competent E. coli cells (BL21 (DE3) Gold pLysS (Statagene) 
for protein expression; XL-1 Blue (Stratagene) for plasmid purification) was 
thawed on ice. Upon thawing, 1 µL (150 µg/mL) of plasmid (pET22b vector 
containing the synthetic STNV gene; pUBS-STNV-C; pSMART-5'-MS2) was 
mixed and incubated on ice for 30 mins. The cells were heat shocked by 
transferring to a 42°C water bath for 90 s before being incubated on ice for a 
further 5 mins. The heat-shocked E. coli were transferred to 0.5 mL of sterilized 
Luria Broth (LB) and the cells were incubated for 1 hour at 37°C. After 
incubation, 20 µL from the transformed E. coli cells were plated out onto LB 
agar containing 100 µg/mL ampicillin and incubated at 37°C overnight. 
 
2.3 Methods for Chapter 3 
2.3.1 STNV VLP protein expression 
Single colonies of STNV-transformed E. coli were picked and grown in 5 mL of 
LB-ampicillin (100 µg/mL). The inoculation was incubated overnight at 37°C, 
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160 rpm. The initial 5 mL cultures were used to inoculate 500 mL flasks of LB 
containing 100 µg/mL ampicillin and the suspension was shaken at 160 rpm 
and at a temperature of 37°C in an orbital inhibitor. Once the cultures reached 
an OD600 of 0.6, the cultures were subjected to a heat shock for 30 mins at 
50°C. The cultures were cooled to 24°C for 20 mins before being induced with 
isopropyl-β-D-thio-galactopyranoside (IPTG) to a final concentration of 1 mM. 
The transformed cells were incubated at 24°C for a further 24 h before being 
harvested by centrifugation at 4°C and 5251 g. A time course was prepared to 
detect the level of protein expression over time, where 1 mL of culture was 
taken every hour after IPTG induction, starting at T=0. The OD600 was 
measured before the cells were pelleted by centrifugation at 16,300 g. A volume 
of Laemmli sample loading buffer was added according to the equation: 
 
Equation 2.2: OD600 x 50 = µL Laemmli sample loading buffer 
 
The pellets from each time point were resuspended and 3.5 µL of each were 
analysed by 15 % SDS-PAGE as described in Chapter 2.2.1.2. 
 
2.3.2 Cell harvest and lysis 
Cell pellets were resuspended in 100 mL STNV native buffer and homogenised 
by pipetting, ensuring that there were no large ‘clumps’. The homogenised 
solution was incubated at room temperature for 30 mins in the presence of 1 mg 
lysozyme (Sigma) prior to five cycles of 30 s on / off sonification. After 
sonification, 1 mg DNase I (Sigma) was added to the cell suspension and 
incubated at 4°C for 1 h. The cell suspension was centrifuged at 15,000 rpm 
(26,892 g) for 30 mins at 4°C to remove any cell debris from the supernatant.  
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2.3.3 Ammonium sulphate precipitation 
The supernatant was ammonium sulphate precipitated by slowly dissolving 
ammonium sulphate until reaching a final concentration of 1.75 M (23 % w/v). 
The precipitate was centrifuged at 15,000 rpm (26,892 g) in a Sorvall SS-34 
rotor to pellet. The pellet was resuspended in 50 mL STNV native buffer and 
dialysed against 5 L of STNV native buffer to remove the ammonium sulphate. 
 
2.3.4 Q-Sepharose anion exchange chromatography 
The dialysed sample was loaded onto an XK 26/60 pre-equilibrated Q-
SepharoseTM anion exchange column at a flow rate of 7 mL/min and the ‘flow 
through’ was collected. The fractions absorbing at 260 and 280 nm were 
analysed by 15 % SDS-PAGE, and the fractions containing STNV were pooled 
and concentrated by ammonium sulphate precipitation as described in 2.3.3.  
 
2.3.5 Size exclusion chromatography 
The ammonium sulphate precipitated sample was resuspended in 5 mL of 
native buffer and dialysed extensively against native buffer to remove the 
ammonium sulphate. The sample was loaded onto a pre-equilibrated Superdex-
200 (PharmaciaTM HiLoad 26/60) column at a flow rate of 2 mL/min. The 
fractions that absorbed at 260 and 280 nm were analysed by 15 % SDS-PAGE 
and TEM. 
 
2.3.6 Sucrose density gradient sedimentation 
The precipitate obtained from ammonium sulphate precipitation was centrifuged 
in a Sorvall SS-34 rotor at 15,000 rpm and the pellet was resuspended in 12-18 
mL of 50 mM HEPES 200 mM NaCl pH 7.5. The ammonium sulphate was 
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removed by extensive dialysis against native buffer before carefully pipetting 2-
3 mL on each gradient and centrifuging using a SW32ti rotor at 18,500 rpm on a 
15-45 % (w/v) sucrose density gradient for 21 h at 4°C. Fractions were collected 
across the gradient and peaks that absorbed at 260 and 280 nm were analysed 
by 15 % SDS-PAGE. The fractions containing STNV were pooled and dialysed 
extensively against native buffer to remove the sucrose. 
 
2.3.7 One-pot disassembly and reassembly of STNV 
Disassembly was achieved by dialysis of 1 mL of recombinant STNV VLPs (1 
mg/mL) into 3 L of disassembly buffer for 3 h at 4ºC. Reassembly was achieved 
by taking the disassembled particles and dialysing in 3 L of reassembly buffer 
for 18 h at 4ºC. Characterisation of native recombinant STNV, disassembled 
recombinant STNV and reassembled recombinant STNV was carried out by 
analysing each sample by Superdex-200 10/300 GL gel filtration 
chromatography (flow rate 0.5 mL/min). The peak fractions from the 
chromatogram (absorbing at 280 and 260 nm) were analysed by SDS-PAGE 
and visualised by transmission electron microscopy (TEM). 
 
2.3.8 One-pot disassembly/ reassembly of STNV in the presence of α,2-
macroglobulin (α2M) 
 
Disassembly was achieved by dialysis of 0.5 mL of recombinant STNV VLPs (2 
mg/mL), in the presence of 1 unit of α2M, into 3 L of disassembly buffer for 6 h 
at 4ºC. Reassembly was achieved by dialysis into 3 L of reassembly buffer for 
18 h at 4ºC. Characterisation of native recombinant STNV, disassembled 
recombinant STNV and reassembled recombinant STNV was carried out by 
analysis by Superdex-200 10/300 GL size exclusion chromatography (flow rate 
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0.5 mL/min). The peak fractions from the chromatogram (absorbing at 280 and 
260 nm) were analysed by SDS-PAGE. An aliquot of each sample was taken 
prior to size exclusion chromatography and visualised by transmission electron 
microscopy (TEM) as described in Chapter 2.2.2. 
 
2.3.9 STNV coat protein (CP) purification 
STNV VLPs (12 mL, 1 mg/mL), 100 µL complete protease inhibitor (Roche) and 
10 µg Pepstatin A, were mixed and incubated for 30 mins. The STNV VLPs 
were disassembled by adding 1/5th volume of 10 X disassembly buffer and 
incubated by agitation for 5 mins at room temperature. The sample was loaded 
onto a pre-equilibrated 1 mL Q-Sepharose FF and SP SepharoseTM FF ion 
exchange columns in series at a flow rate of 0.2 mL/min. The sample was 
flushed through with 15 mL of 1 X disassembly buffer minus NaCl to ensure all 
the sample was loaded onto the columns. The Q-SepharoseTM FF anion 
exchange column was removed and the SP SepharoseTM FF-column was 
washed with 20 column volumes of disassembly buffer minus NaCl, before 
STNV CP was eluted with a 20 mL gradient of 2 M NaCl in 1 X disassembly 
buffer. STNV CP was collected in 2 mL fractions and were analysed by SDS-
PAGE and UV spectroscopy. The protein concentration was calculated by A = 
εcl, where ε = 16,960 M-1 cm-1 and the molecular weight is 21,584 Da. 
 
2.3.10 STNV assembly in the presence/absence of aptamer B3 
STNV CP was purified according to Chapter 2.3.9. Aptamer B3 was 
synthesized by Amy Barker, according to Chapter 2.4.4. STNV CP (0.5 mL, 0.5 
mg/mL) was incubated against reassembly buffer in the presence (80 µg/mL) or 
absence of aptamer B3 using 0.1-0.5 µL Slide-A-Lyzers (3 kDa MWCO) 
69 
 
(Pierce). An aliquot was taken from each sample for TEM as described in 
Chapter 2.2.2. Each sample was analysed by size exclusion chromatography 
(S-200 10/300 GL) at a flow rate of 0.5 mL/min. Fractions with a UV absorbance 
were collected in 2 mL fractions and concentrated by Amicon Ultra® spin 
concentrators (Millipore®) before analysis by SDS-PAGE according to Chapter 
2.2.1.2. 
 
2.4 Methods for Chapter 4 
 
2.4.1 Preparation of template DNA by restriction digest 
Plasmids pET22b-STNV89, pUBS-STNV-C115 and pSMART-5'-MS2116 were 
linearised (10 µg) by incubation at 37ºC for 1 h with 2 units of restriction 
enzymes HindIII (for pET22b-STNV and pSMART-5'-MS2) and XhoI (for pUBS-
STNV-C) (NEB), respectively. The linearised plasmids were analysed by 1 % 
native agarose gel electrophoresis. Restriction enzymes were heat-inactivated 
by incubation at 65ºC for 30 mins. Plasmid DNA concentration was determined 
using Equation 2.3. 
 
2.4.2 Preparation of template DNA by PCR 
MS2 iRNA template was produced from pSMART-5'-MS2 by PCR amplification 
with primers 1419F_T7 and 2346R as described in 116. PCR products were 
analysed by 1 % native agarose gel electrophoresis. DNA concentration was 
determined using Equation 2.3. 
 
Equation 2.3: [DNA] (µg/mL) = A260 x 50 
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2.4.3 In vitro transcription of STNV CP mRNA, STNV-C, MS2 5'RNA and 
MS2 iRNA 
 
1 µg of DNA template was used in each transcription reaction using 
MEGAScript in vitro transcription kit (Ambion) following manufacturer’s 
guidelines. The DNA templates were digested after transcription using turbo 
DNase I obtained with the kit (Ambion). These transcripts were purified by 
phenol: chloroform extraction and ethanol precipitation as described in Chapter 
2.2.3. Nucleotides were removed by Illustra G-25 microspin desalting columns® 
(GE Healthcare) using the manufacturer’s guidelines. All RNAs were analysed 
by denaturing agarose gel electrophoresis as described in Chapter 2.2.1.3 and 
the concentration was determined by UV absorbance as described in Equation 
2.4:  
 
Equation 2.4: [RNA] (µg/mL) = 40 x A260   
 
2.4.4 RNA oligonucleotide synthesis 
RNA oligonucleotides were synthesised by Amy Barker. Aptamer B3 sequence 
(5'-CCU UUU CAA GAC AUG CAA CAA UGC ACA CAG-3'); Aptamer B3 4U 
sequence (5'-CCU UUU CAA GAC AUG CAU UUU UGC ACA CAG-3'); B3 
short sequence (5'-CGU GCA ACA AUG CAC G -3'); MS2 TR sequence (5'- 
ACA UGA GGA UUA CCC AUG U-3'), were synthesized using N-benzoyl-
protected adenosine, N-dimethylformamidinyl-protected guanosine and N-
acetyl-protected cytosine; no protective group required for uracil. The 2' 
hydroxyl group was protected by t-butyldimethylsilyl (TBDMS) and the 3' was 
activated by 2-cyanoethyl-(N,N'-diisopropyl)-phosphoramidite (Link 
Technologies). Ammonia-saturated methanol was used to remove protecting 
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groups and to cleave RNA from controlled pore glass (CPG) resin at room 
temperature for 24 hours. Methanol was removed under vacuum and the pellet 
was resuspended in anhydrous dimethyl sulfoxide (DMSO). One volume of 
triethylamine trihydrofluoride (TEA.3HF) was added and incubated at room 
temperature to remove TBDMS from the 2ʹ hydroxyl groups. RNAs were butan-
1-ol precipitated and resuspended into diethylpyrocarbonate (DEPC) treated 
water (Severn Biotech). Each RNA was purified by ion exchange high 
performance liquid chromatography (HPLC) and analysed by negative mode 
electrospray ionisation mass spectrometry and denaturing PAGE as described 
in Chapter 2.2.1.4. 
 
2.4.5 STNV capsid assembly titrations 
All RNAs were prepared according to Chapter 2.4.3 or 2.4.4, respectively. 
RNAs (20 µg/mL) were kept at a fixed concentration and STNV CP was either 
omitted or added at 1:1, 2:1, 5:1 or 10:1 (w/w) ratios in 500 µL total volume. 
Each reassembly reaction was extensively dialysed in reassembly buffer 
overnight at 4ºC using 0.1-0.5 mL Slide-A-Lyzers (3 kDa MWCO) (Pierce). 
 
2.4.6 Analytical ultracentrifugation – sedimentation velocity (svAUC) 
2.4.6.1 Background 
Molecules in solution can be separated and characterised based on their rates 
of sedimentation under an applied centrifugal force. This type of analysis can be 
performed by analytical ultracentrifugation. The analytical ultracentrifuge is 
similar to any other ultracentrifuge, other than it has a laser light detection 
system that allows the direct measurement of the macromolecules in solution, 
thus the rate of sedimentation can be followed. This can be achieved by 
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measuring the change in UV absorbance of the sedimenting macromolecules in 
solution over time.  
 
Analytical ultracentrifugation can be used to determine the molecular weight, 
the gross shape and can also give information on the heterogeneity of the 
sample. Information regarding the latter can be obtained by even trace amounts 
of oligomers or aggregates, which is very useful in the characterisation of 
complexes in solution. Two basic types of analysis can be performed with the 
analytical ultracentrifuge, namely sedimentation velocity (svAUC) and 
sedimentation equilibrium (seAUC) experiments.  
 
One of the fundamental advantages of sedimentation velocity experiments is 
that biological macromolecules of nearly any size can be investigated in 
solution, within a very broad range of buffer conditions. The sedimentation of 
macromolecules is dependent on three factors; gravitational force, buoyancy 
and the hydrodynamic friction. These parameters are described by the 
Svedberg equation: 
 
Equation 2.5: 
 
 
 
     ̅  
  
 
 
2.4.6.2 Method 
Sedimentation velocity was performed by Amy Barker. Each sample (0.32 mL) 
was placed in a 1.2 cm pathlength 2-sector miniscus-matching epon 
centrepiece cell constructed with sapphire windows. These samples were 
centrifuged at 15,000 rpm in an An50-Ti rotor in an Optima XL-1 analytical 
ultracentrifuge at 20ºC. Changes in absorbance at 260 nm in the solute were 
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detected by absorbance optics, with a total of 100 scans being taken in 
approximately 12 hours. Buffer densities and viscosities were calculated by 
Sednterp version 1.09117. Radial absorbance profiles were fitted using the 
program Sedfit version 12.1b using a continuous distribution c(s) Lamm 
equation model118. 
 
2.4.7 X-ray crystallography of STNV VLPs 
2.4.7.1 Production and purification of VLPs for X-ray crystallography 
Recombinant STNV VLPs (~12mg) were disassembled and STNV CP was 
purified by ion exchange chromatography using the methodology described in 
Chapter 2.3.9. The total amount of CP was determined by UV 
spectrophotometry and analysed by SDS-PAGE. STNV CP was added to each 
RNA (aptamer B3, B3 short and TR) at a ratio of 5:1 (w/w) before being 
extensively dialysed in reassembly buffer. Reassembled VLPs were 
concentrated to 500 µL by Amicon Ultra® spin concentrators (Millipore) and 
purified by size exclusion chromatography (S-200 10/300 GL) at a flow rate of 
0.5 mL/min. Fractions containing purified VLPs were analysed by SDS-PAGE, 
TEM and sedimentation velocity to assess the quality of the sample. 
 
2.4.7.2 Crystallisation conditions 
STNV-B3 crystallisation and data collection was performed by Saskia Bakker. 
The VLPs were crystallised using the conditions previously established for 
recombinant STNV89. Reservoir solutions contained 50 mM phosphate at pH 
6.2-6.8, 0.2-0.8 % (w/v) PEG 6000 and 0-1 mM MgCl2. Drops were set up using 
3 μl VLP (7 mg/mL) and 3 μl reservoir solution. Diamond-shaped crystals 
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appeared after 4 weeks of incubation at 25 °C and measured about 0.1 mm in 
their longest dimension.  
 
Crystals were prepared for data collection by cryoprotection with glycerol before 
flash cooling in liquid nitrogen. Addition of glycerol was carried out in a stepwise 
fashion as follows, 60 s soak in 20 % (v/v) glycerol, 80 % (v/v) reservoir solution 
followed by a 20 s soak in  25 % (v/v) glycerol, 75 % (v/v) reservoir solution and 
finally a 1 s soak in 30 % (v/v) glycerol, 70 % (v/v) reservoir solution. 
 
2.4.7.3 Data collection 
Diffraction data were collected at Diamond Light Source on beam line I02 at a 
wavelength of 0.9795 Å to a maximum resolution of 2.29 Å. To enable 
examination of the less ordered internal structure of the VLP high quality low 
resolution data was required. Three sweeps of data were therefore recorded 
from the same region of the crystal with varied detector and beam stop 
positions with resolution ranges of 116-3.8 Å, 217-7 Å and 30-2.29 Å. 180° of 
data were recorded for each sweep with an oscillation angle of 1° for the very 
low resolution data and 0.5° for the medium and high resolution sweeps. All 
three sweeps of data were processed together using the 3dii option of the xia2 
expert data reduction system. 
 
2.4.7.4 Phasing and refinement 
Phasing and refinement was carried out by Drs Saskia Bakker and Arwen 
Pearson. The data were isomorphous with recombinant STNV VLP. (PDB 1VTZ 
& 3RQV) and this structure was used to provide initial phases for map 
calculation. Rigid body refinement of the entire capsid was carried out using 
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REFMAC5. 60-fold averaged maps were calculated using COOT after which the 
coat protein structure was rebuilt and refined, using strict 60-fold NCS, with 
REFMAC5. 
 
2.4.7.5 Examination of the internal structure 
This was performed by Dr Arwen Pearson. 60-fold sigmaA weighted 2m|Fo|-
D|Fc| and m|Fo|-D|Fc| averaged maps were calculated using the Uppsala 
Software Suite. A mask comprising a single coat protein and the corresponding 
internal segment of the VLP was created using MAMA. 60-fold averaging of the 
mask was carried out using MAVE. 
 
2.4.7.6 Accession numbers 
Accession numbers were assigned by Dr Arwen Pearson. The co-ordinates and 
structure factors for the protein capsid in the presence of the B3 aptamer RNA 
have been deposited with the PDB. 
 
2.4.8 Purification of STNV-B3 ‘half capsids’ 
STNV ‘half capsids’ were prepared from 0.5 mg STNV CP (purified as 
described in Chapter 2.3.9) and 250 µg aptamer B3 (prepared as described in 
Chapter 2.4.4) at a 2:1 (w/w) ratio. Sample was dialysed extensively in 
reassembly buffer at 4ºC before being purified by 15-45 % (w/v) sucrose density 
gradient fractionation in 12 mL tubes (Seton). STNV half capsids were analysed 
by UV absorbance, visualised by TEM and characterised by Amy Barker using 
sedimentation equilibrium. 
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2.4.9 RNase A treatment of reassembled STNV VLPs to remove 
aggregates 
 
100 µL STNV VLPs reassembled with STNV-C and MS2 5'RNAs (5:1 CP: RNA 
(w/w)), respectively, were treated with 1 µL (2.5 units) RNase A (Sigma Aldrich) 
and incubated at room temperature for 30 mins. The STNV VLPs were diluted 
two-fold before being prepared for TEM according to Chapter 2.2.2. 
 
2.5 Methods for Chapter 5 
2.5.1 Purification of Turnip Crinkle Virus 
Turnip Crinkle Virus was purified from frozen leaves of Nicotiana benthamiana 
infected with 35S TCV (derived from TCV-M cDNA) in an Agrobacterium 
tumifaciens vector110; 119. Leaves were kindly provided by Dr Keith Saunders 
and Prof. George Lomonossoff, John Innes Centre, Norwich. The leaves (100 
g) were homogenised by blending with distilled water on ice before being 
strained through muslin under vacuum. Celite (Supelco, 5g per 100 mL of sap) 
was added and the mixture was centrifuged at 15,000 rpm (26,892 g) for 30 
mins using a Sorvall SS-34 rotor at 4 °C. The green pellet was discarded and 
30% (w/v) PEG 6000 (Fluka) and 0.8 mL of 5 M NaCl (Fisher Scientific) were 
added to the supernatant and stirred for 10 mins at 4 °C. The mixture was 
centrifuged for 30 mins at 15,000 rpm (26,892 g) as above. The pellets were 
resuspended in minimal volume of native buffer (10 mM sodium phosphate, 10 
mM magnesium sulphate at pH 7.4) and the extracts were centrifuged in a 
Beckmann preparative ultracentrifuge with SW55Ti rotor for 2 h at 35,000 rpm 
at 4°C. Pellets were resuspended in native buffer and 10 % (v/v) Bentonite (36 
mg/mL) was added to resuspended virus to remove impurities which bind to the 
Bentonite. The suspension was centrifuged for 30 mins at 15,000 rpm (26,892 
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g) to remove the Bentonite. The supernatant was spun using a SW55Ti rotor for 
2 h at 4°C and 35,000 rpm, pellets were resuspended in TCV native buffer and 
spun for 10 mins at 10,000 rpm in an SS-34 rotor at 4ºC. 
 
These last two steps were repeated until the ultracentrifuge supernatant was 
clear. The virus was further purified on a 10-40% sucrose gradient, using a 
Beckmann preparative ultracentrifuge with an SW40Ti rotor, and spun at 35,000 
rpm for 2 h at 4°C. The fractions containing TCV were pooled and dialysed 
using SnakeSkinTM pleated dialysis tubing with a molecular weight cut-off of 3.5 
kDa (Pierce Thermo Scientific) against 5 L TCV native buffer for 24-48 h, 
changing the buffer twice, until the sucrose is removed. Purified TCV was 
analysed by 15 % SDS-PAGE and the concentration was calculated. 
Concentration of the virus was determined by UV absorbance and calculated 
using Equation 2.6 120. 
 
Equation 2.6: [protein (mg/mL)] = (1.55 x A280 – 0.76 x A260) x dilution factor 
 
2.5.2 Expanded TCV chymotrypsin digestion 
250 µL TCV (4 mg/mL) was expanded by adding 100 µL 10X expansion buffer 
and incubated at room temperature for 10 mins. TCV was subjected to protease 
digestion by addition of 2.5 µg of chymotrypsin and incubated for 30 mins at 
room temperature. The reaction was quenched by the addition of 100 µL of 
complete protease inhibitor cocktail (Roche) and 160 µg Pepstatin A (Roche). 
The subsequent proteolysed TCV was separated by size exclusion 
chromatography using 10/300 GL Superdex-200 column run at 0.5 mL/min and 
1 mL fractions were collected. Fractions that contained UV absorbance were 
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concentrated (500 µL) by Amicon Ultra® centrifugal concentrators. The 
concentrated fractions were analysed by SDS-PAGE as described in Chapter 
2.2.1.2. The eluted TCV VLPs were analysed by TEM as described in Chapter 
2.2.2. 
 
2.5.3 Expanded and proteolysed TCV striposome formation 
The purified expanded, chymotrypsin treated TCV (10 µL, 4 mg/mL) was 
prepared as described in Chapter 2.5.2. The sample was incubated for 30 mins 
in the presence of wheat germ extract as per manufacturer’s instructions 
(Promega). Translation was terminated by adding 1 mM cycloheximide final 
volume. The sample was centrifuged at 16,300 g for 10 mins at 4ºC and 5 µL 
was prepared for TEM as described in Chapter 2.2.2. 
 
 
2.5.4 RNase A treatment of native, expanded, expanded and chymotrypsin 
treated TCV 
 
The different states of TCV were prepared as described in Chapter 2.5.2. Each 
sample was incubated in the presence of 0.5 µL RNase A (1.25 units) (Sigma 
Aldrich) for 30 mins at room temperature before being quenched by 1 µL (40 
units) RNase OUTTM (Invitrogen). RNAs were purified from TCV treated with 
RNase A in each state by RNeasy® RNA extraction kit (QIAGEN) according to 
manufacturer’s instructions. The RNA from untreated TCV was also extracted 
as a negative control. Each purified RNA was analysed by 1 % (w/v) denaturing 
agarose gel electrophoresis as described in Chapter 2.2.1.3. 
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2.5.5 Chymotrypsin treatment and biochemical analysis of RP-complex  
Purified TCV (200 µL, 75 mg/mL) was dissociated by adding 200 µL of 2X TCV 
disassembly buffer and 100 µL of complete protease inhibitor and incubated for 
30 mins. The RP-complex was purified from free coat protein dimer by 
Superdex-200 10/300 GL size exclusion chromatography at a flow rate of 0.5 
mL/min, where the RP-complex eluted in the void volume. The resulting 
fractions were concentrated to 400 µL by Amicon Ultra® spin concentrators 
(Millipore) and treated with chymotrypsin (Roche) at a final concentration of 1 
µg/mL. The digested RP–complex was quenched by adding 1 µg of Aprotinin 
and 100 µL (1/10th of a tablet) of complete protease inhibitor (Roche). The 
digested RP-complex was separated by size exclusion chromatography using a 
Superdex-200 10/300 GL column, where fractions which absorbed at 260 
and/or 280 nm were spin concentrated (Amicon Ultra®, Millipore) and analysed 
by 15 % SDS-PAGE as described in Chapter 2.2.1.2.  
 
2.5.6 Chymotrypsin treatment of recombinant STNV VLPs 
STNV VLPs (25 µL, 1 mg/mL) were chymotrypsin (0.5 µg) (Roche) treated and 
incubated for 1 hour at room temperature before being quenched by 10 µL 
Complete protease inhibitor tablets (1 tablet dissolved in 1 mL ddH2O)  (Roche). 
Chymotrypsin treated and untreated STNV VLPs were the analysed by SDS-
PAGE as described in Chapter 2.2.1.2. 
 
2.5.7 Chymotrypsin treatment and biochemical analysis of expanded 
STNV VLPs 
 
STNV VLPs (250 µL, 4 mg/mL) were treated with EDTA (10 mM) and incubated 
at 4ºC for 24 h. Chymotrypsin was added (5 µg) and incubated for 30 mins at 
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room temperature before being quenched by 10 µg Aprotinin and 100 µL 
Complete protease inhibitor tablet (1 tablet dissolved in 1 mL ddH2O)  (Roche). 
The chymotrypsin treated, expanded STNV VLPs were separated by size 
exclusion chromatography using a Superdex-200 10/300 GL column, where 
fractions which absorbed at 260 and/or 280 nm were spin concentrated (Amicon 
Ultra®, Millipore) and analysed by 15 % SDS-PAGE as described in Chapter 
2.2.1.2. The eluted STNV VLPs were analysed by TEM and incubated with 
wheat germ extract as described in Chapters 2.2.2 and 2.5.3, respectively. 
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3. The role of the N-terminal arm during capsid 
assembly 
 
3.1 Introduction 
Previously, the STNV coat protein (CP) gene was cloned into a pET22b 
expression vector that was codon optimised for efficient protein expression in E. 
coli. The expressed CP spontaneously assembled into virus-like particles 
(STNV VLPs)89. These STNV VLPs can be purified in milligram quantities with 
sufficient purity to be crystallised for structural studies, and can be 
disassembled and reassembled in vitro81. Furthermore, the sequence specificity 
of STNV assembly was investigated, where the generation of RNA aptamers 
against the RNA binding sites of STNV CP revealed structural motifs that are 
present in the wild-type genome81. 
 
Detailed in this Chapter is how improvements that have been made to the 
STNV purification protocol have contributed to furthering our understanding of 
STNV capsid assembly. These improvements enhanced yield, minimised 
proteolysis, and therefore maximised the efficiency of STNV capsid assembly in 
vitro. In addition, investigations into STNV CP purification from the VLP were 
examined to ensure in vitro capsid assembly experiments with heterologous 
RNAs could be carried out. Aptamer B3, an obvious RNA candidate based on 
the previous SELEX experiments81, was used in capsid assembly studies. 
 
 
. 
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3.2 Results  
 
3.2.1 STNV CP expression 
The pET22b-STNV89 vector was transformed in BL-21 (DE3) Gold pLysS cells 
(Stratagene) as described in Chapter 2.2.4. This strain of bacteria was used to 
prevent the ‘leaky’ expression that can sometimes occur when using other 
strains of competent cells. The transformation efficiency routinely obtained was 
between 0.1-6 X 109 cfu/µL. Single colonies were then used to inoculate 
overnight cultures of LB-ampicillin as described in Chapter 2.3.1. These were 
used as starter cultures for inoculation of 500 mL flasks of LB-ampicillin, and 
incubated with shaking (160 rpm) at 37ºC until an OD600 of 0.4 - 0.6 was 
reached.  
 
Upon reaching the required OD600, the cultures were subjected to a heat shock. 
A sudden upsurge in temperature in E. coli induces the expression of heat 
shock proteins in vivo where molecular chaperones, such as DnaK, DnaJ, 
GrpE, GroEL and GroES, are expressed. These proteins constitute two of the 
major chaperone systems within E. coli and are important to prevent undesired 
aggregation of proteins as well as refolding proteins that have been 
misfolded121; 122. These properties are obviously advantageous when trying to 
induce the overexpression of a transgene whose product is prone to 
aggregation. Previous expression trials concluded that a 50ºC heat shock 
followed by incubation at 24ºC prior to IPTG induction produced the most 
soluble protein and therefore VLPs123.  
 
In order to harvest as many STNV VLPs as possible, an expression trial was 
performed where 1 mL of culture was taken every hour post induction. The 
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OD600 was measured and equal amounts of cells were loaded onto an SDS-
PAGE, as described in Chapter 2.3.1. 
 
The expression trials showed that STNV CP was not expressed before IPTG 
induction. After one hour, low levels of STNV CP expression are detected, 
increasing every hour until expression saturates after about 7 hours. The level 
of expression remained constant thereafter up until 24 hours (see Figure 3.1). 
Being as STNV particles are extremely stable80, it was decided to harvest when 
the OD600 was highest (after ~24 hours). This ensured that STNV VLPs were 
purified from the most material present in the culture, before the bacterial cells 
reached the ‘decline phase’ of their growth.  
 
 
Figure 3.1: SDS-PAGE of STNV coat protein expression profiles over time 
STNV CP expression was monitored by SDS-PAGE over time. These were 
immediately prior to induction, 0, after 1 h, 2 h, 4 h, 5 h, 6 h, 7 h and 24 h. 
Lanes labelled L = 7 – 176 kDa prestained ladder (NEB); + = STNV VLP 
control. The STNV CP levels increase following IPTG induction until saturation 
after approximately 7 h. No STNV CP is detected prior to IPTG induction. Arrow 
shows STNV CP. 
L        +         0      1h     2h      4h     5h     6h      7h     24h
176 kDa
80 kDa
58 kDa
46 kDa
30 kDa
25 kDa
17 kDa
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The cells were pelleted by centrifugation at 4750 rpm and the pellets were 
frozen at -20°C. The pellets were thawed at room temperature before being 
extensively resuspended in 100 mL native buffer (50 mM HEPES 200 mM NaCl 
pH7.5) containing one tablet of complete protease inhibitor cocktail (Roche). 
This cellular suspension was treated with 1 mg of lysozyme (Sigma Aldrich) and 
left stirring for an hour at room temperature, before being sonicated and DNase 
I treated (Sigma Aldrich). The sample was centrifuged at 15,000 rpm (26892 g) 
using a Sorvall SS-34 rotor at 4ºC to remove cellular debris from the 
supernatant and the supernatant was ammonium sulphate precipitated (23% 
w/v) as described in Chapter 2.3.3. An aliquot was taken of both the 
supernatant and the cell pellet prior to ammonium sulphate precipitation and 
analysed by SDS-PAGE. Approximately 50 % of all STNV CP was obtained in 
the soluble fraction (see Figure 3.2). Aliquots were also taken after ammonium 
sulphate precipitation. The ammonium sulphate precipitated sample was 
centrifuged at 15,000 rpm (26892 g) using a Sorvall SS-34 rotor at 4ºC and an 
aliquot was taken of the supernatant for SDS-PAGE analysis. The pellet was 
resuspended in 50 mL native buffer and an aliquot was taken for SDS-PAGE. 
The SDS-PAGE showed that ammonium sulphate precipitation successfully 
precipitated all of the STNV CP from the supernatant and removed many 
proteins that did not precipitate (see Figure 3.2). Ammonium sulphate 
precipitation was therefore used as both a concentration step prior to further 
rounds of purification, and as an early purification step. 
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Figure 3.2: Monitoring STNV CP by SDS-PAGE 
STNV VLPs are observed both in the supernatant and in the pellet in roughly 
equal amounts. STNV VLPs are efficiently ammonium sulphate precipitated 
away from other proteins in the supernatant. 1 = insoluble fraction/pellet from 
cell lysis; 2 = supernatant from cell lysis; 3 = resuspended ammonium sulphate 
precipitate; 4 = supernatant from ammonium sulphate precipitation; L = 7 – 176 
kDa prestained ladder (NEB); + = STNV VLP control. Arrow shows STNV CP. 
 
 
3.2.2 Strategies for STNV purification 
Previously, recombinant STNV VLPs were purified from E. coli primarily for 
structural characterisation by X-ray crystallography89. The strategy for STNV 
VLP purification took advantage of both the difference in size of the VLPs and 
the difference in charge of the STNV CP relative to other E. coli proteins. The 
STNV VLP has a molecular weight of 1.5 MDa, so the VLP should elute in the 
void volume of most size exclusion chromatography columns. In addition, STNV 
CP has an isoelectric point (pI) = 10, therefore STNV CP shouldn’t bind to a Q-
SepharoseTM anion exchange resin, but should bind to SP SepharoseTM cation 
exchange resin at neutral pH. However, the VLP also contains encapsidated 
RNA. Thus in the VLP, the majority of the positively charged residues are 
making contacts with the phosphodiester backbone of the RNA89. In addition, 
L         +               1             2             3             4  
176 kDa
80 kDa
58 kDa
46 kDa
30 kDa
25 kDa
17 kDa
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negatively-charged moieties on the STNV VLP are coordinated to 92 Ca2+ ions. 
These parameters would therefore affect the ability of the STNV VLPs to bind to 
SP resin, but the STNV VLPs shouldn’t bind to Q-SepharoseTM resin. Thus the 
purification strategy was to purify STNV VLPs by Q-SepharoseTM anion 
exchange chromatography prior to size exclusion chromatography. STNV CP 
can then be purified from the STNV VLPs for capsid assembly experiments. 
 
3.2.3 Q-Sepharose anion exchange chromatography 
Immediately after resuspending the ammonium sulphate precipitate in native 
buffer, the STNV VLPs were dialysed extensively against native buffer to 
remove the ammonium sulphate. This sample was then passed down a Q-
Sepharose anion exchange column in native buffer. This purification step was 
used primarily as a ‘guard’ column, where the majority of E. coli proteins bound 
to the column, whereas the STNV VLPs had little or no affinity (see Figure 3.3). 
The bound proteins were then eluted from the column by washing with 2 M 
sodium chloride (NaCl). The majority of E. coli proteins bound to the column, 
whereas ~50 % of all the STNV CP did not bind.  
 
The fractions eluted from the Q-Sepharose anion exchange column which had 
260 and 280 nm absorbance were analysed by 15 % SDS-PAGE. In general, 
one broad peak was eluted in the flow through (peak 1). A larger peak, which 
contained a shoulder, was then eluted upon washing with 2 M NaCl (peaks 2 
and 3). SDS-PAGE analysis of the flow through (peak 1 in Figure 3.3) showed 
that STNV VLPs eluted predominantly in fractions from the front until the centre 
of the peak (lanes 1-4).   
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Figure 3.3: Q-Sepharose anion exchange and SDS-PAGE 
The above chromatogram follows the A280 (solid blue line) and A260 (dashed 
blue line). The conductivity is monitored by the brown line. SDS-PAGE shows 
STNV VLPs are eluted in the flow through. Lanes on the gel indicated by 
fraction numbers, shown as vertical lines on the chromatogram. Lanes 1-5 = 
fractions from peak 1; Lane 6 = fraction from peak 2; Lanes 7-8 = fractions from 
peak 3; L = prestained 7-176 kDa ladder (NEB); + = STNV VLP control. STNV 
CP shown by white arrow. 
 
The fractions analysed from the tail of peak 1 became more and more 
contaminated, until there was predominantly contaminating proteins (see lane 5, 
Figure 3.3). When the column was washed with 2 M NaCl, a shoulder from the 
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main peak (labelled 2, Figure 3.3) eluted a protein of ~25 kDa in size. This 
protein was not expressed prior to induction, but became more abundant the 
longer the cells were grown. This suggests that this protein, possibly phage 
shock protein, is a stress-related protein that E. coli expresses under certain 
conditions124; 125, such as when exposed to increasing temperature. This protein 
was easily removed by Q-SepharoseTM anion exchange chromatography (see 
Figure 3.3).  
 
Q-Sepharose anion exchange chromatography proved to be a very effective 
step in purification. A variety of differently sized Q-SepharoseTM columns with 
bed volumes of 5 mL, 20 mL, 120 mL and 330 mL were tried in this step of 
purification. The largest of these columns proved to be most effective at 
improving the purity of the sample. Smaller columns did not remove as many 
contaminating proteins as this larger column therefore the largest column was 
used. An additional advantage of using this large column was that more of the 
sample could be loaded onto the column at once. This ensured that all of the 
sample could be loaded in one injection, and that the sample was not 
excessively concentrated prior to purification. 
 
Fractions were therefore collected from peak 1 (omitting fractions from the tail of 
the peak) and were pooled and ammonium sulphate precipitated (23 % w/v) as 
described in Chapter 2.3.3. Peaks 2 and 3 contained many contaminating 
proteins and nucleic acid, so these fractions were discarded.  
 
 
 
89 
 
3.2.4 Size exclusion chromatography 
The ammonium sulphate precipitated sample was centrifuged at 15,000 rpm 
(26892 g) using a Sorvall SS-34 rotor at 4ºC to pellet. The pellet was 
resuspended in 5 mL STNV native buffer and extensively dialysed against 
native buffer to remove the ammonium sulphate. After dialysis, size exclusion 
chromatography was performed using a Superdex-200 26/60 column at a flow 
rate of 2 mL/min, where the UV absorbance was monitored at 260 and 280 nm 
and 3 mL fractions were collected.  
 
The sample started eluting from this column after ~95 mL and stopped eluting 
after 140 mL (see Figure 3.4a). A shoulder from this peak eluted from ~95 mL 
to 100 mL, but no additional contaminating protein was detected by SDS-PAGE 
analysis. In addition, a smaller broad peak also eluted from ~175 mL to 200 mL, 
but was not analysed by SDS-PAGE due to the assumption that the STNV 
VLPs were eluted in the larger peak. The fractions from the shoulder of the 
peak were discarded in case of aggregation of the STNV VLPs and/or low level 
contamination not detected by SDS-PAGE. The fractions from the main peak 
were pooled and analysed by UV absorbance. The A260/280 ratio was routinely 
calculated to be ~1.7, agreeing with values previously determined89. A small 
aliquot from the pooled fractions were diluted 10-fold to be visualised by TEM 
as described in Chapter 2.2.2, and confirmed to be STNV VLPs.  
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Figure 3.4: SEC purification and characterisation of STNV VLPs 
(a) Size exclusion chromatogram of purified STNV VLPs 
Chromatogram shown by absorbance at 280 nm (solid line) and 260 nm 
(dashed line). 
(b) SDS-PAGE of fractions from chromatogram.  
Fractions were collected across the peak between 95 mL and 135 mL. Lanes 1-
8 = fractions eluted from the shoulder (1) and the large peak (2-8) following size 
exclusion chromatography. Dashed lines connect the fractions from the 
chromatogram with analysis by SDS-PAGE. 
(c) EM image of purified STNV VLPs 
Pooled fractions diluted 10-fold and visualised by electron microscopy. Images 
were taken 52,000 times magnified; scale bar = 50 nm. 
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3.2.5 In vitro disassembly and reassembly of STNV VLPs – proteolysis and 
effect on capsid assembly 
 
In order to effectively disassemble and reassemble STNV VLPs in vitro, two 
methods were attempted by Dr Steven Lane that were known to disassemble 
two other ssRNA viruses, namely MS2 and TCV89. MS2 disassembles with the 
addition of two volumes of glacial acetic acid126, while high salt (1 M) and pH 
(8.5) buffer in the presence of ethylenediaminetetraacetic acid (EDTA) (3 mM) 
successfully dissociates other plant viruses, such as Turnip Crinkle Virus 
(TCV)34. Only the latter method resulted in the elimination of T=1 capsids 
following dialysis, as shown by TEM. When the disassembled capsids were 
subjected to dialysis against reassembly buffer (containing 3 mM CaCl2), T=1 
capsids re-emerged as shown by TEM123. This showed for the first time that 
STNV VLPs could be disassembled and reassembled in vitro.  
 
However, when STNV VLPs are disassembled, the coat protein becomes very 
proteolytically sensitive, and appears to be at the mercy of trace proteases28. 
When I attempted to perform these disassembly and reassembly experiments 
using Dr Lane’s protocol, the STNV CP became extensively proteolysed. 
Subsequent attempts to reassemble STNV CP where proteolysis has run to 
completion results in failure (data not shown).  
 
Several methods were employed in an attempt to prevent this proteolysis and 
the subsequent aberration of capsid assembly. The first of these was the 
inclusion of complete protease inhibitor tablets (Roche) in all buffers when 
dealing with the in vitro disassembly and reassembly of STNV VLPs. Although 
inefficient capsid assembly was observed, there was still considerable 
proteolysis of STNV CP (data not shown).  
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The inclusion of complete protease inhibitors in all the buffers was not enough 
to prevent proteolysis, so more drastic action was required to tackle this 
problem. In addition to having protease inhibitors in the buffers, each sample 
was incubated with α2-Macroglobulin (α2M) (Roche) for 30 mins prior to being 
exposed to disassembly conditions. The N-terminal arm of TCV is also 
incredibly proteolytically sensitive, but the addition of α2M helps to prevent 
proteolysis from occurring34. With this rationale, disassembly and reassembly 
experiments were performed in the presence of α2M. 
 
α2M is a 800 kDa homotetrameric plasma protein that circulates around the 
bloodstream of vertebrates127. It functions as a protease inhibitor in vivo, and is 
able to inactivate a huge variety of proteases including members from all the 
known families of proteases128. The mechanism of protease inhibition is due to 
a unique mechanism: the protease binds to α2M at a stretch of amino acids 
termed the ‘bait’ region127; 128. This ‘bait’ region contains a number of peptide 
bonds recognised for cleavage by the various proteases. Subsequent cleavage 
of the bait region of α2M induces a massive conformational change in α2M, 
which results in entrapment of the protease, and renders the protease 
inactive127; 128.  
 
In order to characterise whether α2M prevents proteolysis and mediates efficient 
capsid assembly, 0.5 mL STNV VLPs (2 mg/mL) were dialysed in disassembly 
buffer containing 1 unit of α2M in two separate dialysis reactions. In addition, 0.5 
mL STNV VLPs (2 mg/mL) containing 1 unit of α2M was analysed by size 
exclusion chromatography, where the fractions were collected for SDS-PAGE. 
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Prior to chromatography, an aliquot was taken for TEM to confirm the presence 
of VLPs. 
 
After 6 hours of dialysis against disassembly buffer, one of the samples was 
removed and dialysed against reassembly buffer for 24 h at 4ºC. An aliquot 
from the disassembled sample was also taken for TEM to confirm whether 
disassembly was successful, before being analysed by size exclusion 
chromatography. The reassembled sample was also subjected to analysis by 
TEM, size exclusion chromatography and SDS-PAGE. Figure 3.5 shows an 
overlay from each size exclusion chromatogram relating to STNV exposed to 
native, disassembly and disassembly/reassembly conditions (top). In addition, 
how the chromatogram relates to fractions on an SDS-PAGE and the 
corresponding TEM (bottom). 
 
The size exclusion profile from the native STNV sample showed two major 
peaks which eluted between 7-12mL and a minor peak which eluted between 
13-14mL. The SDS-PAGE from these fractions identified α2M as the major 
species on the gel from the first peak, whereas STNV was the major species in 
the second peak. The third minor peak contains BSA, which is also present in 
the α2M sample (Roche), presumably to prevent undesired aggregation. The 
reason why α2M appears in both these major peaks is not known, but is 
probably due to aggregation. In contrast, it is known that binding proteases into 
the bait region of α2M induces a large conformational change and that α2M also 
binds other proteins such as apoE, with complexes detected as being as large 
as 18.5 nm129. This phenomenon may also contribute to this profile. 
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The elution profile from the disassembled STNV shows that eluted STNV CP 
shifts from between 9-11mL to approximately 15-17mL, confirmed by 15% SDS-
PAGE. This had the same shift in the elution profile observed in prior 
disassembly and reassembly experiments without α2M, but without the same 
proteolysis of the N-terminus (data not shown). The absence of STNV VLPs in 
the TEM of the disassembled sample provided further evidence that STNV 
VLPs were successfully disassembled (see Figure 3.5).  
 
The chromatogram obtained from the reassembled VLPs showed that the main 
peak returns to that which corresponds to native STNV capsid. This is further 
confirmed by analysis of reassembled STNV by TEM, and by the corresponding 
SDS-PAGE analysis from the size exclusion fractions. Although reassembly has 
been successfully initiated, it appears from both the chromatogram and SDS-
PAGE analysis that some STNV CP becomes aggregated. This could be due to 
the α2M. It is known that α2M has a very broad specificity for its protein targets 
and that its protein targets are not always proteases129. Under conditions that 
favour STNV assembly, it may be that some aggregation takes place with α2M. 
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Figure 3.5: STNV disassembly/reassembly in the presence of α2M.  
Native, disassembled and reassembled samples of STNV (0.5 mg) in the 
presence of α2M (1 U) were analysed by size exclusion chromatography (SEC), 
where the fractions that absorbed at 260 and 280 nm were analysed by SDS-
PAGE. An aliquot was taken prior to SEC for TEM. Top panel shows an overlay 
of the SEC chromatogram from each sample. Bottom panel shows each 
individual chromatogram above the SDS-PAGE connected by dotted lines to the 
relevant fractions, and the image captured by TEM is shown at the bottom of 
the panel. Scale bar = 50 nm. 
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3.2.6 STNV CP purification with α2M 
 
To investigate how RNA influences STNV capsid assembly, the STNV CP must 
be purified in a manner which leaves the CP i) free from proteolysis; ii) 
assembly competent; and iii) free from RNA packaged in E. coli. Previous 
attempts to purify STNV CP by size exclusion chromatography failed on all 
three counts28, thus a new approach was adopted using ion exchange 
chromatography. The premise for this was simple; to disassemble STNV VLPs 
in a manner that preserves full-length STNV CP and to separate the RNA from 
the STNV CP based on their net charge. STNV CP has an isoelectric point (pI) 
of 10, presumably due in part to the highly basic N-terminal region89, whereas 
RNA contains a large net negative charge relative to the size of the RNA 
molecule.  
 
There was one main caveat to using ion exchange chromatography with 
disassembled STNV. Previous conditions for STNV disassembly involved 
dialysis into a buffer containing elevated pH (8.5), EDTA (3 mM) and high NaCl 
concentration (1 M)28; 123. Serendipitously, it was observed that STNV VLPs 
disassembled without increasing the NaCl concentration. It was therefore 
possible to carry out ion exchange chromatography on disassembled STNV 
using disassembly buffer minus NaCl.  
 
STNV VLPs were disassembled by dialysis into disassembly buffer without 
NaCl and then subjected to Q-Sepharose anion exchange chromatography. It 
was presumed that the Q-Sepharose resin would be sufficient to out-compete 
the STNV CP and bind all the RNA, and that the STNV CP would elute in the 
flow through from the column. The results from these initial experiments showed 
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that although the majority of the RNA was successfully removed, there 
remained fragments of RNA that was bound to the coat protein (data not 
shown). This shows that STNV CP binds tightly to RNA, and that Q-
SepharoseTM anion exchange chromatography on its own was not sufficient to 
purify STNV CP. 
 
To overcome this limitation, an SP SepharoseTM cation exchange column was 
used to bind STNV CP following Q-SepharoseTM anion exchange 
chromatography. In this way, the Q-Sepharose resin binds RNA, whereas the 
SP resin binds the STNV CP.  
 
STNV VLPs (5 mg) were disassembled by dialysis in disassembly buffer without 
NaCl in the presence of 3 U α2M (Roche). The sample was then loaded onto a 
Q-Sepharose anion exchange and SP cation exchange columns in series. Post 
injection, the flow through from these columns eluted after about 2 mL, where 
the absorbance at 260 and 280 nm were monitored. The 280 nm signal was 
initially higher in the sample, where three fractions were collected between 2 
and 8 mL, followed by a larger 260 nm peak, presumably due to displaced RNA. 
When the UV absorbance returned to baseline (after 10 mL), the Q-Sepharose 
column was removed from the SP column. The SP column was washed for 20 
column volumes before a NaCl gradient was applied. The NaCl gradient 
induced an increase in conductivity which eluted whatever was bound to the 
column. Three fractions from the two peaks were taken, and analysed by SDS-
PAGE (see Figure 3.6).  
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Figure 3.6: STNV CP purification and analysis in the presence of α2M 
(a) Chromatogram of STNV CP purification using Q-Sepharose anion 
exchange and SP cation exchange chromatography in series. The 
absorbance was monitored at 254 nm (blue dashed line) and 280 nm (blue 
unbroken line). Conductivity monitored on second axis (brown).  
(b) SDS-PAGE showing proteolysed STNV CP. Three fractions from two 
peaks were collected and analysed by SDS-PAGE. The proteins that eluted in 
the first peak were collected in fractions from the flow through (i.e. did not bind 
to either Q-sepharose or SP resin) were α2M and BSA, and faint bands 
corresponding to proteolysed STNV CP. The second peak was eluted with a 
NaCl gradient from the SP column, and contained a mixture of full length STNV 
CP and proteolysed STNV CP. Each component is clearly labelled by an arrow 
on the gel.  
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Fractions analysed from the first peak showed that α2M and BSA was present in 
flow through, as well as proteolysed material from STNV CP. The fractions from 
the second peak showed that STNV CP was eluted from the SP column. Two 
species were present on the gel, corresponding to full length STNV CP and 
proteolysed STNV CP. The A260/280 ratio of this material was ~0.6, suggesting 
that all of the RNA had been successfully removed. However, proteolysis 
remained a problem, even in the presence of α2M. This suggests that trace 
proteases in the sample need to be removed prior to STNV CP purification.  
 
3.2.7 B3-mediated capsid assembly using proteolysed STNV CP 
The fractions of STNV CP from Figure 3.6 were pooled and the concentration 
was determined by UV absorbance, using the Beer-Lambert law (STNV-1 CP ε 
= 16,960 M-1 cm-1). STNV CP (0.5 mL, 0.5 mg/mL) was dialysed in reassembly 
buffer overnight at 4ºC in the presence (~80 µg/mL) and absence of aptamer 
B381. Aptamer B3 (30-mer) was synthesized by Amy Barker, using solid phase 
synthesis as described by Murray and Prokop 130. The sequence is given in 
Table 1.2 and Chapter 2.4.4, respectively. 
 
Following dialysis, size exclusion chromatography was performed before 
fractions were analysed by SDS-PAGE, and fractions between 8-12 mL 
analysed by TEM. It was hypothesized that only full length STNV CP would 
support capsid assembly, based on previous Δ15 STNV CP truncation 
experiments, and that aptamer B3 was selected in the presence of immobilised 
STNV CP81. Previously, in vitro capsid assembly experiments with B3 failed to 
produce VLPs28, although STNV CP was digested prior to experimentation. 
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The chromatogram obtained from STNV CP in the absence of aptamer B3 
eluted between ~17-20 mL, suggesting that capsid assembly did not take place. 
Fractions were taken between 10-12 mL and 18-20 mL and concentrated using 
Amicon Ultra® spin concentrators and the fractions were analysed by SDS-
PAGE. Both proteolysed STNV CP was present in the 18-20 mL fractions, but 
no evidence was obtained for any STNV CP in the 10-12 mL fractions. An 
aliquot taken prior to size exclusion chromatography was also analysed by 
TEM, but no capsids were observed.  
 
In contrast, the size exclusion elution profile of STNV CP in the presence of 
aptamer B3 shows three peaks; a peak that elutes between 10-12 mL, one that 
elutes between 18-20 mL and one that elutes between 20-22 mL. Fractions 
were taken from peaks 1 and 2 and concentrated using Amicon Ultra® spin 
concentrators. Presumably, the peak that elutes between 22-24 mL is aptamer 
B3, based on the size of the aptamer and the A260:280 ratio. The concentrated 
fractions were analysed by SDS-PAGE, where it was observed that only full 
length STNV CP was present in the first peak, whereas proteolysed material 
was present in the second. TEMs prepared from peak one confirm that the shift 
in this peak is the result of capsid assembly (see Figure 3.7).  
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Figure 3.7: Proteolysed STNV CP reassembly in the presence of B3  
(a): Overlay of size exclusion chromatograms looking at STNV reassembly 
with and without B3. The chromatogram in green is STNV CP reassembled 
with aptamer B3. The chromatogram in red is STNV CP exposed to reassembly 
conditions without RNA. The solid lines represent absorbance at 280 nm 
whereas the broken lines represent absorbance at 254 nm.  
(b): Characterisation of capsid assembly. Each chromatogram is shown 
separately, with 2 fractions taken (indicated as numbers). These fractions were 
analysed by SDS-PAGE and by TEM. Upper arrow shows full length STNV CP 
and lower arrow shows proteolysed STNV CP. Scale bar = 50 nm 
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3.2.8 Sucrose density gradient fractionation 
In order to remove α2M from STNV VLPs, it was imperative to find a new 
solution to prevent proteolysis. Being as trace proteases are still present in the 
purified VLPs, a new approach was taken to remove the proteases from the 
sample. Instead of size exclusion chromatography being used as a clean-up 
step after Q-Sepharose chromatography, sucrose density gradient fractionation 
was performed for the final purification step.  
 
After Q-Sepharose anion exchange chromatography, fractions from peak 1 
were pooled and ammonium sulphate precipitated (see Figure 3.3). The 
ammonium sulphate precipitated sample was then centrifuged at 26,892 g, and 
the pellet was resuspended in 12 mL native buffer. The sample was then 
extensively dialysed against native buffer to remove the ammonium sulphate. 
 
In total, 6 sucrose density gradients (15-45% (w/v)) were prepared in 38 mL 
tubes (Seton), where 2 mL of sample was loaded on top of each sucrose 
density gradient. The gradients were centrifuged using a SW32ti rotor at 18,500 
rpm for 21 h at 4ºC and allowed to stop without braking to avoid disruption to 
the gradients. The gradients after centrifugation contained a band near the 
middle of the tubes with a ‘cloudy’ appearance (see Figure 3.8d, white arrow 
shows cloudy band). The gradients were fractionated and the absorbance at 
260 and 280 nm was measured (see Figure 3.8a). The fractionation profile 
showed 2 peaks which absorbed at both 260 and 280 nm. These peaks were 
then analysed by SDS-PAGE, where the 1st peak contained contaminating 
proteins and the 2nd peak contained STNV VLPs. The 2nd peaks from all the 
gradients were pooled and extensively dialysed against native buffer to remove 
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the sucrose. An aliquot was taken and diluted 10-fold before being analysed by 
TEM, which confirmed the presence of STNV VLPs (see Figure 3.8c). The yield 
according to UV absorbance and level of purification estimated by SDS-PAGE 
analysis suggests that sucrose density gradient fractionation was at least 
equivalent to size exclusion chromatography (see Figure 3.8).  
 
 
Figure 3.8: Sucrose density gradient fractionation of STNV VLPs 
(a) Sucrose density gradient fractionation profile of STNV VLP 
purification.  
The solid line monitors the A280 and the broken line monitors A260. The peaks 
labelled 1 and 2 were analysed by SDS-PAGE and peak 2 by TEM. Flattening 
of the peak indicates going off scale. 
(b) SDS-PAGE analysis of peaks 1 and 2. 
Contaminating proteins are eluted in peak 1 whereas STNV VLPs are eluted in 
peak 2, indicating that STNV VLPs were efficiently purified.  
(c) Electron micrograph of STNV VLPs from peak 2. 
STNV VLPs from peak 2 were diluted 10-fold and analysed by negative stain 
TEM. 
(d) Photograph of sucrose density gradient. 
The gradient holder (black) is cropped to show the sucrose density gradient. 
The white cloudy band in the middle of the gradient is STNV VLPs. 
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3.2.9 One-pot disassembly/reassembly of STNV VLPs after sucrose 
density gradient fractionation 
 
To assess whether sucrose density gradient fractionation could remove trace 
proteases from STNV VLPs, another disassembly/ reassembly was performed 
with Amy Barker. STNV VLPs (0.5 mL, 1 mg/mL) using sedimentation velocity 
experiments in the absence of α2M. Aliquots were taken for SDS-PAGE 
analysis and TEM at every stage prior to being analysed by sedimentation 
velocity.  
 
The STNV VLP has a sedimentation coefficient (S20,w) ~42 S, comparable to the 
native STNV-1 virion (38-45 S)80. When the material is disassembled, several 
heterogeneous peaks emerged, ranging from ~1.5 S to 30 S. Amongst these 
heterogeneous peaks, a sharp peak was present at 1.5 S, presumably owing to 
the STNV CP (see Figure 3.9). Several peaks are present that correspond to 
the RNA. These peaks are likely to be different sizes and/or conformers of the 
RNA packaged in E. coli. Sedimentation velocity of STNV CP mRNA transcript 
also produces heterogeneous peaks beginning at ~10 S (see Figure 4.5), 
suggesting that a subset of this material is the mRNA.  
 
The reassembled material contains no heterogeneous peaks and sediments at 
~42 S, suggesting that the STNV VLPs have reassembled. The SDS-PAGE 
from each sample showed that no proteolysis occurred (see Figure 3.9c), 
therefore the efficiency of reassembly is very high (>95 %) when proteases are 
not present. TEMs from each sample showed that STNV VLPs are removed 
when exposed to disassembly conditions, whereas the capsids re-emerge 
under reassembly conditions (Figure 3.9b). 
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Figure 3.9: In vitro disassembly and reassembly of STNV VLPs 
(a) Normalised c (S) versus (S) plots of, from top to bottom, STNV VLP, 
disassembled STNV and reassembled STNV VLP.  
(b) TEM micrographs corresponding to the samples shown on the left. 
(c) SDS-PAGE from each sample. L = 7-176 kDa prestained ladder (NEB); + = 
STNV VLP control; 1 = STNV VLP (top); 2 = Disassembled STNV (middle); 3 = 
Reassembled STNV (bottom) 
 
3.2.10 STNV CP purification after sucrose density gradient fractionation 
Previously, it was clear that by including a sucrose density gradient fractionation 
step into STNV VLP purification, removal of proteases could be achieved (see 
Figure 3.10). Although dialysis into disassembly buffer without NaCl proved 
successful at disassembling STNV VLPs, it was not as efficient as with 1 M 
NaCl. Directly adding 10 X disassembly buffer without NaCl to a 4/5th volume of 
the STNV VLPs resulted in efficient disassembly. In addition, this method 
proved to be quicker, thus minimising the amount of time STNV CP was 
exposed to any potential trace proteases. 
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STNV VLPs (12 mL, 1 mg/mL) purified by sucrose density gradient fractionation 
were disassembled by adding 1/5th volume of disassembly buffer. The sample 
was then immediately loaded onto Q-Sepharose anion exchange and SP cation 
exchange columns in series. After 30 mL, the Q-Sepharose anion exchange 
column was removed and the SP column was washed for 30 column volumes. 
Following washing, the STNV CP was eluted by a NaCl gradient and the 
fractions were analysed by SDS-PAGE (see Figure 3.10). The SDS-PAGE 
analysis showed that STNV CP was not proteolysed and the A260:280 ratio of 
~0.6 indicated that the RNA was successfully removed. 
 
In order to characterise the STNV CP in both disassembly buffer and 
reassembly buffer, sedimentation velocity experiments were performed under 
these conditions with Amy Barker. The results from sedimentation velocity 
under disassembly conditions showed that STNV CP has a major component 
which has a S20,w =2.037 S (estimated Mr 18,033 Da), with minor species 
observed both at ~4 S and ~6 S, corresponding to monomer, trimer and 
pentamer, respectively. Sedimentation velocity experiments performed with 
STNV CP under reassembly conditions produced identical results to that of 
STNV CP under disassembly conditions, suggesting that STNV VLPs cannot 
assemble in the absence of RNA (Appendix, Figure 9.1). Equilibrium 
sedimentation of these samples under these conditions showed that there was 
no appreciable self aggregation (data not shown). The mass of STNV CP was 
determined using mass spectrometry, and is calculated at 21,584.17±0.67 Da, 
which is consistent with what is expected of STNV-1 CP minus the N-terminal 
methionine (21,583.52 Da) (Appendix, Figure 9.2). 
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Figure 3.10: Purification of full length STNV coat protein 
STNV VLPs were disassembled and purified in parallel by Q-Sepharose/SP ion 
exchange chromatography. STNV RNA binds to the Q-Sepharose anion 
exchange resin, whereas the coat protein binds to the SP resin. The anion 
exchange column is removed and the coat protein is eluted by a gradient of 
NaCl. Solid blue line represents A280 whereas the blue dashed lines represent 
A254. The conductivity is shown in brown. The fractions from the peak were 
analysed by 15 % SDS-PAGE, where dashed blue lines shows which fractions 
from the chromatogram were analysed.  L = 7-176 kDa prestained ladder 
(NEB); + = STNV VLP control; 1 – 5 = Fractions from NaCl eluted STNV CP     
L          +           1            2         3           4            5
0
20
40
60
80
100
120
140
160
0
50
100
150
200
250
300
0 10 20 30 40 50 60 70 80 90 100
C
o
n
d
u
c
ti
v
it
y
 (
m
/S
)
A
b
s
o
rb
a
n
c
e
 2
5
4
 +
 2
8
0
 n
m
 (
m
A
U
)
Elution volume (mL)
Absorbance 280nm (mAU)
Absorbance 254nm (mAU)
Conductivity (m/S)
176 kDa
80 kDa
58 kDa
46 kDa
30 kDa
25 kDa
17 kDa
7 kDa
108 
 
 
 
 
 
 
 
 
Figure 3.11: Sedimentation velocity of STNV CP 
STNV-1 CP was purified by ion exchange chromatography and analysed by 
AUC. The inset shows a rescaled c (S) axis from 2.5-7 S highlighting the minor 
species present in the sample. 
 
Figure 3.11 indicates that 2/3 objectives were achieved when the goals of STNV 
CP purification were set out. In order to test the third criteria of successful STNV 
CP purification, namely capsid assembly competency, reassembly experiments 
were carried out using purified STNV CP in the presence and absence of 
aptamer B3.  
 
3.2.11 B3-mediated capsid assembly with full length STNV CP 
In order to determine whether the purified STNV CP remains capsid assembly 
competent, capsid assembly experiments were performed in the presence and 
absence of aptamer B3. Although it was observed by AUC that STNV CP does 
not form capsids in the absence of RNA, this was included as a negative 
control.  
 
0.5 mL STNV CP (0.5 mg/mL) was subjected to dialysis against reassembly 
buffer in the presence and absence of aptamer B3 (100 µg/mL). The dialysed 
samples were then analysed by size exclusion chromatography using a pre-
equilibrated 10/300 GL S-200 column. Each sample was loaded onto the 
column at a flow rate of 0.5 mL/min and the absorbance was monitored at 260 
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and 280 nm. The fractions with UV absorbance were analysed by SDS-PAGE 
and TEM. 
 
STNV CP that had been dialysed against reassembly buffer in the presence of 
aptamer B3 mainly eluted in one peak between ~8-12 mL. Minor peaks are also 
present between 18-20 mL and 22-24 mL, presumably corresponding to STNV 
CP monomer and aptamer B3, respectively. TEMs of the peak which eluted 
between 8-12 mL showed the presence of capsids and species which look like 
incomplete capsids (see Figure 3.12).   
 
Fractions from peaks 1 and 2 were concentrated with Amicon Ultra® centrifugal 
concentrators and analysed by SDS-PAGE. STNV CP was present and 
unproteolysed in peak 1, whereas no STNV CP was detected in peak 2, as is 
expected at this very low UV absorbance. The peak between 22-24 mL is where 
aptamer B3 eluted previously (see Figure 3.7). 
 
STNV CP dialysed in the absence of RNA was also loaded on to a pre-
equilibrated 10/300 GL S-200 size exclusion column at a flow rate of 0.5 
mL/min. As expected, the STNV CP eluted between ~16-20 mL, with no UV 
absorbance detected where capsids elute. Analysis by SDS-PAGE shows that 
no STNV CP is detected between 8-12 mL, suggesting that STNV CP doesn’t 
spontaneously assemble into capsids in the absence of aptamer B3, thus 
confirming what was observed with sedimentation velocity analysis. SDS-PAGE 
also confirms that no proteolysis was observed in either sample and no capsids 
were observed by TEM. 
 
110 
 
 
Figure 3.12: B3-mediated capsid assembly 
(a) Overlay of size exclusion chromatograms 
Capsid assembly studies were carried out using STNV CP with and without 
aptamer B3. Solid lines represent 280 nm whereas dashed lines represent 254 
nm.  
(b) Characterisation of capsid assembly 
The chromatograms are shown along with fractions that were analysed by SDS-
PAGE connected by dotted lines. TEMs of each sample are also shown; scale 
bar = 50 nm.  
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3.3 Discussion 
The results in this chapter illustrate the importance of the highly basic N-
terminal region in regards to STNV capsid assembly. Many other viruses also 
contain highly basic N-terminal regions, and some of these viruses can 
assemble into empty particles when their CP N-terminus is proteolysed34; 88; 131. 
However, truncation of the N-terminus does not promote capsid assembly in 
STNV, and no appreciable self aggregation has been observed in this 
proteolysed state. Tryptic digests of EDTA-expanded STNV particles results in 
one cleavage product, where Arg 28 becomes cleaved, just past the N-terminal 
helix80.   
 
Previously, STNV CP truncation mutants (STNV Δ12 CP) were expressed in E. 
coli to analyse the effect of the N-terminus on capsid assembly in vivo81. During 
purification, it became evident that this protein was assembly deficient. This 
deficiency in capsid assembly implicates the first 12 residues as being vital for 
making appropriate contacts between either neighbouring subunits or nucleic 
acid. From these 12 deleted residues, 5 of them are positively charged at 
neutral pH, suggesting they perform crucial charge neutralisation functions. In 
the recombinant STNV X-ray crystal structure, it’s clear that at least residues 
12-24 are in close proximity to RNA89. Residues 1-11 are invisible in both 
recombinant and wild-type STNV crystal structures, probably due to these 
residues being disordered77; 78; 89. It is conceivable that these residues make 
contacts with the asymmetric RNA genome, and therefore density is lost by 
icosahedral averaging. 
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Despite multiple attempts, no capsid assembly was observed in the absence of 
RNA. Sedimentation velocity analysis of STNV CP overwhelmingly suggests 
that STNV CP exists as a monomeric species (>99 %) under both disassembly 
and reassembly conditions, with minority species existing in trimeric and 
pentameric forms. It is possible that the reason why STNV CP will not self-
assemble into capsids in the absence of RNA is because of repulsive effects 
from the highly basic N-terminus. If protein-protein interactions were the 
dominant determinant of capsid assembly, then surely there would be assembly 
products when proteolysed STNV CP is placed under assembly conditions in 
vitro. In addition, STNV Δ12 CP failed to assemble in vivo, whereas the full 
length CP produced STNV VLPs under the same conditions. This suggests 
RNA: CP interactions are critical for capsid assembly. 
 
But what is the nature of these RNA: CP interactions? Are they sequence 
specific, or are they solely dependent on electrostatic interactions between the 
N-terminus of the CP and the phosphodiester backbone of the RNA? These 
questions have partially been answered by SELEX experiments in the presence 
of immobilised STNV CP81. The results of this analysis showed that from the 17 
aptamers generated, all but 2 had a stem-loop structure displaying the motif 
(AXXA) in a 4, 5 or 6 loop, respectively. Bioinformatics analysis showed that 
these aptamers had significant sequence similarity to several positions on the 
STNV-1 genome. The functional relevance of one of these aptamers, B3, was 
analysed by capsid assembly experiments in vitro. These capsid assembly 
experiments showed that aptamer B3 could initiate capsid assembly in vitro and 
that minimal fragments (30-mers) were capable of supporting assembly. The 
A260:280 ratios of these STNV-B3 VLPs were ~1.7, suggesting that multiple stem 
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loops were encapsidated. The next Chapter describes the sequence specificity 
of the STNV: CP interactions on the efficiency of STNV VLP assembly, and 
characterises the X-ray crystal structure of STNV-B3 VLP.  
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4. Sequence-specific interactions overcome an 
electrostatic barrier preventing capsid assembly of 
empty STNV VLPs 
 
4.1 Introduction 
Previously, it was determined that STNV CP forms sequence-specific 
interactions with a series of stem loops, each displaying an AXXA motif81. This 
motif can be displayed in the context of a 4, 5 or 6 nucleotide loop. In the 
previous Chapter, it was shown that aptamer B3 could trigger capsid assembly 
in vitro, and that STNV CP will not assemble in the absence of RNA.  
 
This Chapter addresses whether other RNAs support STNV assembly, what the 
efficiency of capsid assembly is relative to each of these RNAs, and whether 
multiple copies of the AXXA motif within genomes are functionally significant. 
This has been explored using a combination of svAUC and TEM to determine 
the relative capsid assembly efficiency of STNV CP in the presence of these 
different RNAs. These include aptamer B3 and a sequence variant, other short 
RNAs that present the AXXA motif differently and longer RNAs including a 
cognate STNV genome (see Figure 4.1). These RNAs were subjected to 
reassembly conditions at a fixed concentration, with increasing amounts of 
STNV CP titrated into these RNAs. In addition, VLPs were reassembled in the 
presence of aptamer B3, B3 short and TR on a large scale and purified. These 
purified VLPs were crystallised. STNV-B3 VLP crystals diffracted to a high 
resolution and their structure was solved by X-ray crystallography to 2.3 Å.  
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Figure 4.1: The STNV system and stem loops used in capsid assembly 
(a) The STNV capsid.  
The X-ray crystal structure of recombinant STNV is shown as a blue cartoon. 
The view is looking down the three-fold axis of symmetry.  
(b) Central view through the STNV VLP  
A 45 Å slab is cut through the STNV VLP, where the N-terminal helices are 
coloured green, and the structure of 7 nucleotides per coat protein monomer of 
ordered RNA is also shown (orange).  
(c) Close up view of the STNV coat protein subunit.  
STNV CP is a wedge-shaped jelly roll β-sandwich. The N-terminal region 
contains a net positive charge, where it is visible until Thr12. The unstructured 
portion (magenta) of the N-terminus contains a further four basic amino acid 
side chains as indicated by the underlined sequences shown.   
(d) The sequences and MFold predicted secondary structures of the RNA 
stem loops used for probing capsid assembly. 
B3 short and MS2 TR are shown next to each other, with B3 and B3 4U shown 
below. Note B3 and B3 4U are identical in terms of their sequences and 
structures other than the 4 residues in the loop. Figure taken from Ford et al 
(submitted) courtesy of Dr Neil Ranson.  
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4.2 Results  
 
4.2.1 RNA production and purification 
In order to investigate the sequence specificity of RNA on the efficiency of 
capsid assembly, both STNV CP and RNAs must be amenable to 
experimentation. Chapter 3 describes in detail how STNV CP was purified and 
the measures that were put into place to ensure the production of full length, 
assembly-competent STNV CP. Similarly, the RNAs were prepared diligently, 
being careful to avoid RNase contamination. These were prepared either by in 
vitro transcription from an already characterised pre-existing DNA template or 
by using RNA synthesis, utilising solid-phase phosphoamidite chemistry as 
described in Chapter 2.4.4. Oligonucleotides ≤30 nt in length were prepared by 
solid phase synthesis, purified and characterised by mass spectrometry and 
denaturing PAGE, as described in Chapter 2.2.1.4. RNAs >30 nts were 
transcribed from a pre-existing template and purified as described in Chapter 
2.2.3. The purified products were analysed by 1 % (w/v) denaturing agarose gel 
electrophoresis as described in Chapter 2.2.1.3. 
 
The capsid assembly efficiency of aptamer B3 and a sequence variant, B3 4U, 
were compared by STNV CP titrations using a svAUC assay and 
complemented by TEM images. These RNA oligonucleotides were identical in 
sequence, other than the ACAA loop sequence of B3 was replaced with UUUU 
in B3 4U (see Figure 4.1). This sequence variant was designed to test the 
importance of the AXXA motif for capsid assembly. A truncated version of the 
B3 stem loop was also prepared with an additional base pair to stabilise the 
stem and a single-stranded base at either end (B3 short, 16 nt). In addition, the 
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known capsid assembly initiation signal in MS2, TR (19 nt)64, was synthesised. 
This RNA stem loop oligonucleotide is composed of a stem interrupted by a 
single base bulged adenine, but displays the motif (AUUA) in the loop. Capsid 
assembly using these oligomeric RNA stem loops were compared, both to 
analyse whether the sequence of the stem was important for capsid assembly, 
and whether the 5' and 3' flanking sequences in aptamer B3 affected capsid 
assembly.  
 
Although STNV VLPs can package RNA oligonucleotides, STNV packages its 
genome of 1239 nt in vivo. It was shown previously that the STNV-1 genome 
contains up to a total of 30 stem loops displaying the -AXXA- motifs81. Longer 
RNAs were therefore prepared by in vitro transcription from DNA templates for 
capsid assembly. The STNV CP mRNA89 (590 nt) and a cognate STNV-C115 
(1221 nt) genome were transcribed from digested pET22b-STNV89 and pUBS-
STNV-C115 plasmids, respectively. These RNAs were compared for in vitro 
capsid assembly studies to determine whether the stem loops in the STNV 
genomes were functionally significant. STNV CP mRNA contains fewer stem 
loops than the STNV-C genomes, both because the mRNA is shorter and 
because it was mutated to ensure it was codon optimised for efficient translation 
in E. coli 89. It was therefore hypothesised that STNV-C RNA would be more 
efficient at assembly than STNV mRNA.  
 
Similarly, multiple putative packaging signals (PSs) have recently been 
identified in the MS2 genome. These PSs were identified using a combination of 
bioinformatics, structural and biophysical data (Dykeman et al, submitted). 
There are similar PSs present in the genomes of STNV. For these reasons, two 
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MS2 sub-genomic RNA fragments were prepared. One of these RNAs, MS2 
iRNA (927 nt), was transcribed from a PCR template derived from the pSMART 
plasmid encompassing the internal fragment from the MS2 genome. This RNA 
contained the TR stem-loop as well as similar PSs, but is ~25% shorter than the 
STNV genome. Furthermore, these PSs may not be optimally spaced for STNV 
encapsidation. For these reasons, it was hypothesized that MS2 iRNA should 
trigger capsid assembly, but may not be as efficiently packaged as the cognate 
genome. MS2 5'RNA was transcribed directly from the same linearised 
pSMART plasmid, and is 2469 nt long (i.e. roughly twice as large as the STNV 
genome). The reason why this RNA was selected is because it contains 
multiple PSs for MS2, but should not be encapsidated by STNV CP, due to the 
size constraints imposed on the interior of the T=1 capsid. 
 
In vitro transcription was performed using the commercial MEGAScript 
(Ambion®) transcription kit using manufacturer’s instructions, and purified as 
described in Chapter 2.2.3. The yield routinely obtained was ~10 µg per 25 µL 
transcription reaction per RNA. Each of the long RNAs were analysed by 
denaturing 1 % (w/v) agarose gel electrophoresis to determine the size and the 
purity of the product (see Figure 4.2a).  
 
Oligonucleotides (≤30 nt) were synthesised and purified by an established in-
house method by Amy Barker according to Chapter 2.4.4. Each oligonucleotide 
was subjected to denaturing PAGE and the molecular weight was determined 
by ESI mass spectrometry (see Appendix, Figures 9.3-9.6). 
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Figure 4.2: Gel electrophoresis of RNAs 
(a) Denaturing agarose electrophoresis of RNA transcripts 
1 = STNV mRNA; 2 = STNV-C RNA; 3 = MS2 iRNA; 4 = MS2 5' RNA; L = 1 kb 
DNA ladder (NEB) 
(b) Denaturing PAGE of RNA oligonucleotides 
1 = MS2 TR; 2 = B3; 3 = B3 4U; 4 = B3 short; L = 10 bp DNA ladder (NEB) 
 
 
4.2.2 Determining the effect of sequence-specificity by STNV CP titrations  
In order to determine whether capsid assembly was sensitive to the preferred 
loop sequence motif derived by SELEX (AXXA)81, two 30-mer oligonucleotides 
encompassing variations on this motif were prepared (see Figure 4.1). These 
consisted of aptamer B3 and an otherwise identical fragment (B3 4U) in which 
the 4 base loop sequence of B3 (ACAA) was replaced (UUUU). The efficiency 
of these fragments at promoting capsid assembly was tested. STNV CP was 
then titrated into a fixed concentration of RNA (2 µM) in each reaction and 
dialysed against reassembly buffer. For 0.5:1 reactions, this compared 1 M 
STNV CP in 2 µM RNA, i.e. less than stoichiometric with respect to a T=1 VLP, 
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if each CP subunit binds one RNA stem-loop, rising to 5:1 or 10 M of STNV 
CP. The end products of assembly were analysed using sedimentation velocity 
analytical ultracentrifugation (svAUC) and negative stain transmission electron 
microscopy (TEM) as described in Chapters 2.4.6 and 2.2.2, respectively. The 
svAUC was analysed using a continuous distribution c(S) vs. S Lamm equation 
model118.  The percentage of assembled T=1 capsids in each reaction was 
estimated from the area of the peaks in the c(S) vs. (S) plots (see Table 4.1). 
The data are displayed as c(S) vs. S plots for CP: RNA molar ratios ranging 
from 0:1 to 5:1. Under the same buffer conditions, the recombinant STNV VLP 
has a sedimentation coefficient of 42 S (indicated by grey line in each 
titration)81. There is an obvious difference in the efficiency of capsid assembly 
between aptamer B3 and the mutant lacking the AXXA motif (Table 4.1, Figure 
4.3). Aptamer B3 promotes formation of species sedimenting at 42 S at a molar 
ratio of 1:1. This is below the protein: RNA stoichiometry expected for a T=1 
capsid with 30 stem-loops bound. As well as the 42 S species, the reassembly 
also yields an intermediate species sedimenting at ~28 S. TEMs show that they 
correspond to intact T=1 capsids (42 S) and incomplete shells with the 
dimensions compatible with a T=1 architecture (28 S), respectively. In contrast, 
the mutant sequence appears to be less efficient at stimulating assembly at a 
1:1 ratio, and is significantly hindered at a ratio of 2.5:1. Even at high STNV CP 
concentrations (5:1) the mutant fragment creates more of the 28 S intermediate 
than the VLP. These results are fully consistent with the AXXA motif being a 
preferred RNA binding sequence for STNV CP81.  
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Figure 4.3: A comparison of STNV CP assembly efficiency reassembly 
using B3 4U and B3 RNAs.  
Left panels show a titration of increasing CP: RNA molar ratios in reassembly 
reactions carried out as described in Chapter 2.4.5 analysed by velocity 
sedimentation.  The corresponding images on the right are TEMs of the sample 
at the end of capsid assembly reactions. The RNA concentrations were held 
constant at 2 M. Grey line represents the Sw,20 of the recombinant VLP. 
 
 
4.2.3 Purification of 28 S intermediate from B3-reassembled VLPs 
In order to determine whether the 28 S intermediate could be isolated, a large 
scale capsid assembly reaction at a 1:1 molar ratio was prepared, as described 
in Chapter 2.4.8. Because sucrose density gradient fractionation and svAUC 
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are similar techniques, separation was attempted by sucrose density gradient 
fractionation with a 15-45 % (w/v) gradient. During fractionation, it was evident 
that 3 species were present, analogous to the sedimentation velocity assay. 
The first peak at the top of the gradient eluted between 0-1 mL, where the high 
absorbance at 260 nm suggests this peak is aptamer B3.  
 
Figure 4.4: Separation of STNV ‘half capsids’ from complete capsids 
STNV capsid assembly was performed with STNV CP and aptamer B3 at a 1:1 
molar ratio as described in Chapter 2.4.8, where the products were purified by 
sucrose density gradient fractionation. Two higher order species were 
separated, where the corresponding peaks have been labelled 2 and 3. Peak 1 
is free aptamer B3. Peaks 2 and 3 were dialysed in native buffer to remove the 
sucrose and analysed by TEM (inset). Peak 2 contained STNV ‘half capsids’, 
where the curvature was similar to the complete T=1 capsid. Peak 3 contained 
purified STNV particles with a T=1 morphology.  
 
Peaks 2 and 3 were collected and dialysed against native buffer. These 
samples were then analysed by UV absorbance spectroscopy and TEM to 
determine their A260:280 ratios and morphology of these species relative to STNV 
VLPs. The UV absorbance showed that STNV VLPs prepared at this 
concentration ratio isolated from peak 3 had an A260:280 ratio of ~1.2, whereas 
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the species isolated from peak 2 had an A260:280 ratio of ~1.4. This suggests that 
both species contained less RNA than both wild-type STNV and recombinant 
STNV. The implication is that STNV VLPs can assemble at this sub-
stoichiometric concentration, despite a subset of these STNV CP binding sites 
not being occupied by RNA. TEMs of these fractionated species clearly show 
that the 28 S species (peak 2) are partially assembled STNV VLPs with similar 
curvature to recombinant particles (see Figure 4.4, peak 2 (inset)). Further 
analysis of this species by sedimentation equilibrium suggests that the 
molecular weight of these species is ~750 kDa, which roughly corresponds to 
half the molecular weight of an STNV capsid (Appendix, Figure 9.7). 
Presumably this species is an intermediate en route to a complete STNV-B3 
VLP, as the relative amounts of T=1 capsid increase with STNV CP 
concentration.  
 
4.2.4 Removal of flanking sequences increases the efficiency of capsid 
assembly, but efficiency is indifferent to base-paired sequences in the 
stem 
 
A truncated version of aptamer B3 encompassing the stem loop region was 
synthesised. In order to stabilise its secondary structure as a stem loop, an 
additional base pair was added to extend the stem (B3 short, 16 nt). In addition, 
TR, the known assembly initiation site for RNA bacteriophage MS2 (19 nt), 
which has a loop sequence of (AUUA) was prepared (see Figure 4.1d). B3 short 
and TR present their AXXA motif on either a fully base paired stem or one 
interrupted by a single base bulge (see Figure 4.1d). However, they both lack 
the 5' and the 3' flanking sequences of aptamer B3. In contrast to the loop 
sequence sensitivity seen previously, both the shorter stem loops promote 
capsid assembly with similar efficiencies. Formation of the intermediate species 
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is only seen at high CP concentrations, and even then the intermediate species 
are in minority. B3 short is significantly more efficient at promoting capsid 
formation than aptamer B3, where at the highest CP concentration, 
approximately 90 % of the material being T=1 capsids compared to ~50-60 % 
for the larger RNA encompassing the same preferred binding motif. These 
results suggest that flanking sequences either side of the stem loop are partially 
inhibitory of assembly, and that capsid assembly can be initiated by stem loops 
as short as 16 nt in length. It also suggests that capsid assembly is not sensitive 
to sequences in the stem of the oligonucleotide.  
 
Table 4.1: Capsid assembly efficiency of T=1 particles with different RNAs 
 
[CP] 1 µM 2 µM 5 µM 10 µM 
RNA  %RNA %T=1 %RNA %T=1 %RNA %T=1 %RNA %T=1 
B3 53.7 13.6 19.9 26.9 7.2 61.9 3.0 52.6 
B3 4U 87.7 4.2 66.4 11.6 35.3 15.4 0.1 40.6 
         
B3 Short 83.1 14.8 57.3 31.6 2.7 92.9 4.0 86.7 
TR 80.1 15.1 64.7 29.2 15.9 69.9 0.9 73.4 
         
mRNA 11.4 35.0 1.3 23.0 0.5 37.3 0.0 25.3 
STNV-C 18.4 19.9 7.4 54.1 0.0 23.1 0.0 27.7 
         
MS2-i 39.3 0.0 26.2 * 0.0 50.5 0.0 41.3 
MS2-5' * 0.0 6.5 * 0.0 14.9 0.0 17.0 
* indicates where the peaks of the c(S) vs. S plots overlap making it impossible 
to distinguish these components from other reassembly intermediates. 
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Figure 4.5: A comparison of STNV CP assembly efficiency reassembly 
using B3 short and MS2 TR stem loops. Left panels show a titration of 
increasing (from bottom to top) CP: RNA ratios in reassembly reactions as 
described in Chapter 2.4.5. The corresponding TEM images (right) are the 
representative of the sample at the end of the reassembly reaction. The RNAs 
were kept at a fixed concentration of 4 µM. 
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4.2.5 STNV X-ray structure 
 
4.2.5.1 Large-scale purification of STNV-B3, -B3 short and -TR VLPs for 
crystallisation  
 
In order to characterise the structure of the VLPs by X-ray crystallography, the 
capsid assembly reactions in the presence of aptamer B3, B3 short and TR 
were repeated on a larger scale. Large scale STNV CP purifications were 
performed as described in Chapters 2.3.9 and 3.2.10, respectively. These large 
scale reassembly reactions were purified by size exclusion chromatography 
using a Superdex-200 10/300 GL column. VLPs eluted between 8-12 mL, the 
fractions were analysed by SDS-PAGE and VLPs from 8-12 mL collected and 
pooled (see Figure 4.6). The VLPs were then dialysed in ddH2O and 
concentrated using Amicon Ultra® spin concentrators. The purified version from 
all of these VLPs had an A260:280 ratio of ~1.7, which indicates they had a 
comparable amount of encapsidated RNA relative to one another and to the 
recombinant VLP.  
 
The STNV VLPs described above were then subjected to crystallisation 
conditions as described by Lane et al.89 (Crystallisation, cryo-protection and 
data collection of STNV-B3 VLPs were performed by Dr Saskia Bakker). Each 
sample produced crystals that diffracted well, however full data sets could not 
be obtained from crystals of STNV-TR and STNV-B3 short VLPs. These 
crystals appeared smaller, cracked and thinner than their STNV-B3 VLP 
counterparts. The reasons for this are unclear, but could be due to differences 
in crystal packing. It may be that further optimisation of crystallisation conditions 
are required for the acquisition of crystals that produce full data sets. Due to 
these reasons, data concerning the large-scale production of STNV-TR and 
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STNV-B3 short VLPs for crystallisation will not be presented here, but 
chromatograms are available in the Appendix (Figures 9.8 and 9.9). 
 
The data from STNV-B3 were collected by Dr Saskia Bakker at the Diamond 
Light Source on Beam line IO2, using a wavelength of 0.9795 Å. These data 
sets were recorded at different detector distances and beam stop distances, 
generating data over a range of resolutions (see Figure 4.8). It is important that 
data are collected at high and low resolutions because the RNA component is 
not seen at high resolution with STNV77; 78; 89.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6: Large-scale purification of STNV–B3 VLPs 
STNV-B3 VLPs were purified by size exclusion chromatography (top). The 
VLPs eluted between 8-12 mL. Fractions were analysed by SDS-PAGE 
(bottom) where the dotted lines signify the fractions that were analysed. + = 
STNV VLPs; L = 7-176 kDa prestained protein marker (NEB)  
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4.2.5.2 Characterisation of STNV-B3 VLPs 
STNV-B3 VLPs were characterised by svAUC and TEM to assess the quality of 
the sample prior to crystallisation (svAUC was performed by Amy Barker as 
described in Chapter 2.4.6.2). 
 
The svAUC analysis shows that the overwhelming majority of the sample 
sediments at a S20,w = 41.8. This corresponds very well with the value obtained 
from svAUC of recombinant VLPs (S20,w = 41.7)
81 (see Figure 4.7a). The TEM 
also confirms the presence of purified STNV-B3 VLPs, with few aggregates or 
partially-formed VLPs present in the sample (see Figure 4.7b). These results 
suggest that size exclusion chromatography has sufficiently purified STNV-B3 
VLPs in a way to support crystallisation. 
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Figure 4.7: Characterisation of STNV-B3 VLPs 
(a) svAUC of STNV-B3 VLPs purified by size exclusion 
svAUC analysis shows that the VLPs are uniform in size and sediment with 
similar S20,w relative to recombinant STNV VLPs. STNV VLPs control is shown 
as a grey line. 
(b) TEM of STNV-B3 VLPs 
TEMs were captured at 49,000X  magnification. Scale bar (bottom left) = 50 nm 
 
 
 
 
 
 
 
 
(a)
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Figure 4.8: STNV-B3 diffraction patterns. 
Data collection from STNV-B3 VLPs were recorded at very low resolution (217-
30 Å; left), low resolution (116-3.8 Å; middle) and high resolution (30-2.29 Å; 
right). The crystal that was used for the collection of these data sets is shown 
top right. Figure taken from Dr Saskia Bakker’s thesis.  
 
 
4.2.5.3 STNV-B3 protein structure 
The structure of STNV-B3 VLP coat protein is very similar to those of previously 
published structures77; 78; 89. The CP has a backbone r.m.s.d. of 0.138 Å 
compared to wild-type STNV-1 (PDB entry 2BUK)77 and 0.271 Å compared to 
the VLP containing the mRNA (PDB entry 3S4G), respectively89. From these 
structures, the most variable region identified is the N-terminal helix, which was 
previously described as the most flexible89. The main difference between the 
STNV-B3 VLP structure and previous structures is that the N-terminus is more 
ordered in this structure, permitting an additional turn at the N-terminus of the 
helix to be modelled, which correspond to residues 8-11 (RKSA) (see Figure 
4.9). This suggests that sequence-specific binding of aptamer B3 juxtaposes 
the RNA such that phosphodiesters in the stem help to overcome electrostatic 
repulsions between CP N-termini. A similar mechanism is expected to occur 
with longer RNAs displaying multiple AXXA motifs, but due to the intrinsic 
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asymmetry of those RNA sequences, the conformations at the differing N-
termini cannot follow strict icosahedral symmetry. This may account for the 
apparent disorder of the N-termini in the previous STNV structures77; 78; 89.  
 
4.2.5.4 STNV-B3 RNA density 
In order to identify the STNV CP B3 binding site, 60-fold averaged 2Fo-Fc maps 
were calculated using data between 217 and 6 Å resolution. Even though the 
quality of the electron density does not permit the modelling of aptamer B3, 
there is strong electron density for the RNA that encompasses what is observed 
in the previously reported recombinant STNV VLP89. There is also considerable 
additional density around the end of the N-terminal helices that lie along the 
particle two-fold axes (see Figure 4.9b). However, this density cannot be 
distinguished between the remaining residues of the CP N-terminus or 
additional RNA.  
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Figure 4.9: The X-ray structure of the STNV-B3 VLP.  
(a) Ordered density in the N-terminal helices. The STNV coat protein is 
shown in cartoon representation and coloured as in Figure 4.1. The orange 
mesh is the 60-fold averaged 2Fo-Fc electron density of the STNV-B3 structure 
with the parts of the map corresponding to the STNV capsid masked away, and 
contoured at ~0.03 e-/Å3. The blue mesh is the density for the proteinaceous 
shell of the structure contoured at ~0.07 e-/Å3. The extra density at the N-
terminal end of the helices is clearly visible, and an atomic model for the extra 
turn of helix that occupies this density is shown in magenta.   
(b) The B3 RNA density. The view is from the inside of the capsid, outward 
along an icosahedral 2-fold axis. The protein cartoon and orange mesh are as 
described in (a), whilst the grey surface is the solvent accessible surface of the 
mRNA modelled in 89. Figure taken from Ford et al (submitted).  
 
 
4.2.5 The effects of multiple packaging signals on capsid assembly in 
vitro 
 
In this Chapter and Chapter 3, I have shown that STNV CP can self-assemble 
in the presence of short stem loops under reassembly conditions. However, 
wild-type STNV-1 self-assembles around its genome of 1239 nt. A series of 
titration experiments were thus set up using RNAs of a longer length as 
described in Chapter 4.2 under the same conditions as those of the stem loops. 
RNA concentrations for each titration were fixed at 20 µg/mL to directly 
compare capsid assembly efficiency of each RNA relative to the concentration 
of the phosphodiester backbone. Molar ratios are shown in Table 4.2. The 
results obtained from each titration were strikingly different.  
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The STNV-C RNA forms a considerable amount of VLP (~50%) at a CP 
concentration of 2 µM compared to ~20% for the mRNA at this concentration. 
Subsequently at higher ratios (≥5:1) the STNV-C appears to form a second 
higher order species which TEMs suggest are fused double capsids. 
Subsequent RNase A treatment of these fused capsids result in the double 
shells falling apart (see Figure 4.12). This result is suggestive of multiple 
assembly initiation events on the same RNA and that these fused capsids are 
tethered by RNA. Such double shells also occur at lower ratios on the mRNA, 
which is less efficiently packaged throughout the titration.  
 
The results from this series of titrations suggest that the STNV-C genome is 
more efficient at producing T=1 capsids than a mutated shorter sub-fragment. 
This makes sense if the multiple preferred binding sites, suggested to exist in 
Bunka et al.,  have sequences at defined spacings on the RNA genome that 
facilitate the process81. Further, it is also consistent with the specificity and 
fidelity of assembly seen in single molecule Fluorescence Correlation 
Spectroscopy (smFCS) experiments60. Note, the CP subunits in these assembly 
reactions are from STNV-1 and so the genomic interaction with the STNV-C 
genome is not specific to its cognate coat protein. However, both RNAs are 
expected to present multiple copies of the preferred protein binding stem loops 
at similarly defined spacings81. Unfortunately, the STNV-1 genome could not be 
obtained for these CP titrations monitoring capsid assembly. It would be 
interesting to see how capsid assembly efficiency varied between the STNV-1 
genome and the other sequences of RNA. 
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Figure 4.10: A comparison of the STNV CP assembly efficiency 
reassembly using STNV mRNA and STNV-C RNA. Left panels show a 
titration of increasing (from bottom to top) CP: RNA ratios in reassembly 
reactions as described in Chapter 2.4.5. The corresponding TEM images (right) 
are representative of the sample at the end of each reassembly reaction. The 
RNAs were at a fixed concentration of 20 µg/mL (100 nM mRNA; 50 nM STNV-
C RNA) 
 
 
Table 4.2: Concentrations of long RNAs 
RNA Length Concentration 
STNV mRNA 590 nt 100 nM 
STNV-C RNA 1221 nt 50 nM 
MS2 iRNA 927 nt 60 nM 
MS2 5'RNA 2468 nt 24 nM 
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4.2.6 Sub-genomic MS2 RNAs are not efficiently packaged by STNV CP 
Similar multiple putative packaging signals (PSs) have recently been identified 
in the MS2 genome (Dykeman et al, submitted). These putative PSs are 
variations on the TR stem loop used here to trigger STNV assembly. It was 
hypothesised that STNV RNAs would be more efficient at triggering capsid 
assembly compared to the MS2 counterparts because the structure and 
spacing between binding sites are different relative to the two sets of RNAs. 
Discrimination between genomes in assembly has already been shown by the 
respective coat proteins in the single molecule FCS assays, which re-
emphasises the importance both of such sequences and their locations60.  
 
Many of the MS2 PSs contain a loop with an -AXXA- motif, and so capsid 
assembly was examined in vitro by packaging sub-genomic MS2 RNAs with the 
STNV CP in titration assays described previously. Two MS2 sub-genomic RNAs 
were compared, iRNA (927 nt) and MS2 5'RNA (2469 nt). Astonishingly, both 
RNAs will support capsid assembly as shown by the production of particles 
which sediment at 42 S (see Figure 4.11). However, the majority of the products 
from MS2 5'RNA sediments with a much higher S-value than STNV VLPs. TEM 
images show that they consist of clumps of multiple capsids, each roughly the 
same diameter as STNV capsids. Such species could be created if multiple 
assembly initiation events occurred on a single RNA and proceed 
independently. Since these cannot form completed capsids the RNA cannot be 
fully protected, and brief treatment with RNase A released single particles from 
the larger aggregates consistent with this view (see Figure 4.12). Similar 
formation of these multi-capsids have been observed in vitro, when packaging 
“excess” RNA has been reported for cowpea chlorotic mottle virus132. In 
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addition, capsid assembly from MS2 RNAs is of a far lower efficiency compared 
to the STNV RNAs. At 1 µM, two defined species are present in assembly with 
MS2 5' RNA. One of these species sediments at ~35 S, suggesting partially-
assembled capsids are present. TEM images of this sample shows that these 
species are indeed incomplete capsids, with what appears to be RNA 
protruding out at one distinct site (see Figure 4.11, first TEM panel). The 
implication is that STNV CP may struggle to completely package the large size 
of MS2 5'RNA. In contrast, MS2 iRNA does not initiate capsid assembly with 
high efficiency at low CP concentrations. Only at a CP concentration of 10 µM 
are capsids observed with any high degree, with a subset of these species 
existing as large aggregates. Together, these results suggest that the 
packaging signals in STNV RNAs are functional. Similar signals that are present 
in the sub-genomic RNAs of MS2 do not efficiently trigger assembly, whereas 
the STNV-C genome does.   
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Figure 4.11: A comparison of the STNV CP assembly efficiency 
reassembly using STNV mRNA and STNV-C RNA. Left panels show a 
titration of increasing (from bottom to top) CP: RNA ratios in reassembly 
reactions as described in Chapter 2.4.5. The corresponding TEM images (right) 
are representative of the sample at the end of each reassembly reaction. The 
RNAs were at a fixed concentration of 20 µg/mL (MS2 5'RNA ~0.024 µM; MS2 
iRNA ~0.06 µM) 
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Figure 4.12: RNase A treated samples 
(a): RNase A treated STNV-C reassembly 
TEMs were taken of reassembled STNV CP with STNV-C RNA ([CP] = 5 µM) 
prior and post RNase A treatment as described in Chapter 2.4.7.  
(b): RNase A treated MS2 5'RNA reassembly 
TEMs were taken of reassembled STNV CP with MS2 5'RNA ([CP] = 5 µM) 
prior and post RNase A treatment as described in Chapter 2.4.7. 
 
 
 
  
Untreated RNaseA treated
RNaseA 
treatment
STNV-C RNA
MS2 5’ RNA
RNaseA 
treatment
Untreated RNaseA treated
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4.3 Discussion 
In Chapter 3, it was shown that the N-terminus of STNV CP is essential for 
capsid reassembly in vitro. Further evidence of this was presented in Bunka et 
al., where N-terminal truncation mutants were prepared that failed to assemble 
in vivo81. STNV capsid assembly is also dependent on the presence of RNA. 
Many viral coat proteins have extended N-terminal regions encompassing 
sequences rich in basic residues. It was always assumed that these N-terminal 
regions made non-specific electrostatic interactions with the phosphodiester 
backbones of their genomes. However, no details have been obtained from 
these interactions to date. The results in Chapters 3 and 4 have substantially 
increased our understanding of these interactions, and have enabled a detailed 
model for STNV capsid assembly to be proposed (see Figure 4.13).  
 
In the presence of aptamer B3, STNV CP assembles into a T=1 capsid, 
although an intermediate species is also produced. RNA-induced assembly 
appears to be sensitive to the loop regions, since the sequence variant of B3 4U 
is much less efficient at triggering assembly. Although details of the sequence 
specific interactions are not present in the electron density map, the interaction 
must be an important determinant for capsid assembly, as mutation of the loop 
region severely impairs assembly. The loop sequences are possibly important 
for juxtaposing the stem loops in a way that enables the stems to lie adjacent to 
the N-termini helices. Presumably this orientation allows the section of 
polypeptide from residue 12 to become ordered by neutralising the positive 
charges of the N-termini at these regions. This would add to the positive 
charges (R14, K17 and R18) that have already been recognised in the VLP. 
Similar groups are present at the N-termini of STNV-2 and STNV-C CP, 
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implying that these positive charges are positioned in structurally relevant 
positions to make contacts with RNA, and that these contacts are important for 
capsid assembly. The fact that capsid assembly is less efficient with aptamer 
B3 than it is with B3 short and TR suggests that the 5' and 3' extended regions 
in B3 are inhibitory to assembly. This implies that assembly is sensitive to 
sequences outside the preferred stem loop.  
 
The data presented in Chapters 3 and 4 show that the N-terminal region plays a 
specific role in capsid assembly, and that assembly efficiency is governed by 
RNA sequence specificity. The RNA seems to aid the assembly of protein: 
protein interactions by overcoming an electrostatic barrier present in the 
absence of RNA. In Chapter 3, it has been shown that purified STNV CP does 
not assemble in the absence of RNA. The state of STNV CP aggregation was 
analysed by svAUC under both reassembly and disassembly buffer conditions. 
The results from these were identical, where the overwhelming majority of this 
species is monomeric. Two minority species are also present in these samples, 
possibly corresponding to trimer and pentamer, respectively. The STNV-B3 X-
ray crystal structure implies that RNA binding shifts the equilibrium towards that 
of CP trimeric formation, suggesting that the trimer is the basic capsomere of 
STNV assembly.  
 
If RNA binding initiates formation of the trimeric capsomere, what is it that 
brings together each capsomere into a capsid? The answer may lie in the X-ray 
crystal structure of the VLP89. Positively charged residues from neighbouring 
trimers (R66, R91 and K123) are positioned in a way so their side chains can 
make contacts with the phosphodiester backbone of the RNA of a neighbouring 
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trimer. These contacts are made to both the stem region (R66) or may interact 
with the loop region (R91 and K123) around the three-fold axes of the VLP. 
 
In single molecule capsid assembly studies, STNV CP compacts and 
assembles STNV-C RNA into T=1 capsids, but fails to compact MS2 RNA 
under the same conditions60. This observation suggests that STNV-C RNA has 
PSs at defined spacings relative to one another that are not as ideally spaced in 
the MS2 RNA. Other RNAs are going to contain STNV PSs by chance, but 
these RNAs are unlikely to contain the frequency of these PSs at specific 
locations with ideal spacings relative to one another. By initially contracting the 
genome, the virus pays an initial ‘entropic deposit’, such that this energetic cost 
can be recouped later by a reduction in the subsequent reduced energy barriers 
involved in the formation of assembling a compacted genome. The CPs bound 
to the compacted genome are likely to be more stable due to enhanced protein: 
protein interactions as well as the protein: RNA contacts compared to transient 
species that form on cellular RNAs.  
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Figure 4.13: Schematic model of the STNV assembly process. (a) STNV 
coat protein (CP) subunits (blue oval) have an N-terminal extension that is 
partly helical (green) and partly unstructured (magenta). These extensions are 
highly positively charged with 7 Arg/Lys residues in the 24 residues at the N-
terminus. (b) Binding of RNA stem loops, exemplified by the B3 stem loop, at 
least partly neutralises the positive charge on the N-terminus allowing the N-
terminal helix to become longer and more ordered. (c) Once the N-terminal 
region has had its positive charge neutralised by RNA binding, the CPs can 
trimerise, forming an assembly-competent trimeric capsomere. (d) These 
trimeric capsomeres can then assemble to form higher order structures and 
ultimately the T=1 capsid (e). 
 
  
143 
 
5. Mechanisms for uncoating in (+) ssRNA icosahedral 
plant viruses 
 
5.1 Introduction 
Plant viruses can cause significant losses in terms of crop production in the 
horticultural and agricultural industries. For example, viral diseases of rice in 
Southeast Asia can cause devastating losses, and have been estimated at 
costing around $1,000,000,000 per annum133. Host defence mechanisms have 
recently been recognised that control the spread of infection in planta, including 
roles in RNA silencing134. These host defence mechanisms are of consequence 
to the viral life cycle. In TCV, the coat protein, p38, has been shown to have a 
dual functionality; both protecting the genome from environmental factors and 
providing protection against some of these host defences during uncoating109.  
 
The work described in this Chapter aimed to probe the roles of the capsid in 
facilitating controlled disassembly in two model (+) ssRNA icosahedral plant 
virus systems, TCV and recombinant STNV. The main focus of this work is on 
TCV, where the project was initially started by Dr Saskia Bakker, who had 
completed cryo-EM reconstructions of the native virion and an expanded form. I 
came onto the project because of my knowledge and experience with plant 
viruses and size exclusion chromatography. The following subsections give 
some background to this work prior to my involvement with the project. My 
contribution to this project commences from Chapter 5.2 onwards. 
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5.1.1 Cryo-EM structure of TCV reveals internal density which is absent in 
the X-ray crystal structure 
 
A 3D image reconstruction of native TCV was performed by Dr Saskia Bakker 
and determined by cryo-EM using single-particle processing and icosahedral 
averaging at a resolution of ~11 Å. The subsequent EM density map contained 
the spiked-like appearance that is characteristic of the Tombusviridae. The 
electron density corresponding to the S and P domains in the crystal structure 
of TCV110 were fitted to the EM map to increase the understanding of the EM 
structure. A cross-section of the EM map reveals that the virion is composed of 
three layers of density each connected at defined points on the particle. The 
atomic coordinates from the S and P domains in the crystal structure fit the EM 
density from the outermost shell extremely well (between the atomic radii 180-
110 Å, see Figure 5.1), suggesting that this density relates to the S and P 
domains in the native particle. The two inner shells of density present at lower 
contour levels are therefore likely to be a mixture of N-terminal R domains from 
the CPs and internal RNA. The middle shell of density (between 110-82 Å) 
seems to be connected to the S and P domains at 5-fold, 3-fold and 2-fold 
symmetry axes (see Figure 5.1a). The innermost shell of density (between 72-
50 Å) appears to be connected to the middle shell along the 2-fold symmetry 
axes. At higher contour levels, the innermost shell appears to be almost 
completely absent. At this contour level, the middle shell has a distinct cage-like 
appearance, with an apparent hexagonal and pentagonal lattice centred on the 
three-fold axis. The absence of the inner density at this higher contour level 
suggests that this region may have a lower occupancy, or is intrinsically 
disordered relative to the outer shells, or both.  
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Figure 5.1: Internal density from the cryo-EM structure of native TCV 
(a) Cross sectional cut-away view of native TCV 
A central 25 Å cut-away cross-section from TCV EM electron density. The 
outermost layer is transparent to allow the modelled coordinates from the X-ray 
crystal structure to be fitted. The inner shells are coloured using a radial 
scheme from pink (50 Å) to blue (180 Å) and labelled across the virion. 
Icosahedral symmetry axes are also shown by lines. 
(b) Cut-away version of the virion 
Removal of the outermost layer of density reveals density of a cage-like 
structure which probably corresponds to N-terminal R domains and RNA. Same 
colour scheme is used as in A. Figure taken from 113. 
 
 
5.1.2 Cryo-EM structure of expanded TCV reveals pores at the particles 
three-fold symmetry axes 
 
TCV, like that of many plant viruses, such as TBSV21 and SBMV135, contains 
calcium ions which function to stabilise the particle. The calcium ions in the 
homologous TBSV are coordinated by amino acid residues Asp155 and Asp157 
from one CP subunit and by Glu127 and Asp199 from the adjacent CP (see 
Figure 5.2b). When TCV enters the cytoplasm of a newly-infected cell, the low 
concentration of calcium ions are thought to initiate the removal of these 
calcium ions. The resulting electrostatic repulsion from side chains that 
coordinated these calcium ions, as well as the electrostatic repulsions from 
RNA, results in expansion of the TCV particle. In the crystal structure of 
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expanded TBSV, this expansion event is stabilised by increased ordering of the 
N-terminal R domains in the A/B dimers136. Treatment with high ionic strength 
results in the disassembly of expanded TCV, but not expanded TBSV34. 
 
In order to examine the effects of expansion in TCV by cryo-EM, Dr Saskia 
Bakker treated TCV with EDTA in a low ionic strength buffer at pH 8.5 to mimic 
the cytoplasm of the plant cell. This resulted in particles that were expanded: 
these particles were used to produce a 3D reconstruction of icosahedrally 
averaged expanded TCV at ~17 Å. The expanded particles were ~5 % larger 
than the native virions, measuring ~190 Å radii compared to ~180 Å in the 
native particles113. Similarly to the native virions, the expanded particles also 
contained three layers of density, with each residing at slightly higher radii 
relative to the native virions113. The structure from the outermost layer of the 
expanded particle was relatively similar in appearance to the native. In contrast, 
significant differences exist between the inner shells of density. In the expanded 
particle, the density from the middle shell becomes progressively weaker, and 
the cage-like structure that appears in the native structure becomes less 
apparent113. However, at the lower contour levels, visible columns of density are 
present that connect the innermost shell to the middle shell at the two-fold axes. 
There are two main reasons which may contribute to the weaker density in the 
expanded state. Firstly, the expanded state could affect the internal volume of 
the virion (a 5 % expansion results in 17 % larger intrinsic volume). Secondly, 
RNA and/or N-terminal R domains may be more dynamic in the expanded state 
relative to the native state. This would make sense if the genome of TCV is 
preparing for exiting the particle113.  
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Figure 5.2: Structural comparison between native and expanded states 
(a) Radial distribution of states 
On the left, the native virion is contoured so that each shell of density is shown. 
In the middle panel, the expanded particle is shown to show the same internal 
volume to native virions. The right panel shows density from the expanded 
particle to at a higher contour level to show density for the weaker inner shells 
of density. The ruler on the left corresponds to the radial distance from the 
centre of the particles. 
(b) Cartoon representation of the results of expansion. 
Only the asymmetric trimers of the particles are shown for clarity. On the left, 
the native trimer contains calcium ions (shown as yellow spheres) at the 
interface between CPs in the locations they are shown in the homologous X-ray 
crystal structure of TBSV (PDB code 2TBV). The calcium ions are coordinated 
by acidic side chains and shown inset (D155 and D157 from one subunit; E127 
and D199 from the other). The pores shown in the cryo-EM in the expanded 
virus are shown being surrounded by a grey mesh. The effect of expansion of 
two amino acids which remain at the same radial level (D203 and S202) are 
separated by a red arrow. The distance between them in the native particle is 
6.5 Å compared to 17 Å in the expanded particle. The figure was taken from 
Bakker et al.113 
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There is also a big difference in capsid integrity between the expanded particle 
and the native virus (see Figure 5.3). The expanded particles appear to have 
developed pores at distinct sites on the protein capsid, whereas the native 
capsid does not. To better understand the nature of expansion, the coordinates 
from the S and P domains from the crystal structure were fitted in to the 
expanded density. This showed that there was no discernible change in the 
hinge angles between the S and P domains, and that pentamers and hexamers 
that build the capsid remained intact113. The pores occur due to the pentamers 
and hexamers moving apart by about 10 Å. In the expanded crystal structure of 
TBSV, the β-annuli are intact136. However, the resolution from these cryo-EM 
maps do not allow direct visualisation of β-annuli, therefore it cannot be 
confirmed if the β-annuli are intact in the expanded state of TCV113.  
 
 
Figure 5.3: Comparison of native and expanded TCV. 
(a) Surface representation of native and expanded TCV. 
Native virion is on the left and expanded TCV is on the right. The structures are 
coloured using identical radial colour schemes, so that the expanded particles 
are shown as a deeper blue compared to their native counterparts. Both models 
have been contoured to show approximately the same density for their protein 
capsids.  
(b) Inside view of the back half of native and expanded TCV 
The native is on the left and the expanded particle is on the right. Native 
particles have clearly more density on the interior of the capsid compared to the 
expanded form. Figure taken from Bakker et al. 113 
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5.1.3 Biochemical analysis of the different states of TCV reveals 
differences in stability and protease susceptibility, but not RNase 
susceptibility 
 
Electron density from the cryo-EM structure of the expanded particle described 
above contains pores. However, the precise size of these pores cannot be 
determined due to the limits of the resolution on this map. One obvious function 
of these pores could to mediate the extrusion of molecules from inside the 
particle to outside, such as their N-terminal R-domains and/or their RNA 
genome. To assay this possibility, Dr Saskia Bakker performed protease and 
nuclease digestion on each state of the TCV virion to determine the sensitivity 
of each of these states to digestion.  
 
Native, disassembled, expanded and recontracted forms of TCV were 
challenged against chymotrypsin over time and the digestion products were 
analysed by SDS-PAGE. Native chymotrypsin has a characteristic banding 
pattern of two major protein species; one band of ~80 kDa, which corresponds 
to the p80 protein and one product of ~38 kDa, which corresponds to the full 
length TCV CP. Also, there are 2 minor species of ~30 kDa (see Figure 5.4a). 
Challenge of native TCV against chymotrypsin reveals no change in the 
digestion pattern, even at the longest time point, suggesting that native TCV is 
resistant to proteases. This re-emphasises the great stability of TCV.  
 
In contrast, when disassembled TCV was subjected to chymotrypsin challenge 
over time, the SDS-PAGE digestion products showed that full-length TCV CP 
got rapidly degraded into products ~30 kDa (see Figure 5.4a; black arrow). 
These products were analysed by mass spectrometry and N-terminal 
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sequencing. This analysis revealed that these digestion products are consistent 
with the removal of the R domains, confirming what was suggested previously.  
 
Chymotrypsin treatment of expanded TCV particles leads to the same 30 kDa 
digestion products, albeit with slower kinetics. However, a significant proportion 
of this material was undigested, suggesting that a subset of the TCV CP 
remained protease resistant. The approximate ratios of these products on the 
gel suggest that ~1/3 TCV CP were undigested, suggesting that only the A/B 
conformers may be protease sensitive. Since the pores in expanded TCV are 
too small to allow proteases to enter the particle directly, the protease digestion 
sites for the C/C dimers are likely to be inaccessible.  
 
Expanded particles were recontracted by the addition of excess calcium ions 
and also challenged against chymotrypsin. From these particles, minimal 
proteolysis was observed, suggesting that the expansion of TCV was largely 
reversible. Cryo-EM maps generated against recontracted TCV particles 
produced identical maps to that of the native particles113. 
 
As well as protease challenge against the different states of TCV, similar 
analysis was also carried out by RNase A. As expected, the RNA from native 
virus was protected against RNase A treatment. Interestingly, considering that 
expanded TCV is sensitive to protease treatment, the expanded particles 
showed resistance to RNase A. This was not simply a consequence of the 
buffering conditions used to expand the virus, as the RNA was rapidly degraded 
by RNase A in the disassembled virion (see Figure 5.4b).  
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Figure 5.4: Biochemical analysis of the differing states of TCV 
(a) Chymotrypsin digestion assay 
TCV was challenged against chymotrypsin in each state and its digestion 
products analysed by SDS-PAGE. The native particles appeared to be 
unaffected by protease treatment, whereas the disassembled particles were 
rapidly digested to the ~30 kDa digestion products, which roughly correspond to 
the CP S and P domains. After 60 mins, the expanded particles have roughly 
1/3 of CP as the full-length product. In recontracted virions, chymotrypsin does 
not appear to cleave the CP, implying that recontraction is largely reversible. 
Negative stain TEM images are shown above each prior to addition of 
chymotrypsin. Grey arrow points to full-length CP and black arrow to the 30 kDa 
digestion products.  
(b) RNase A assay of native and expanded TCV 
Denaturing agarose gels of RNase A treated samples from native (left), 
expanded (centre) and free RNA (right). Time points are shown at the bottom of 
the gels in mins.  
(c) TEM of TCV incubated in wheat germ translational extract  
TEM shows a TCV particle attached by a thin tether of what looks like RNA to 3 
ribosomes. 
(d) Schematic of TCV striposome complex  
Cartoon based on known 3D structures of what is shown in (c). Figure taken 
from Bakker et al. 113 
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Despite the insensitivity of expanded particles to RNase A digestion, when 
expanded TCV was incubated in wheat germ translational extract and examined 
by negative stain TEM, particles were seen extruding a thin tether, which is 
presumed to be RNA, connected by particles which appear to be ribosomes 
(see Figure 5.4c). This is fully consistent with a co-translational disassembly 
mechanism mediated by ribosomes. Such striposome formation has also been 
observed in other plant viruses99, most notably with TMV101. 
 
5.1.4 svAUC on the different states of TCV reveal differences in 
sedimentation coefficients 
 
To determine the stability of the expanded state of TCV, and to characterise the 
differences which occur during expansion, a series of samples were prepared 
for svAUC, which was performed by Amy Barker (see Figure 5.5). The S20,w of 
native TCV was calculated at ~120 S.  When expanded TCV was spun at high 
velocity, the expanded virion seemed to dissociate into smaller constituents, 
although here was no overlap with fully disassembled TCV. This shows that 
expanded particles are not as stable as native TCV. 
 
TCV particles were expanded by EDTA chelation and recontracted by addition 
of excess calcium ions. In contrast to the expanded particles, recontracted 
particles sediment as though they are VLPs, but having lost some lower 
molecular weight components. This result contradicts the previous observation 
from the low resolution cryo-EM reconstruction. This structure suggests that 
recontracted virus resembles the native particle, and that the expansion state is 
fully reversible (data not shown). The cryo-EM reconstruction was determined at 
a relatively low resolution and also employed icosahedral averaging. The 
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implication is that the cryo-EM reconstruction may not distinguish between any 
non-asymmetric features seen in the recontracted state. Expanded, 
chymotrypsin treated and recontracted virus sediments similarly to recontracted 
virus, suggesting that the recontracted virus has lost some lower molecular 
weight material. 
 
 
 
 
 
 
 
 
 
Figure 5.5: svAUC analysis of the different states of TCV 
The key (inset) shows the samples analysed by svAUC. Native TCV sediments 
~125 S. Both expanded and disassembled TCV show heterogeneous peaks 
corresponding to fractionated particles, although these peaks do not overlap. 
This suggests expanded TCV is metastable, and falls apart under the stress of 
centrifugation. Recontracted and chymotrypsin treated and recontracted TCV 
both sediment at similar S values, suggesting that recontraction of TCV is not 
fully reversible. Figure taken from Bakker et al. 113 
 
 
The results in the next subsection describe the point in time where I came onto 
the project and discuss my contribution to this work. 
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5.2 Results 
5.2.1 Expanded, chymotrypsin treated TCV leads to partial extrusion of 
viral RNA 
 
The results from the proteolysis experiments described in Chapter 5.1.3 might 
arise in two different ways. When particles are expanded and treated with 
chymotrypsin, perhaps a subset of these particles are completely proteolysed, 
or it may represent the average proteolysis from all the particles in the sample. 
To analyse which of these scenarios is most likely, expanded chymotrypsin 
treated TCV was prepared so that roughly 50 % of the subunits were cleaved. 
The chymotrypsin was then quenched with excess protease inhibitors as 
described in Chapter 2.5.2. This expanded proteolysed sample was then 
fractionated by size exclusion chromatography. The fractions with UV 
absorbance were collected, and 500 µL from these fractions were concentrated 
by Amicon Ultra® centrifugal concentrators and analysed by SDS-PAGE. Note, 
the concentrated particles were possibly disrupted by centrifugation, but the 
protein content was analysed rather than the particles themselves. 
 
The fractionation profile shows that a VLP peak is eluted between 8-11 mL 
which also absorbs strongly at 260 nm, suggesting the RNA is retained within 
VLPs. This peak has significantly less proteolysed CP compared to the material 
that was loaded (see Figure 5.6). Fractions that eluted between 13-17 mL 
contained most of the proteolysed material, and had the characteristic banding 
patterns of TCV CP with the R domains cleaved on SDS-PAGE. Another minor 
peak was eluted between 17-19 mL, which seems to show smaller fragments of 
protein, probably the N-terminal R domains and/or separated S and P domains.   
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Figure 5.6: Chromatogram of expanded, chymotrypsin treated TCV and 
SDS-PAGE analysis of fractions 
The top of the figure shows a cropped version of a size exclusion 
chromatogram looking from 5 mL to 20 mL to show the UV absorbance from 
expanded proteolysed TCV. The dashed lines on the chromatogram represent 
A260, whereas the solid lines show the A280. The dotted blue lines connecting the 
chromatogram and the SDS-PAGE indicate the fractions analysed by SDS-
PAGE. The exact fraction numbers are shown above the lanes of the SDS-
PAGE. L = 7-176 kDa prestained protein ladder (NEB); load = sample prior to 
size exclusion analysis. 
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Figure 5.7: Negative stain EM image of expanded and proteolysed TCV 
This image shows the heterogeneity and disruption to the particles. Some of 
these particles have what seem to be their genome and/or N-termini poking out 
at a defined location (white arrow heads). Inset is an aligned average of this 
type of particle, calculated by multivariate statistical classification. The scale 
bars, both in the main panel and the inset, represent 50 nm. Figure adapted 
from Bakker et al113. 
 
These results are consistent with the dissociation of cleaved subunits from 
intact particles. Presumably, the A/B dimers would be released by proteolysis 
because the β-annuli are required for particle integrity. It could be imagined that 
this dissociation of subunits may arise in stages, where N-termini may become 
externalised and accessible to protease. Subsequent cleavage results in the 
dissociation of the cleaved CP dimer, thus making the VLP even more porous 
than the expanded particle.  
 
Negatively stained expanded and proteolysed particles were observed by TEM 
(see Figure 5.7). These images are enlightening. Although expanded TCV 
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particles are icosahedrally symmetric nature, expanded and proteolysed VLPs 
contained a mixed population of particles that appear to have lost their 
symmetry. Some of these images are consistent with extrusion of the viral 
genomes at defined sites from the VLP, although the level of extrusion appears 
to vary between these particles. However, it seems that most of these particles 
are significantly disrupted, or at least disrupted to some degree (see Figure 5.7 
and inset).  
 
5.2.2 Incubation of expanded, chymotrypsin treated TCV incubated with 
wheat germ extract provides evidence of striposome formation 
 
In order to test whether expanded proteolysed particles are potential uncoating 
intermediates, these particles were incubated in the presence of wheat germ 
extract according to the manufacturer’s guidelines. Emma Wroblewski, an 
undergraduate project student, and I prepared size exclusion chromatography-
purified expanded, chymotrypsin treated TCV using the conditions described in 
Chapter 2.5.2. These particles were then incubated in the presence of wheat 
germ extract for 30 mins at room temperature following the manufacturer’s 
guidelines (Promega). The sample was then diluted 50-fold and prepared for 
TEM as described in Chapter 2.2.2. The TEMs showed that striposomes could 
be formed under these conditions in high yield (see Figure 5.8).  
 
Previously, Dr Saskia Bakker incubated expanded TCV in the presence of 
wheat germ extract in vitro translation kit (Promega). However, no product was 
detected in these experiments that related to a possible translation product. In 
order to further characterise TCV disassembly, expanded proteolysed TCV was 
incubated in the presence of wheat germ extract in vitro translation kit 
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(Promega) using manufacturer’s guidelines. However, again, no translation 
products were detected.  
 
 
Figure 5.8: Gallery of Striposomes 
Striposomes were isolated from expanded TCV treated with chymotrypsin. 
These striposomes have either 2 (top panel) or 3 (bottom panel) ribosomes 
bound via a thin tether of RNA. Scale is identical in each micrograph. (Scale bar 
= 50 nm) 
 
 
5.2.3 Expanded and proteolysed TCV particles are resistant to RNase A 
degradation   
 
It was shown in Chapter 5.1.3 that expanded particles are resistant to RNase A 
treatment, despite the RNA genome being capable of exiting from pores in the 
particles and forming striposomes. Because the RNA genome appears to 
extrude from expanded, chymotrypsin treated particles in the EM images in 
Figure 5.8, RNase A treatment was performed by Emma Wroblewski under my 
supervision. These RNase A-treated particles were incubated for 1 h at room 
temperature before the RNase A was quenched through addition of 1 µL 
RNaseOUTTM, and the RNA purified as specified in Chapter 2.5.4. Remarkably, 
expanded chymotrypsin treated particles seemed to be resistant to RNase A 
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treatment. These results also agreed with Dr Saskia Bakker’s results (Figure 
5.5), which suggest that expanded TCV is resistant to RNase A, but free RNA is 
readily degraded. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9: 1 % (w/v) denaturing agarose gel electrophoresis of RNase A 
treated samples 
TCV samples were prepared and treated with RNase A. The RNA was then 
extracted as described in Chapter 2.5.4. Expanded TCV, RNase A treated TCV 
RNA and untreated TCV RNA were prepared as controls. 1 = Expanded TCV 
and RNase A treated; 2 = RNase A treated TCV RNA; 3 = RNase A treated 
expanded, proteolysed particles; 4 = untreated TCV RNA control; L = 1kb DNA 
ladder (NEB). 
 
5.2.4 Chymotrypsin treatment of RP-complex suggests p80 is protected 
from cleavage by the RNA genome 
 
Despite being extensively studied, many features of the p80 protein have so far 
remained a mystery. The elusive nature of p80 is partly due to its scarcity; the 
stoichiometry being calculated as 1 molecule of p80 protein: 89 CP2 per TCV 
particle34. There is no open reading frame which codes for a product of 80 kDa 
in the TCV genome, suggesting that it is made by an as yet uncharacterised 
method. Stockley et al extensively characterised the p80 protein and found that 
it contained an identical amino acid composition within experimental error to 
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TCV CP. Tryptic digest and mass spectrometry analysis confirmed that p80 was 
a covalently linked CP dimer112. The exact nature of this cross-link is unknown, 
but it has been speculated that its formation may be catalysed by the TCV 
genome, based on the fact that RNA has been shown to catalyse a vast array of 
chemical reactions. The exact function of p80 is unknown, but putative role(s) in 
uncoating have been mooted as possible function(s)34. 
 
Despite this paucity of information, the p80 protein is enriched in the RP-
complex111. Because of the unique nature of p80, and the p80 analogues found 
in other plant viruses such as SBMV and TBSV, the RP-complex was 
chymotrypsin treated. Its susceptibility to proteolysis and its migration by size 
exclusion chromatography was analysed. The eluted fractions with UV 
absorbance were then analysed by SDS-PAGE. It was hoped that this 
experiment would provide useful information regarding the nature of the 
interaction between p80 and the RNA genome within the RP-complex and/or 
the virion.  
 
In order to carry out this experiment, copious amounts of RP-complex were 
needed to be able to detect the p80 protein. In light of this, 200 µL of TCV (75 
mg/mL) was disassembled in the presence of protease inhibitors and the RP-
complex was purified by size exclusion chromatography in an analogous 
manner to Sorger et al 34 (data not shown). The purified RP-complex was then 
concentrated by Amicon Ultra® centrifugal concentrators and chymotrypsin 
treated as described in Chapter 2.5.5. The digestion was quenched after 30 
mins, and the digestion products were fractionated by size exclusion 
chromatography.  
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Figure 5.10: Size exclusion chromatography fractionation and SDS-PAGE 
analysis of chymotrypsin digested RP-complex 
The top of the figure shows a chromatogram of proteolysed RP-complex 
monitoring the absorbance at 260 nm (dashed line) and 280 nm (solid line). The 
dotted lines connecting the gel and the chromatogram show how the gel 
corresponds to the gel. Fraction numbers are also indicated above the lanes of 
the gel. Load = sample prior to fractionation; + = RP-complex prior to 
concentration and chymotrypsin treatment; L = 7-176 kDa prestained protein 
marker (NEB). 
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The chromatogram produced two peaks; a major peak eluted between 8-11 mL, 
and absorbed strongly at 260 nm, suggesting this species was predominantly 
RNA (see Figure 5.10). The second peak seemed broader, and eluted between 
~12-17 mL. This peak had a higher absorption at 280 nm than 260 nm, 
suggesting that digested protein was separated from the rest of the RP-
complex.   
 
The fractions collected from size exclusion with UV absorbance were then 
concentrated using Amicon Ultra® centrifugal concentrators. The concentrated 
fractions were then analysed by SDS-PAGE as described in Chapter 2.2.1.2. 
SDS-PAGE analysis of these fractions showed that the overwhelming majority 
of TCV CP2 was proteolysed, forming digestion products with similar mobility to 
those seen in the expanded virion, suggesting similar cleavage sites are 
accessible. These results also suggest that proteolysis mediates dissociation of 
TCV CP2 from the RP-complex. In contrast, the majority of the p80 protein 
remained uncleaved, and eluted with the RNA. 
 
In all, these results show that p80 is much more resistant to proteolysis than 
TCV CP2 in the RP-complex, and that once cleaved, TCV CP2 dissociates from 
the RNA genome. Furthermore, p80 protein remains undigested, and is eluted 
with the RNA genome, implying that it is somewhat protected against protease 
digestion by the RNA genome. But what is the nature of this protection in the 
context of how it interacts with the TCV genome? It is likely that p80 binds to a 
unique site on the TCV genome. It is also possible that p80 has two RNA 
binding sites and that these are located at opposite ends of the genome. The 
p80 complex would therefore essentially circularise the RNA. This is analogous 
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to what happens in MS2, where the A protein (which is essential for MS2 
infection) binds to sites close to each end of the genome, circularising it137.  
 
5.2.5 STNV VLPs may have a similar disassembly mechanism to TCV 
It has long been hypothesised that calcium release and subsequent expansion 
mediates the first stage of uncoating in the (+)ssRNA icosahedral plant 
viruses82. However, the results described here suggest that proteolysis of the N-
terminal R domain is a putative second stage in the uncoating mechanism in 
TCV. Other viruses also contain highly basic N-terminal regions21; 78; 79; 135; 138; 
139, and so it is possible that they share this strategy for uncoating. Our 
recombinant version of one of these viruses, STNV, was therefore subjected to 
the same EDTA and chymotrypsin treatment as described with TCV. It was 
hypothesised that removal of the N-termini by proteolysis following expansion 
may mediate the formation of an uncoating intermediate in an analogous way to 
TCV uncoating. 
 
STNV virions are very stable, and have been shown to be resistant to protease 
cleavage80. In order to test whether recombinant STNV VLPs were also 
protease resistant, STNV VLPs were incubated in the presence of chymotrypsin 
(Roche) as described in Chapter 2.5.6. SDS-PAGE analysis showed that STNV 
VLPs were resistant to chymotrypsin treatment, analogous to the wild-type 
virion (see Figure 5.11).  
 
In contrast, STNV VLPs treated with EDTA and chymotrypsin as described in 
Chapter 2.5.7 resulted in proteolysis of STNV CP. The digestion products seen 
by SDS-PAGE were very similar to what was observed in Unge et al, 
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suggesting that the N-terminal domain is proteolysed under these conditions 
(see Appendix, Figure 9.10). This, taken together with the already known 
observation that the N-terminus of STNV CP is extremely proteolytically 
sensitive, makes sense if a similar uncoating mechanism to TCV exists in 
STNV. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11: Chymotrypsin treatment of native STNV 
SDS-PAGE above shows that native STNV is resistant to chymotrypsin 
treatment. - = STNV without chymotrypsin; + = STNV VLPs treated with 
chymotrypsin; L = 7-176 kDa prestained protein marker (NEB). 
 
 
In order to test the hypothesis of proteolysis-mediated uncoating, EDTA and 
chymotrypsin treated STNV VLPs were subjected to size exclusion 
chromatography and SDS-PAGE, akin to expanded proteolysed TCV. The 
results were striking. Expanded, proteolysed STNV eluted as VLPs between ~8-
12 mL, similarly to expanded, proteolysed TCV. The proteolysed subunits were 
also dissociated from these particles (see Figure 5.12). When these purified 
proteolysed particles were analysed by TEM, the particles appeared 
asymmetric with extrusions emanating from the STNV particles (see Figure 
5.13). These results with a plant satellite virus are also fully consistent with a 
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proteolysis-mediated mode of uncoating, and with the TCV data suggest it may 
be a common feature of these viruses. 
 
 
 
Figure 5.12: Size exclusion chromatography profile and SDS-PAGE 
analysis of EDTA chymotrypsin treated STNV VLPs elution 
The above chromatogram between 5-20 mL shows the UV absorbance (A280 = 
solid line; A260 dashed line) profile from EDTA and chymotrypsin treated STNV 
VLPs and the fractions analysed by SDS-PAGE. Dotted lines connect the 
fractions to the gel, as well as the fraction numbers being explicitly labelled 
above the lanes. Load = sample prior to being loaded onto the size exclusion 
column; L = prestained protein marker (NEB).  
 
L   Load  8        9       10     11    12     13     14     15     16     17     18      19       
175 kDa
80 kDa
63 kDa
46 kDa
30 kDa
25 kDa
17 kDa
0
50
100
150
200
250
300
350
5 10 15 20
A
b
s
o
rb
a
n
c
e
 2
6
0
 a
n
d
 2
8
0
 n
m
 (
m
A
U
)
Elution volume (mL)
Absorbance 280 nm
Absorbance 260 nm
166 
 
 
 
 
Figure 5.13: TEM images of expanded proteolysed STNV VLPs show 
similar extrusions to TCV 
Purified EDTA and chymotrypsin treated STNV VLPs were analysed by TEM at 
30,000 X magnification. A portion of the micrograph is blown up and shown 
alongside it, showing similar extrusions that were also present in the TCV VLPs.    
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5.3 Discussion 
The tailed DNA bacteriophage are the most abundant entities in the 
biosphere140. Upon binding of the phage to a host cell membrane, the free 
energy stored in the electrostatic repulsions between the DNA phosphate 
groups results in the DNA exiting the capsid via the protective tail.  
 
Although some (+) ssRNA icosahedral viruses have similar packaging densities 
to the tailed bacteriophages, the repulsive nature is reduced due to the 
existence of positive side chains at the N-or C-termini of these viruses, thus 
providing a neutralising effect. Also ssRNA genomes are extensively base 
paired and thus form branched polymers in contrast to the linear polymer of 
dsDNA. This avoids the problems DNA phages have in overcoming the 
persistence length of their genomes during the packaging event. Unlike tailed 
DNA bacteriophage, in vitro capsid assembly and packaging of their RNA 
genomes do not require the input of free energy, probably due to the 
neutralisation functions of these positively charged regions and the increased 
flexibility of RNA relative to DNA. If this is the case, disassembly and uncoating 
must destabilise the native capsids in such a way to mediate the release of their 
genome, i.e. work needs to be done to release these genomes whereas the 
pressure inside dsDNA phages provides the necessary impetus for release in 
those particles. In TCV and STNV, and also other plant viruses, the required 
capsid instability is driven by chelation of calcium ions from the capsids, which 
mediates expansion events. The expanded conformation of these virus particles 
creates pores on the surface of the previously sealed container, theoretically 
large enough to permit the exit of the viral RNA. In TCV, this expanded 
conformation is not very stable, dissociating by the addition of high salt 
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concentration34 or in response to high speed centrifugation113. Uncontrolled 
dissociation of particles in planta would expose the RNAs to the host defences 
such as the plant RNAi silencing pathway.  
 
It is from this expanded state that host cell factors must interact with the TCV 
genome. The reduced ordering seen in the expanded particle relative to native 
TCV suggests that viral RNA and/or the N-termini become more dynamic. This 
is made evident by the increased susceptibility of expanded TCV CP to 
chymotrypsin, although no change in RNase susceptibility was found. Since the 
viral RNA remains inaccessible to nuclease, the implication is that some of the 
N-termini become dissociated from the RNA, and become extruded from the 
particle. In the expanded state of TBSV, this appears to be the case, where the 
N-termini of the B subunits appear to become extruded to the exterior of the 
particle136. Presumably, such a process would likely be mediated by both the 
expansion event and by the entry of cellular counterions.  
 
In contrast to nuclease protection of the genome in the expanded state, TCV 
forms striposomes in this state when in the presence of wheat germ extract. 
This suggests that RNA can exit from pores, and that one end of the RNA can 
bind to ribosomes. Although a high affinity ribosome binding site has been 
identified at the 3' end of its genome141, the likelihood is that the 5' end exits the 
capsid first. This way the ribosome can bind functionally, and the free energy of 
translation can be used for a Brownian ratchet mechanism, extruding the RNA 
and allowing additional ribosomes to bind the 5' end of the genome. This would 
assist in pulling the rest of the genome through the capsid, coating the RNA in 
ribosomes, thus masking the genome from the host cell’s RNA silencing 
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mechanism108. The protein capsid would therefore retain its protective 
functionality right up until the end of genome uncoating and RNA translation.  
 
Although striposomes are seen from expanded particles in the presence of 
wheat germ extract, these striposomes were relatively rare (Saskia Bakker, 
pers. comm.), suggesting that additional steps in uncoating may be necessary. 
The asymmetric particles seen in Figure 5.7 are an obvious candidate for such 
an uncoating intermediate. The partial extrusion of viral RNA from these 
particles suggest that removal of N-terminal R domains mediates charge 
repulsion events allowing the initial extrusion of the genome. The loss of 
positively charged R domains via proteolysis would increase the electrostatic 
potential of the RNA, thus allowing for this extrusion event to take place. Figure 
5.14 proposes a model for TCV disassembly.  
 
Figure 5.14: A model for TCV uncoating 
(a) Native TCV 
TCV in its native state is sealed with all the R domains inside the particle 
contacting the genome.  
(b) Expanded TCV 
Chelation of calcium ions mediates an expansion event, which makes the 
genome and N-termini more dynamic. Some of these R domains become 
accessible to proteases. 
(c) Proteolysed TCV 
Extruded N-termini become proteolysed, which leads to the extrusion of the 
genome and generation of asymmetric particles. 
(d) Translation 
The replication machinery of the plant cell is then allowed access to the 
extruded genome, and is able to bind to ribosomes, resulting in the formation of 
striposomes. 
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This model is consistent with all the data reported in this Chapter, together with 
the fact that the N-terminal R domains of TCV CP are exquisitely sensitive to 
proteolysis. These observations strongly suggest that expanded proteolysed 
particles are indeed an intermediate towards uncoating.  
 
Parallels can be drawn between TCV and many other plant viruses, both in 
terms of its structural and biochemical similarities142. Conditions for in vitro 
expansion and disassembly of one of these viruses, STNV, draw comparisons 
to TCV. Like TCV, STNV virions will expand upon chelation of stabilising 
calcium ions, and recombinant particles will dissociate with EDTA treatment in 
high ionic strength at pH 8.534; 80; 81; 113. However, no observed increase in 
diameter has been determined for EDTA-treated recombinant STNV, as 
characterised by TEM, svAUC or cryo-EM (data not shown). It is possible that 
STNV virions expand more than the recombinant capsid due to the differences 
of their packaged RNA. It may be that STNV virions have increased 
electrostatic repulsion resulting from a more condensed RNA genome 
compared to the recombinant89. However, EDTA-treated recombinant particles 
appear to be more sensitive to proteases than untreated recombinant capsids, 
suggesting that the N-terminal regions, including the short helix become more 
dynamic upon chelation of calcium, and that the N-termini can be extruded from 
pores on the surface of the capsid. It has been shown that not all plant viruses 
containing calcium expand upon chelation of calcium ions. For example, in red 
clover necrotic mottle virus (RCNMV), calcium chelation elicits the introduction 
of pores in the capsid with no discernible increase in capsid diameter143. 
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EDTA and chymotrypsin treatment of recombinant STNV particles results in 
cleavage of the N-terminal region from a subset of CP subunits. The precise 
location of the cleavage site has not been determined, but the proteolysed 
subunits appear to have similar banding patterns by SDS-PAGE to the STNV 
virion treated with trypsin80. The trypsinated cleavage site at Lys 28 results in 
the removal of the N-terminal helix80. It is therefore likely that Phe 30 is a 
potential chymotrypsin cleavage site in the EDTA-treated recombinant particle.  
 
Size exclusion chromatography of EDTA and chymotrypsin-treated STNV 
produced asymmetric particles with similar characteristics to those seen with 
TCV. However, when incubated with wheat germ extract, no striposomes were 
found by TEM. It is possible that the mRNA extruded from the recombinant 
capsid is not adequately presented to ribosomes, since it is not a bona fide 
STNV genome and lacks suitable eukaryotic ribosome binding sites. It would be 
interesting to see whether STNV VLPs assembled around an STNV-C genome 
would expand similarly to STNV virions analysed by Unge et al, and if these 
particles are capable of producing striposomes. 
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6. General Discussion 
The (+) ssRNA icosahedral viruses are pathogens which infect host cells from 
every kingdom of life. In this class of virus, the processes of capsid assembly 
and disassembly are extremely poorly understood. These critical stages in the 
virus life cycle are carefully orchestrated, and maintain a high degree of 
molecular precision. In this thesis, two model (+) ssRNA icosahedral viruses 
have been interrogated, and specific mechanisms for capsid assembly and 
uncoating are proposed. The results described in this thesis suggest that 
common strategies may be utilised by this class of virus. 
 
In the case of STNV, the CP N-terminus is essential for capsid assembly81. N-
terminal deletion mutants of as little as 12 amino acids result in an assembly-
deficient protein81. In addition, the N-terminus of STNV CP is extremely 
proteolytically sensitive in disassembled VLPs, although STNV capsids are 
protease resistant. Cleavage occurs at residues close to the N-terminal helix, 
such that the N-terminal helix is removed. A known tryptic cleavage site has 
been identified at Arg28, which results in removal of the N-terminal helix80. 
Proteolysed STNV CP in this way is rendered assembly deficient. 
 
Many other viruses also contain basic N- or C-terminal extensions. In most 
cases, deletion or proteolysis of these extensions prevents capsid assembly of 
the correct architecture, although in some cases smaller sub-particles are 
assembled34; 144; 145; 146. Deletion of the first 31 amino acids from the N-terminus 
of FHV CP however, results in the formation of a variety of differently sized 
particles147. In contrast, deletion mutants of up to 20 amino acids in the N-
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termini of recombinant norovirus VLPs do not affect capsid assembly, although 
longer N-terminal deletion mutants abrogates assembly148.  
 
For these viral CPs with basic N- or C- termini, why assembly is perturbed by 
their removal could be due to multiple factors. In the case of viruses with a 
triangulation number greater than 1, the coat protein subunits must be able to 
exist in different conformations. To compose an icosahedral capsid, these 
conformations must be present at specific locations within the surface lattice, so 
as to designate curvature at the right locations. High resolution structural 
studies of these viruses show that differences between these conformers can 
be very subtle149. Most of these conformers involve the switching between an 
ordering and disordering of flexible regions in the coat protein at the N- or C-
terminus147. Truncation of N-terminal regions in TCV for example, prevents the 
formation of flat contacts between dimers, thus perturbing the formation of T=3 
particles, and initiating the production of T=1 particles.  
 
In the case of STNV, capsid assembly is dependent on the presence of RNA 
and full length STNV CP with an intact N-terminal helix. The positively charged 
N-terminal helix is therefore an obvious candidate in mediating important 
protein: RNA contacts that are essential for the formation of a T=1 capsid. The 
question was therefore asked, what is the nature of these protein: RNA 
interactions?81. In order to determine whether STNV packages RNA in a 
sequence-specific manner, SELEX experiments were performed using 
immobilised STNV CP, where RNA aptamers were directed against the RNA 
binding sites of the CP. Several RNA ligands were identified, which contained 
sequence similarity to portions of the STNV-1 genome. One of these aptamers, 
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B3, contained 16/24 matches, including a 10/10 contiguous stretch. Secondary 
structure predictions of these aptamers by MFold revealed that each aptamer 
could fold into stem-loop structures, each displaying the motif AXXA in the 
context of a 4, 5 or 6 nt loop. When the genomes of STNV-1, -2, and -C were 
analysed for potential stem loop structures based on the structures of these 
aptamers, around 30 stem-loops were identified for each of the genomes. Since 
there appears to be no single high affinity packaging signal present in the STNV 
genome, a series of stem-loops could be used to facilitate capsid assembly. 
Many RNAs will contain STNV binding sites by chance, thus accounting for non-
specific RNA packaging. However, genomic RNAs have an advantage over 
random RNAs since they contain multiple copies of this preferred binding motif, 
and at ideal spacings. Binding of STNV CP to multiple binding sites on a 
cognate STNV-C genome has been shown to trigger collapse of the RNA60. 
This collapsed state does not occur upon STNV CP binding to MS2 sub-
genomic fragments under the same conditions. Similar results were observed 
using the MS2 system in this lab, suggesting that viral CPs chaperone folding of 
their genomic RNAs through local CP interactions to multiple putative PSs60.  
 
Recently, SELEX experiments against TCV CP2 were performed by Gareth Platt 
under my joint supervision with Dr David Bunka, using material that I purified. 
Two libraries were produced, one n30 library and an n50 library. Preliminary 
analysis of these libraries has identified at least two significantly populated 
aptamer sequence families. Several of these align to multiple regions of the 
TCV genome, suggesting a similar scenario of packaging signals to STNV and 
MS2 (see Figure 6.1).  
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Figure 6.1: SELEX against TCV CP2 produced several hits from portions 
on the TCV genome.   
(a) Secondary structures of aptamers 
Preliminary analysis of SELEX has revealed two aptamer sequences with 
similar secondary structures to the known PS identified in Qu and Morris.  
(b) Matches to the TCV genome 
Sequence alignments of aptamers reveal regions of similarities in important 
regulatory regions, including CP start and stop codons. Figure courtesy of Dr 
Eric Dykeman. 
(a) 
 
(b) 
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The aptamers appear to be folded into secondary structures resembling the 
minimal assembly sequence previously identified in vivo by Qu and Morris33. 
The aptamers both contain regions of base-paired stems interrupted by two 
bulges, whilst displaying a purine-rich loop. The matches of the aptamers to the 
genome appear to be present in regulatory important regions. Such sites 
encompass the start and stop codons in the TCV genome, implying that TCV 
CP may bind to these sites to play important roles in translational repression, in 
an analogous manner to MS2. These results, although preliminary, further 
exemplify the exquisite control of capsid assembly, and demonstrate how 
different viruses may utilise similar mechanisms in their life cycles. 
 
Another example of how viruses may utilise similar mechanisms is in the 
process of uncoating. Many plant viruses share similar characteristics, both 
biochemically and structurally. In Chapter 5, a putative disassembly mechanism 
has been proposed for TCV. It is likely to be shared by other plant viruses, such 
as STNV80; 83; 84, SBMV135 and CCMV150, where divalent cations are used to 
stabilise their capsids. These calcium ions can be removed from these capsids 
in vitro by EDTA treatment, which mimics the conditions of the plant cell 
cytoplasm in vivo. In the plant cell, regulation of calcium ions is tightly 
controlled. Calcium ions in the plant cell are used as an intracellular messenger 
for signalling.  In plant cells, the intracellular calcium ion concentration is 
thought to be in the region of 100 nM, compared to 1 mM for magnesium ions84; 
151. Removal of calcium ions from the capsids of these viruses results in charge 
repulsion between negatively charged side chains, which usually results in 
expansion of the capsid shell and subsequent pore formation.  
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The expanded state has long been thought of as the first step in disassembly82. 
In the two model systems tested in this thesis, expansion produces particles 
that are sensitive to proteases. Proteolysis mediates the release of a subset of 
coat protein subunits from these particles, such that the remaining protein shells 
lose their icosahedral symmetry. These particles also appear to be extruding 
RNA at specific sites. In the case of TCV, when these particles are incubated in 
the presence of wheat germ extract, the formation of “striposomes”, which are 
thought to be polysomal arrays of ribosomes bound via thin tethers of extruding 
RNA, can be visualised by TEM. The formation of these striposomes suggests 
that ribosomes may be instrumental in the uncoating mechanisms of these 
viruses.  
 
The protrusions seen in EDTA and chymotrypsin-treated STNV VLPs suggest 
that this is a common uncoating strategy. Other plant viruses such as SBMV 
and CCMV have proteolytically sensitive N-terminal domains. It would be 
interesting to see whether these expanded virus particles contained similar 
protrusions when protease treated. Protease treatment of the coat proteins of 
SBMV and CCMV results in the production of a single product, indicating that 
the protein remains folded in a way that prevents other residues becoming 
accessible to protease digestion152; 153. These results are fully consistent with 
the uncoating mechanism described in Chapter 5 being ubiquitous for this 
family of plant viruses.  
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7. Future Work 
 Chapter 4 describes crystallisation of STNV VLPs packaged with TR and 
B3 short. These were crystallised in identical conditions to that of the 
wild-type STNV-1, recombinant STNV and STNV-B3 VLPs. However, a 
full data set could not be acquired from these crystals. If I had more time, 
I would purify these VLPs on a large scale and try different crystallisation 
conditions to generate nicely diffracting crystals so that full data sets 
(high and low resolution) could be obtained. From these data sets, it is 
hoped that an electron density map could be generated to visualise CP: 
RNA interactions in high resolution. 
 Chapter 4 also describes the formation of ‘half capsid’ intermediates. If I 
had more time, I would purify these species on a large scale and perform 
cryo-EM to generate a three-dimensional structure. I would also attempt 
to crystallise these species to see if they would diffract. To my 
knowledge, this would be the first capsid intermediate structure ever to 
be solved. 
 Chapter 5 describes how STNV VLPs undergo an extrusion event upon 
EDTA and chymotrypsin treatment. It would be interesting to see if these 
VLPs bind to ribosomes in an analogous manner to TCV if they 
contained a bona fide STNV genome. 
 In the general discussion, preliminary data from SELEX against RNA 
binding sites of TCV CP2 is discussed. Analysis identified several 
aptamers mapping the TCV genome at important regulatory regions. It 
would be interesting to see if these aptamers could initiate capsid 
assembly, and how efficiently each aptamer was able to initiate assembly 
relative to other RNAs.  
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9. Appendix 
 
On accompanying CD: 
 
Table 9.1: E. coli strain genotypes 
Figure 9.1: svAUC analysis of STNV CP under reassembly conditions 
Figure 9.2: Mass Spectrum of STNV CP 
Figure 9.3: Mass Spectrum for aptamer B3 
Figure 9.4: Mass Spectrum for B3 4U 
Figure 9.5: Mass Spectrum for B3 short 
Figure 9.6: Mass Spectrum for TR 
Figure 9.7: Sedimentation equilibrium AUC of STNV ‘half capsids’ 
Figure 9.8: Size exclusion chromatogram for STNV-TR VLPs 
Figure 9.9: Size exclusion chromatogram for STNV-B3 short VLPs 
Figure 9.10: SDS-PAGE of EDTA, chymotrypsin treated STNV VLPs 
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